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1  Introduction 
The redox equivalent obtained from the oxidation of NADH and FAHD2 are used for 
energy transduction and ATP synthesis in mitochondria. The most accredited theory 
on  the  evolution  of  mitochondria  is  the  endosymbiontic  theory  of  Margulis  (1), 
according to which mitochondria derive from a ʱ proteo-bacterium which established 
a symbiosis with a host cell. Some principles behind this theory were criticised, for 
example the exchange of ATP/ADP between host and and symbiont  (2), on the 
basis of mitochondrial DNA analysis, indicating this eventual exchange as unlikely. 
The  advantage  for  this  symbiosis  lies,  probably,  in  the  exchange  of  metabolic 
intermediates useful for the host, which could offer a protected environment to the 
simbiont, assuring advantages for both organisms. 
1.1  Function and structure of the respiratory chain 
By  oxidative  phosphorylation,  living  organism  can  transform  and  use  energy. 
Organic molecules, introduced with the diet or obtained from the storage of nutrients 
such  as  sugar  or  fat,  are  oxidized  by  glycolysis,  tricarboxylic  acid  cycle  or  β-
oxidation  to  obtain  FADH2 (flavin  adenine  dinucleotide)  and  NADH  (nicotinamide 
adenine  dinucleotide).  These  high  energy  nucleotides  are  oxidized  by  protein 
complexes resident in the inner mitochondrial membrane. By transferring electrons 
to  molecular  oxygen  and  reducing  it  to  water,  protons  are  pumped  across  the 
membrane,  generating a  proton gradient. The protein  complexes  involved  in  the 
electron transfer to oxygen are known as the aerobic respiratory chain. 
The chemio-osmotic theory of Peter Mitchell (3) describes how the proton gradient is 
generated across the inner mitochondrial membrane (and across the cytoplasmatic 
membrane in bacteria) and represents the basis for the production of ATP. 
The back flow of protons along the chemical gradient across the membrane is used 
by  the  last  complex  of the oxidative  phosphorylation  to  convert  ADP  (adenosine 
diphosphate)  to  ATP.  Little  is  still  known  about  the  exact  proton  pumping 
mechanism of each complex, whereas the electron transfer process seems to be 
better  understood.  Five  complexes  in  total  are  involved  in  the  oxidative 
phosphorylation,  highly conserved between bacteria and eukaryotes, not  only for 
their functions but also for their basic structure and composition. Introduction 
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The mitochondrial oxidative phosphorylation is situated in the inner membrane, and 
hosts five membrane-integral protein complexes. In the electron transfer process, 
also ubiquinol and a soluble cytochrome c operate as shuttles between complexes. 
As a result, protons are translocated into the intermembrane space generating the 
electro-chemical gradient which will be used by the last complex to regenerate ATP 
from ADP and inorganic phosphate. 
 
 
Fig. 1: Model for the mitochondrial respiratory chain. From the left, in dark blue the recently 
solved structure of complex I (taken from Thermus thermophilus; PDB: 3M9S, at present the 
only available structure for complex I). In light blue the structure of the mitochondrial complex II 
(PDB: 1ZOY). In red, the yeast complex III with bound cytochrome c in purple (PDB: 1KYO), and 
in green the mitochondrial cytochrome c oxidase (PDB: 1OCR). In pink, the structure of the 
mitochondrial ATP-synthase (PDB: 1QO1). The vertical gray arrows indicate the complexes able 
to  transfer  protons  across  the  membrane.  The  stoichiometry  is  not  represented  here.  The 
smaller arrows indicate reactions between the complexes. 
 
The first complex is the NADH:ubiquinone oxidoreductase, or complex I, made up of 
approximately 45 polypeptide chains with a molecular weight of more than one MDa 
(4).  It  catalyzes  the  oxidation  of  NADH  and  the  reduction  of  ubiquinol,  with  a 
stoichiometry of four protons per two electrons translocated to the intermembrane 
space. It has a very particular “L” shape, from which it is possible to identify at least 
two domains: a hydrophobic, transmembrane part and a hydrophilic arm which is 
protruding into the mitochondrial matrix. The latter includes the NADH binding site 
and all the cofactors (5-8), namely a non-covalently but tightly bound FMN (flavine Introduction 
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mononucleotide)  and  eight  iron  sulphur  clusters  (two  of  them  binuclear  and  the 
remaining  six  tetranuclear)  (9).  Recently  (5,  10)  crystal  structures  of  the  entire 
complex  I  have  been  obtained,  from  bacteria  and  mitochondria,  showing  a  very 
interesting feature, implicated in the mechanism. The quinone binding site is not 
embedded in the membrane as it was previously thought due to its hydrophobic 
nature, but it is in the peripheral arm, where the two domains come in contact to 
form the whole complex. In the membrane arm, typical features of ion antiporters 
are found which are considered to be involved in the proton pumping mechanism. 
From the quinone reduction site a conformational change is transferred through the 
transmembrane  domain  by  a  very  long  amphipatic  helix,  coming  in  contact  with 
discontinuous  helices  in  the  antiporter-like  subunits,  allowing  proton  pumping. 
Proton transfer coupled to the quinone electrochemistry is highly unprobable, since 
the binding site accommodates the substrate in the peripheral arm and not, as until 
recently believed, in the transmembrane part (6-8, 11).  
Complex II (succinate:ubiquinone oxidoreductase) (12, 13) works as an alternative 
electron entry point, since it can oxidize succinate to fumarate and use FADH2 as a 
cofactor obtained from the tricarboxylic acid cycle. The complex can be divided into 
two  groups  of  subunits:  two  hydrophilic  ones  facing  the  mitochondrial  matrix, 
containing  a  FAD  and  different  iron  sulphur  centers,  and  a  hydrophobic  one 
spanning the inner membrane, being the binding site for ubiquinone and inhibitors. 
This  is  the  only  complex  in  the  mitochondrial  respiratory  chain  that  transfers 
electrons without pumping protons. It allows, nevertheless, to re-oxidize FADH2 to 
FAD, which enters again the Krebs cycle. 
The  reduced  ubiquinol  in  the  membrane  is  the  substrate  for  the 
ubiquinol:cytochrome c oxidoreductase (complex III). This complex is composed of 
11  subunits,  and  is  a  homodimer  as  confirmed  from  the  analysis  of  different 
structures from several organisms (see 1.2). The redox cofactors included in the 
complex are a 2Fe-2S cluster, a cytochrome c1 and a cytochrome b containing two 
heme  groups  Its  function  is  defined  by  the  so  called  Q  cycle  mechanism,  first 
described by Peter Mitchell (14), by which two ubiquinol molecules are oxidized and 
one ubiquinol is regenerated. The product of the reaction is reduced cytochrome c, 
which works as an electron shuttle to cytochrome c oxidase.  
This last component, cytochrome c oxidase, is a homodimer in mitochondria and a 
monomer  in  bacteria  (15-18).  In  total,  four  electrons  have  to  be  transferred  to Introduction 
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oxygen to reduce it to water, with a mechanism which is still at present intensively 
discussed  and  studied,  since  the  different  catalytic  intermediates  are 
spectroscopically  distinguishable  (19).  Electrons  are  passed  sequentially  from 
cytochrome  c  to  the  CuA  center,  from  here  to  the  heme  a  and,  at  last,  to  the 
binuclear  center  heme  a3/CuB  where  oxygen  reduction  takes  place.  The  proton 
pumping activity starts when electrons are passed from heme  a to the binuclear 
center with a stoichiometry of one proton pumped per transferred electron. 
The  ATP-synthase  (20-24)  uses  the  backflow  of  protons  along  the  gradient  to 
regenerate ATP from ADP and phosphate. 
 
1.1.1  Paracoccus denitrificans as a model organism 
Paracoccus denitrificans is a gram negative bacterium belonging to the group of the 
ʱ-proteobacteria.  It  was  first  isolated  by  Beinjerinck  (25)  as  Micrococcus 
denitrificans,  being  able  to  anaerobically  convert  nitrate  into  molecular  nitrogen. 
Initially, P. denitrificans was the only member of its genus, but analysis of the 16S 
rRNA could show that other bacteria such as Thiobacillus versutus shared a high 
homology with P. denitrificans thus being included in the same taxonomic group (26-
29). All bacteria belonging to the genus Paracoccus have a high GC content in their 
genomic DNA, estimated between 60 and 70 %. In this work, the strain PD1222 was 
used,  whose  genome  sequence  was  published  in  2006  (30);  it  includes  two 
chromosomes (chromosome 1, 2.9 Mbp, Gene bank CP000489, and chromosome 2, 
1.7  Mbp,  Gene  bank  CP000490)  and  a  megaplasmid  (0.65  Mbp).  The  total  GC 
content is 67 % and 2799 protein-coding genes have been identified. 
The  endosymbiontic  theory  from  Margulis  (1)  discussed  the  origin  of  the 
mitochondrion and suggested it to be the development of an ancestral prokaryote 
having  a  respiratory  chain,  which  established  a  symbiosis  with  its  host,  a 
protoeukaryote. The host was a plastid free, amoeboid cell, which used fermentation 
for ATP production. By taking up the prokaryote, the host acquired the possibility of 
performing aerobing respiration. According to this theory, the outer mitochondrial 
membrane derived from the host, whereas the inner one shows a high degree of 
homology  with  present-day  bacteria.  In  this  process,  the  prokaryote  retained  its 
respiratory chain and altered the properties of its membrane, in order to adapt to the Introduction 
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new environment. The prokaryote  in question is often identified with  Paracoccus 
denitrificans (or other related bacteria), since the properties of its respiratory chain 
are quite close to mitochondria. For instance, the lipidic membrane composition, the 
use of ubiquinone 10, two b-type and two c-type cytochromes, the presence of an 
aa3  oxidase  and  sensitivity  to  rotenone  and  antimycin  A  find  correspondence  in 
mitochondria (27).  
Paracoccus  denitrificans  has  a  versatile  respiratory  chain:  there  are  also  two 
alternative  terminal  oxidases,  the  ba3  oxidase  (oxidizing  quinol)  and  the  cbb3 
oxidase  (with  high  affinity  for  the  substrate,  and  expressed  under  low  oxygen 
conditions). Other metabolic pathways are also available  (31), such as methanol 
and methylamine dehydrogenases, sulphur oxidation; moreover, also succinate can 
be used as an organic substrate and in anaerobic conditions nitrate can be used as 
an electron acceptor instead of oxygen. 
In  comparison  with  the  mitochondrial  complexes,  Paracoccus  denitirifcans 
respiratory complexes are smaller: complex I is made of 14 subunits instead of 45 
(32),  complex  III  only  three  instead  of  10  to  11  (33),  and  complex  IV  only  four 
compared  to  13  (34).  Moreover,  the  latter  is  a  monomer  and  not  a  dimer  (as 
observed in mitochondria). The catalytic subunits, nevertheless, present a very high 
homology  to  the  eukaryotic  ones,  while  the  accessory  subunits  are  missing 
completely.  
All  those  features  make  important  working  with  P.  denitrificans  as  a  model 
organismus, due also to the easy microbiological handling and to the accessibility to 
its genetic material. 
1.2  The cytochrome bc1 complex 
The  bc1  complex  (ubihydroquinone-cytochrome  c  oxidoreductase)  is  a  key 
component  of  several  aerobic  and  anaerobic  respiratory  chains.  It  is  not  only 
involved  in  the  electron  transfer  of  mitochondria,  but  plays  also  a  role  in 
denitrification  and  nitrogen  fixation.  It  belongs  to  the  bc  complex  family,  widely 
distributed  in  proteobacteria,  archea,  cyanobacteria  and  eukarya  (35).  In 
photosynthetic  organisms,  a  so  called  cytochrome  b6f  complex  is  found,  or 
plastoquinol-plastocyanin oxidoreductase. Several differences in comparison to the 
bc1 complexes have been noted. In the cytochrome b6f complex, cytochrome b is Introduction 
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not a single subunit but two, there is a different number of residues between the 
histidines coordinating the b hemes than observed in the cytochrome bc1 complex, a 
cytochrome  f  replaces  cytochrome  c1  and  the  genes  for  cytochrome  b  and  the 
Rieske  protein  are  present  on  separate genetic  loci  (36-39). The  b6f  complex  is 
involved in the electron transfer between the photosynthetic centers II and I. The 
following discussion will focus on features of the bc1 complex.  
The bc1 complex is a multi subunit enzymatic complex present in mitochondria in the 
inner  membrane  and  in  the  cytoplasmic  membrane  of  bacteria  (22,  39-47)  It 
catalyzes the oxidation of ubihydroquinone and the reduction of cytochrome c, which 
carries electrons to cytochrome c oxidase. The catalytic mechanism is described by 
an electron bifurcation reaction, in which one electron feeds into the high potential 
chain,  i.e.  Rieske  cluster  and  cytochrome  c1,  to  be  subsequently  passed  to 
cytochrome c, and the second electron is driven through the low potential chain (the 
two hemes b) to a quinone molecule from the Q-pool in the membrane. After two 
catalytic  cycles,  two  ubihydroquinone  molecules  are  oxidized,  one  ubiquinone  is 
reduced and two cytochromes c molecules are reduced.  
During the overall electron transfer process, protons originating from the oxidation of 
quinol are released on the positive side of the membrane (intermembrane space in 
mitochondria, or the periplasmic space in bacteria). Meanwhile, the re-reduction of a 
ubiquinone through the low potential chain leads to the uptake of protons from the 
matrix  (in  mitochondria,  respectively  the  bacterial  cytoplasm)  increasing  the 
electrochemical  gradient.  The  overall  reaction  of  the  bc1  complex  is  listed  in 
Equation. 1. 
red pos ox neg c cyt H Q c cyt H QH 2 4 2 2 2     
 
 
Equation  1:  Net  reaction  of  two  turnovers  of  the  cytochrome  bc1  complex.    QH2: 
ubihydroquinone;  Q:  ubiquinone;  Cyt cox/red:  oxidized/reduced  cytochrome c;  neg,  pos: 
negative/positive membrane side. 
1.2.1  Subunits of the cytochrome bc1 complex 
The  structural  genes  of  the  eukaryotic  complex  are  all  localised  in  the  nuclear 
genome, with the exception of the cytochrome b gene present on the mitochondrial 
genome.  Only  three  subunits  (namely  cytochrome  b,  cytochrome  c1  and  Rieske 
protein) contribute to catalysis directly, and the accessory subunits (up to eight in 
the bovine, four in the avian and seven in yeast complexes) have unclear functions Introduction 
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until now. (Section 1.2.1.4 will later discuss some features of the additional subunits.) 
These facts make studies of the mitochondrial complex more complicated than in 
bacteria, where the only three to four subunit are present and the structural genes 
are typically organized in a gene cluster within the genome. 
1.2.1.1  Cytochrome b 
Cytochrome b is a central subunits taking part in the catalytic cycle. It is composed 
of eight transmembrane helices spanning the membrane so that the N- and the C- 
termini both face the matrix side in mitochondria (the cytoplasm in bacteria). The 
eight helices, denominated from A to H, are organised in two bundles: the helices A 
to E coordinating the two cofactors, and helices F to H (48). Seven loops in total are 
present in the cytochrome b protein: four large loops and three small ones. The 
large loops are ab, cd, de and ef. Of them, the de loop is the only one facing the 
matrix side and lacking a clear secondary structure, whereas the the ab and ef loops 
form a single helix each. The cd loop consists of two helices organized in a hairpin 
like arrangement, cd1 and cd2. The two helix bundles make contact on the matrix 
side and diverge then into the intramembrane space to form the Qo pocket where 
ubiquinol is oxidized. The ISP docks on cytochrome b on the so called ISP docking 
cavity, on the positive side of the membrane. The Qo site is delimited by helices B, C 
and E and buried by the ef loop, capped by the cd1 and cd2 helices on top (49). 
When the ISP is bound transiently on cytochrome b for catalysis, the His
161 (bovine 
numbering), ligand of the iron sulphur cluster, also contributes to the Qo site (48-56).  
Helices B and D coordinate the two cofactors in cytochrome b: the heme bL (low 
potential)  and  the  heme  bH  (high  potential).  The  names  for  the  two  hemes  are 
derived from their redox potential properties: about 30 mV and 120 mV, respectively, 
as shown by potentiometric titrations (57). The hemes are coordinated by two His 
residues each, and along with four Gly residues in close contact with the heme ring, 
are extremely conserved among several organisms (39, 49, 58). It is interesting to 
note that the two  bL  hemes in the dimeric complex are in close distance: in the 
bovine structure (49, 52) and in the avian structure (55) the distance between the 
two iron atoms is 21 Å and 20.7 Å respectively. The edge to edge distance is about 
14 Å, as calculated for the yeast complex (59). This would allow electron transfer 
between  the  two  monomers,  as  reported  already  (60-62)  and  analyzed  and 
confirmed later in this work (63).  Introduction 
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A second quinone binding pocket is present in cytochrome b, the Qi site, formed by 
helices A D and E with contributions from the small loop a preceding the first helix 
(64),  where  the  ubiquinone  binds  to  be  reduced,  after  two  catalytic  cycles,  to 
ubihydroquinone. 
Cytochrome  b  is  a  major  binding  site for  inhibitors,  which  have  historically  been 
divided into two classes: class I for the Qo site inhibitors and class II for the Qi site. 
The first class was again divided into three subgroups: Ia for compounds containing 
a  β-methoxyacrylate  group  such  as  MOA-stilbene  and  myxothiazol,  Ib  for  the 
inhibitors having a chromone ring such as stigmatellin, and Ic for hydroxyquinone 
analogues  such  as  5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole  (UHDBT).  This 
subdivision was based on effects these different inhibitors exerted on the complex: 
the first group was characterized from a red-shift in the bL spectrum, the second 
from an increase in the redox potential of the ISP and the spectral red-shift, and the 
third only for a slight change in the redox potential of the ISP. 
According to Esser et al. (48) a new classification should be considered: class P for 
the Qo site inhibitors, class N for the Qi site and class PN for those molecules (i. e. 
NQNO) able to bind on both pockets. The class P should be then again divided into 
Pf for the inhibitors able to block the movement of the ISP globular domain, and Pm 
for the ones displacing it away from cytochrome b, according to the informations 
gained from the crystal structures. The new classification is summarized in Table 1. 
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Table 1: Classification of the bc1 inhibitors. UHDBT: 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole; 
MOAS: methoxyacrylate stilbene; MOA: methoxyacrylate; NQNO: 2-n-nonyl-4-hydroxyquinoline N-
oxide (adapted by Esser et al.(65). 
 
In this work, stigmatellin, JG-144, mixothiazol and MOA-stilbene have been used to 
investigate the response of the iron sulphur protein (ISP) head domain. Stigmatellin 
binds  at  the  Qo  site,  and  hydrogen-bonds  the  Glu
272  (bovine  numbering)  of  the 
conserved  PEWY  sequence  (also  involved  in  the  interaction  with  the  substrate 
quinol,  (66,  67))  and  the  His
161  (bovine  numbering)  of  the  ISP  (68,  69).  The 
hydrogen bond is most likely what fixes the head domain in the  b conformation, 
since other Pf inhibitors (such as JG-144) are not able to completely inhibit the ISP 
movements (see 1.2.1.2) (70). Mixothiazol and MOA-stilbene are both Pm inhibitors, 
sharing the same binding pocket at the Qo site. Both hydrogen-bond the Glu
272 as all 
the methoxyacrylate containing inhibitors (48, 71-73). Both molecules diminish the 
occupancy of the ISP head domain to the surface of cytochrome b (48, 74). 
1.2.1.2  The Rieske iron sulphur protein (ISP) 
The  iron  sulphur  protein  is  inserted  in  the  membrane  by  the  TAT  translocation 
machinery (75). The signal sequence is N-terminal, and even if cleaved off from the 
mature  subunit  it  stays  in  the  bovine  complex  as  an  accessory  subunit,  strictly 
associated with the two core subunit on the matrix side (49, 52, 53).  
A high resolution structure (1.5 Å) was obtained by Iwata et al. (76), where only the 
globular domain of the bovine ISP (residues 68-196) obtained by proteolysis by Link 
Class  Sub-
group 
Examples  Structural features  ISP position 
P  F  Famoxadone 
stigmatellin 
UHDBT 
Benzoquinone 
analogues having a 
planar active group 
ISP forced into a 
fixed 
conformation 
                      M  Myxothiazol  
MOAS 
azoxystrobin 
Containing a 
common MOA 
moiety 
ISP in mobile 
conformation 
N    Antimycin A  Planar active group  No effect 
PN    NQNO 
funiculosin 
Planar active group  ISP in fixed 
conformation Introduction 
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et al. (77) was described. The overall fold is made up by three layers of antiparallel 
β-sheets, and an ʱ-helix followed by a long loop between the sheets β3 and β4. The 
globular domain is connected to a transmembrane helix, anchoring the subunit to 
the membrane. The β-sheets 1-2 and 2-3 form two sandwiches, the latter housing 
the cluster in the so called cluster binding fold, highly conserved. The Rieske cluster 
2Fe-2S is coordinated by two Cys and two His residues: the Fe1 is ligated by the 
Cys
139 and Cys
158, and Fe2 by His
141 and His 
161. Two more conserved Cys residues 
form a disulphide bridge (78) which is important for the stabilisation of the cluster: 
loss of one of those residues leads to the loss of the cluster. Another loop is also 
important in this respect: the Pro loop (residues 174-177), Gly-Pro-Ala-Pro, needed 
for the correct cluster insertion and positioning. 
The overall stability of the cluster is further ensured by a network of hydrogen bonds 
with residues belonging to the base fold. The typical consensus sequence for the 
binding of the cluster is Cys-X-His-X15-47-Cys-X-X-His. Even if the overall structures 
are  quite  different,  almost  all  residues  involved  in  the  cluster  binding  and 
stabilisation are extremely conserved. The metal binding domain is similar to the 
one of rubredoxins (76), small electron transport proteins with Fe atoms coordinated 
by four Cys residues. The coordination of the Fe1 and the sorrounding of the cluster 
itself share a high degree of similarity with the aforementioned proteins. The Rieske 
cluster in the hydroquinone oxidizing bc1 complexes has a higher redox potential  
(~ 300 mV) compared to the one of other menaquinone oxidizing complexes and of 
plant  ferredoxins.  This  difference  is  due  to  several  factors,  such  as  the  overall 
charge of the cluster, its solvent exposure (since just the liganding histidines are 
shielding it from the solvent environment), the nature of the ligands (since histidines 
are more electronegative than the sulphur atoms coordinating the cluster in plants 
ferredoxins) and the strong hydrogen bond pattern (56, 76, 79-81). The higher redox 
potential of the cluster has implications for quinol oxidation and the catalytic cycle, 
avoiding two electrons to short circuit in the same turnover and flow into the high 
potential chain (see paragraph 1.2.4.1).  
The redox potential of the Rieske cluster is also pH dependent: in the studies on the 
water soluble ISP fragment (76) increasing the pH from 5 up to 10 gave a drastic 
change  in  the  Em  values.  With  electrochemical  experiments,  two  residues  were 
found  responsible  for  this  dependency,  being  identified  with  the  two  liganding 
histidines (56, 68, 82-84). No other residue in the proximity of the cluster is likely to Introduction 
11 
undergo  redox  dependent  deprotonation.  No  conformational  changes  were 
observed in the overall ISP structure. The His
161 (bovine numbering) is thought to 
deprotonate the semiquinone to yield the correspondent anion. This implication will 
be further analysed in the section 1.2.4.1. 
Several mutations were tested on the cluster and the sorrounding residues in order 
to  study  the  properties  of  the  cluster  itself  and  gain  information  on  the  electron 
transfer mechanism of the bc1 complex. From these studies it was concluded that 
the hydrogen bond network is extremely important not only for the stability of the 
subunit and indirectly of the complete complex but also for the redox potential (85). 
Moreover, it could be stated that the position Ser
183 (bovine numbering) is important 
not only for being a part of the hydrogen bonding network, but also for the correct 
insertion of the cluster in the apoprotein which can affect inhibitor binding on the Qo 
and Qi sites (86).  
An important feature of the ISP is its movement: from the crystal structures obtained 
by different groups (50, 51, 55, 65, 87, 88) it was observed that the head domain of 
the iron sulphur protein assumed different positions. Iwata et al. (49) indicated that 
the subunit could have three different states: the “c1 state”, the “intermediate state”, 
and the “b state”. The three states reflect different positions of the head domain and 
the neck region. Contacts with cytochrome c1 and the ef loop of cytochrome b were 
recorded, mostly van der Waals interactions apart from the hydrogen bond between 
the propionate of heme c1 and the His
161, the latter thought to allow fast electron 
transfer. In the intermediate state, the distance Rieske-cytochrome c1 and Rieske-
cytochrome b is similar, as calculated from the crystal structures, and no specific 
interaction  between  the  subunits  was  observed.  No  more  contacts  are  visible 
between cytochrome c1 and ISP head domain at all, while there are now hydrogen 
bonds  with  cytochrome  b  (ISP  Lys
90  with  cytochrome  b  Asp
171)  and  extensive 
contacts with the ef loop. In the b position, obtained in presence of stigmatellin, the 
ISP head domain is fixed close to the cytochrome b, not allowing electron transfer in 
the high potential chain, not only for the long distance to cytochrome c1, but also for 
the hydrogen bond connecting the His
161 to the inhibitor molecule, simulating the 
situation in presence of semiquinone. Zhang et al. (88) named the relative positions 
of the ISP as “proximal” and “distal”, respectively corresponding to the “b” and the 
“c1” positions described by Iwata (49). Introduction 
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The movements of the head domain of the ISP are due to the flexibility of the so 
called hinge region, residues 63-72 in the bovine complex. The overall structure of 
the  head  domain  does  not  change  when  it  moves,  therefore  the  neck  appears 
flexible and lets the domain swing. Several studies were performed using random 
and directed mutagenesis on the region in order to assess the criteria regulating the 
movements. The first studies indicated that the flexibility is more important than the 
length (89, 90), showing that reducing the flexibility diminished the activity of the 
complex of about 70% compared to wild type. Later, Darrouzet et al. (91) indicated 
that no single residue is strictly necessary in the hinge region: all the residues in the 
sequence  could  be  changed  individually  without  particular  loss  of  activity. 
Diminishing  the  length  of  the  region  brings  a  loss  of  activity,  but  it  does  not 
completely inhibit the complex, which indicates that the neck region is extremely 
flexible  and  still  able  to  let  the  head  domain  move.  Other  studies  in  yeast  (92) 
showed that residues deletion doesn´t produce drastic consequences, but insertion 
of single amino acids is not tolerated, since brings to improper fold of the subunit 
and therefore total loss of enzymatic activity. 
1.2.1.3  Cytochrome c1 
The cytochrome c1 receives electrons from the ISP in the bc1 complex and transfers 
them to the acceptor cytochrome c. It is structurally composed of a transmembrane 
helix with the C-terminal extension in the mitochondrial matrix (or cytoplasmic side in 
bacteria) and a N-terminal globular domain. Cytochrome c1 is made up of 7 helices 
(6 in the globular domain) and a double stranded β-sheet. Three helices (namely ʱ1, 
ʱ2 and ʱ3) are conserved in all class I cytochromes c in general, and also very well 
conserved  in  this  subunit.  A  tripetide  Pro-Asn-Leu  (present  in  mitochondrial 
cytochromes c) starting from residue 111 in the aforementioned structure is another 
typical sequence, where the Pro provides a hydrogen bond for the heme liganding 
His (49). The structure of the globular domain, compared to the one of cytochrome c, 
presents some insertions and deletions, underlying the different functions of the two 
proteins and also reflecting the different interaction partners (ISP for cytochrome c1 
and complex IV for cytochrome  c). The globular  domain houses a  c-type heme, 
covalently bound by thio-ether bonds to Cys
37 and Cys
40 (bovine numbering) present 
in  the  typical  consensus  sequence  CXXCH.  The  heme  iron  is  coordinated  by 
residues His
41 and Met
160, and one of its propionates makes a salt bridge with His
161 Introduction 
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of  the  ISP  when  the  latter  is  in  the  “c1  position”.  The  N-terminal  sequence  of 
cytochrome c1 is in close contact with subunit 8, also called the hinge protein, rich in 
acidic aminoacids (47, 93, 94) (about the function and features of subunit 8, see 
section 1.2.1.4). 
1.2.1.4  Accessory subunits 
In  the  bovine  crystal  structure  some  additional  subunits  are  presents,  whose 
function is not yet clear. Some insights have been gained for the subunits Core I and 
Core II, subunit 8 (the hinge protein) and subunit 9 (signal sequence cleaved off the 
mature ISP). 
Core I und Core II 
The two core subunits face the matrix of the mitochondrion and they are members of 
the MMP family (membrane metallo-proteins), indicating that the bc1 complex may 
be  bifunctional  and  also  involved  in  mitochondrial  protein  processing.  The  MMP 
family members are heterodimers made up of an ʱ and a β monomer, and located in 
the mitochondrial matrix. The first monomer is involved in recognizing and binding 
the signal sequence, and the second one contains the metal binding site. The core 
proteins II and I are respectively homologues to the ʱ and the β monomers, and 
dependent on Zn
2+ for the catalysis. After purification, the bc1 complex shoes no 
cleavage activity anymore (49, 52, 95) 
Hinge-Protein 
It plays a role in the correct transient complex formation between cytochrome c1 and 
cytochrome  c  (see  paragraph  1.2.3).  It  is  also  known  as  acidic  protein,  since  it 
contains  24  acidic  residues  out  of  78  in  total.  It  is  composed  of  two  helices 
connected  by  a  disulphide  bridge,  and  together  with  cytochrome  c1  forms  a 
negatively charged docking position for the highly basic cytochrome c (96-98) 
Subunit 9 
Subunit 9 represents the N-terminal signal sequence of the ISP after the cleavage 
by the two core subunits. It is 78 amino acids long and contains two β-sheets, of 
which the one on the C-terminal side is in close contact with the N-terminal domain 
of the core II. This seems to be essential for the recognition by the core subunits of 
the  cleavage  site  on  the  ISP.  After  cleavage,  this  peptide  remains  with  the  bc1 Introduction 
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complex as an additional subunit, but no specific function could be identified until 
now. 
1.2.2  The cytochrome bc1 complex from P. denitrificans  
The cytochrome bc1 complex from Paracoccus denitrificans is composed only by the 
three redox active subunits (33, 99-101). The three subunits form a minimal complex, 
if compared with the 11 subunit mitochondrial complex.  
1.2.2.1  Genetic organization 
The genes coding for the proteins in the bc1 complex are present in the fbc operon 
localised  on  the  chromosome  1,  containing  the  fbc  F,  fbc  B  and  fbc  C  genes, 
respectively  coding  for  the  ISP,  cytochrome  b  and  cytochome  c1.  The  structural 
genes are most likely transcripted in a polycistronic mRNA, since they are separated 
only by short sequences of 10 to 12 nucleotides, where Shine-Dalgarno sequences 
are present for ribosome binding (102). 
1.2.2.2  Protein subunits 
Cytochrome b contains 440 amino acids and has a calculated molecular weight of 
~51 kDa. On SDS PAGE, the subunit shows an apparent molecular weight of about 
45 kDa. Also the bacterial cytochrome b subunit has eight transmembrane helices 
and the two b-type hemes. The sequence homology with other organism (such as 
those of the Rhodobacter group, and the mitochondrial one as well (27, 103) is very 
high, once again pointing towards the use of P. denitrificans as a model oganismus. 
The ISP shows the properties similar to Rieske proteins from other bc1 complexes. 
In P. denitrificans, it has 190 amino acids and a molecular weight of about 20 kDa. 
The cytochrome c1, the last gene on the operon sequence, has a feature that is 
found neither in other bacteria nor in the eukaryotic complexes. The protein can be 
divided into three domains, as shown in Fig. 2. 
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Fig.  2:  Top,  the  fbc  operon  from  P.  denitrificans,  schematic  view.  Bottom, 
representation of the three domains in the cytochrome c1 gene product. 
 
The  N-terminal  domain  is  unique:  it  has  a  very  peculiar  composition,  between 
residues 46 and 197. Following a 24 residue N-terminal signal sequence which is 
cut to obtain the mature protein, a fairly monotonous stretch of 150 amino acids can 
be  identified,  composed  of  40  %  Ala,  14  %  Pro  and  38  %  negatively  charged 
residues (mostly Glu), arranged in a specific fashion so that tandem repeats of the 
sequence APA EEA AAE EAP AE and the repetition of the trimer PAA are found. No 
positive charge is found in the so called “acidic domain” (Fig 3). 
 
 
Fig. 3: Cytochrome c1 amino acid sequence from P.denitrificans. In blue the tandem 
repeats and in red the PAA trimer. In bold, the signal sequence.  
 
The mature subunit has a molecular weight of about 45 kDa, but on SDS PAGE 
shows an apparent molecular  weight  of 60-68 kDa, according to the percentage 
used for the acrylamide gel. This behaviour could be due to an anomalous binding 
of SDS on the acidic domain during the denaturation step before the gel run, as 
described by Rath et al.(104, 105). 
The acidic domain has no homology to any of the other bc1 complexes known, but 
resembles the small acidic subunit found in the eukaryotic complex, the so called 
“hinge  protein”  in  the  bovine  complex  (98,  106)  and  its  equivalent  in  yeast,  the 
QCR6p (97, 107, 108). In the section 1.2.3 the interaction between cytochrome bc1 
and cytochrome c will be addressed.  Introduction 
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Some years ago, a deletion mutant missing the acidic domain in the fbc C gene was 
obtained by E. Gerhus in our lab (109). By XhoI/ NotI restriction and subsequent 
ligation the domain was deleted, but this brought several problems in the purification 
procedure.  The  wild  type  complex  is  normally  purified  by  anion-exchange 
chromatography  since  the  acidic  domain  rich  in  negatively  charged  aminoacids 
binds  quite  strongly  on  the  column.  The  deletion  caused  the  loss  of  this  highly 
charged domain, and therefore the classical purification procedure could no longer 
be  followed.  During  my  diploma  thesis  (110)  I  introduced  at  the  C-terminus  of 
cytochrome  b  a  10X  His  tag  to  allow  purification  by  affinity  chromatography,  
Ni
2+-NTA,  and  succeeded  in  obtaining  a  pure  complex  further  used  for 
characterization. At the same time, in collaboration with the group of Prof. Carola 
Hunte,  Thomas  Kleinschroth  obtained  crystals  of  the  deletion  mutant  and  could 
define the structure (manuscript submitted, Fig. 4).  
 
. 
Fig.  4:  Structure  of  the  deletion  mutant  of  the  bc1  complex  from  Paracoccus 
denitrificans: the left monomer highlights the cofactors and the stigmatellin molecule 
used in the crystallization, the right monomer shows the three subunits in their -
traces.  In  yellow  the  ISP,  in  red  the  cytochrome  b  and  in  blue  the  cytochrome  c1 
(Kleinschroth et al., manuscript submitted).  Introduction 
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1.2.3  Interaction between the cytochrome bc1 complex and the 
substrate 
Extensive  studies  have  been  performed  on  the  yeast  complex,  and  the  protein 
crystallized with both cytochrome c isoforms bound on the cytochrome c1 (93, 94, 
111). The Qcr6p subunit has 79 % acidic residues on its N-terminal part, which is 
also interacting with cytochrome c1. In the high resolution structure with the isoform 
1  about  40  residues  cannot  be  defined,  indicating  that  this  domain  has  a  large 
degree of mobility. A similar result was obtained by Iwata et al. (49) in the bovine 
enzyme: the first 14 amino acids, mainly Glu, could not be assigned on the structure. 
The subunit is involved in the interaction with cytochrome c. Several groups (96, 98, 
107, 112) indicated that the loss of the acidic subunit leads to a reduction of the 
cytochrome c reductase activity. Other studies (108) indicated also the involvement 
of  the  acidic  subunit  in  the  half-of-the-sites  mechanism.  Interestingly,  the  yeast 
structure  (111)  gave  no  indication  for  interactions  occurring  between  Qcr6p  and 
cytochrome c at 1.9 Ǻ resolution. In the bovine complex, it was speculated that the 
missing N-terminal domain of subunit 8 could form a negatively charged docking site 
for the basic cytochrome c (49).  
Hunte  et  al.  (94,  111,  113,  114)  defined  the  binding  domain  and  properties  of 
isoform 1 cytochome c for the yeast complex. The past literature demonstrated that 
the  interaction  between  the  two  proteins  was  governed  by  the  ionic  strength. 
Interestingly, only two short range weak interactions, peripheric to the interaction 
site,  are  visible  (Glu
235  and  Lys
92,  and  Ala
164  backbone  oxygen  and  Lys
85, 
respectively  on  the  complex  and  cytochrome  c),  and  two  more  were  envisaged 
being  mediated  through  water  molecules.  The  residues  involved  in  those 
interactions are highly conserved, suggesting in any case an important role for the 
ionic interaction between the two partners.  
The  contact  area  between  cytochrome  c  and  the  bc1  complex  in  yeast  is  quite 
hydrophobic: the interaction is mediated by non-polar residues around the heme 
crevices on both poteins (Ala
103 and Ala
87, Met
233 and Arg
19, Phe
230 and Thr
18, Ala 
168 
and Val
34, and Phe
230 and Arg
19 respectively on the bc1 complex and cytochrome c), 
the latter being a cation π interaction (114). The two hemes are quite close to each 
other and no residue is likely to be involved in the electron transfer reaction, strongly 
suggesting  a  direct  heme-to-heme  electron  exchange.  The  definition  of  the 
interaction area between the proteins lead to the hypothesis of a two-step model, Introduction 
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also applicated to the interaction plastocyanin-cytochrome b6f (115) in which the two 
protein partners are directed to each other by long range electrostatic interactions so 
that the encounter happens in a directed fashion, maximizing the probability of a 
successful  collision  between  them,  and  hydrophobic  short  range  interactions 
stabilize the complex allowing electron transfer (111, 114, 116-118). The short range 
ionic interactions are quite weak, and no water molecule mediates the binding of 
cytochrome  c  on  the  enzyme,  indicating  the  presence  of  a  transient  complex 
formation  required  for  efficient  electron  transfer.  The  surface  of  cytochrome  c  is 
highly  hydrated,  possibly  indicating  that  water  molecules  can  have  a  role  in 
destabilizing  the  interaction  between  the  two  proteins  and  help  the  release  of 
cytochrome c (114). The acidic subunit is believed to regulate the interaction with 
cytochrome c1 so that the two proteins come close to each other in an orientation 
suitable for  electron transfer,  therefore  enhancing the  probability  of  a successful 
collision. 
Using  a  ruthenium  photoexcitation  technique  the  electron  transfer  between 
cytochrome c1 and cytochrome c in the bovine complex was measured, and once 
again the two step model could be confirmed (119). The results indicated that at low 
ionic strength the proteins formed a complex which showed intracomplex electron 
transfer with very high rates. Increasing of the ionic strength makes the process 
diffusion-limited with the long range interactions directing the partners towards each 
other  so  that  the  interaction  between  them  allows  a  successful  electron  transfer 
event,  and  a  further  stabilisation  of  the  transient  complex  by  short  range 
hydrophobic interaction. The electron transfer rate measured was 6.0 * 10
4 s
-1, three 
orders of magnitude slower than the rate calculated from the structural data, which 
was explained by the presence of the ruthenium derivative on the cytochrome c. 
Studies  on  the  Rhodobacter  sphaeroides  complex  revealed  no  intracomplex 
electron  transfer,  but  a  very  important  role  of  the  acidic  residues  found  on  the 
cytochrome c1 subunit. 
Previous  investigations  in  our  group  (118),  analyzing  soluble  fragments  of  the 
interaction  partners,  confirmed  the  two  step  model  and  revealed  that  the  acidic 
domain  in  Paracoccus  denitrificans  cytochrome  c1  is  not  directly  involved  in  the 
electron transfer process, as no difference in the electron transfer reaction between 
the wild type and the domain deletion mutant was observed. It must be noted that 
the  soluble  fragments  have  a  higher  degree  of  diffusion  and  mobility  in  the Introduction 
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measurements  than  the  membrane-bound  counterpart,  which  more  closely 
represent the situation found in the membrane-embedded complex. However, this 
should not change the way the two proteins interact, giving hints on the kind of 
forces coming into play. The interaction between cytochrome c1 and its partners will 
be further analyzed in the section 1.2.3 
1.2.4  Cytochrome bc1 complex mechanism 
The mechanism by which the bc1 complex is able to couple electron transfer and 
proton  pumping  is  widely  accepted  nowadays,  and  has  become  known  as  the 
“modified Q cycle”. In the beginning, Peter Mitchell proposed the first version of the 
Q cycle, which could not take into account all the structural informations we have 
now (14).  
With the information gained from the high resolution crystal structures in the second 
half of the 1990’s, several models could be postulated, all of them sharing the same 
idea: electron transfer is bifurcated at the Qo site, to lead to the high-potential chain 
to cytochrome c1, and over the low-potential chain to a quinone molecule which is 
then fully reduced in two turnovers (120). How the bifurcation happens, what the 
mechanism of quinol oxidation is, how any shortcircuit reaction could be avoided 
and the ways by which protons are transported are a matter of debate, and several 
groups proposed different ideas. 
1.2.4.1  The modified Q-cycle 
The ubiquinol oxidation in the Qo site funnels electrons into two separated pathways: 
one electron is transferred to the ISP docked in the proximal position, and after the 
head domain moves in direction of the cytochrome c1 this electron reduces the c1 
heme. Cytochrome c docked to the complex receives the electron and dissociates. 
The second electron from the ubyhydroquinone is delivered into the low potential 
chain, to the bL heme, and from here to the bH to the Qi site, where a ubiquinone 
molecule is reduced in two steps to ubihydroquinone and released into the Q-pool. 
The oxidation of two ubihydroquinone molecules at the Qo site releases four protons 
into  the  positive  side  of  the  membrane,  whereas  the  reduction  of  one 
ubyhydroquinone subtracts two protons from the matrix side, by this producing an 
electrochemical gradient (Fig. 5). 
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Fig. 5: Schematic representation of the Q cycle: quinol and quinone (from the Q-pool, 
black arrows) are oxidized and reduced respectively at the Qo and the Qi site. After 
quinol oxidation, one electron is transferred to the FeS cluster in the ISP (green), and 
from here to the cytochrome c1 (blue) and to the electron acceptor, cytochrome c. The 
second electron from quinol oxidation goes into the low potential chain, to the two b 
hemes in cytochrome b (yellow) to finally reduce, in two turnovers, quinone to quinol. 
During the cycle, four protons are transferred to the intermembrane space, and two 
protons  are  taken  up  from  the  matrix  for  quinone  reduction.  The  orange  arrows 
indicate the electron transfer steps, while the blue ones the proton transfer across the 
membrane. 
1.2.4.2  Quinol oxidation at the Qo site 
The electron bifurcation is essential for the coupling of proton pumping. The second 
electron  coming from quinol  does  not  enter  the  high  potential  chain  even  in  the 
complex  inhibited  by  antimycin  (120)  and  it  can  therefore  be  stated  that  the 
bifurcation is obligatory for the complex.  
Until now, it was not possible to obtain a structure with a quinol molecule bound at 
the Qo site, since all the complexes were crystallized with inhibitors. In the native 
complex without inhibitors, is not possible to identify clearly the ISP head domain 
since its mobility makes the electron density not unequivocal enough. An important Introduction 
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information gained from the structures is the hydrogen bonding occurring between 
the ISP and stigmatellin which is thought to stabilise the binding of the substrate 
(121-123). In this case, stigmatellin would be considered as a quinone intermediate 
bound at the Qo site, since the ISP is reduced when stigmatellin is bound and stays 
docked in the proximal position.  
Some  groups  (83,  122,  124-126)  could  identify  the  typical  EPR  signal  of  a 
semiquinone in the complex, identifying it with a semiquinone bound at the Qo site 
as an intermediate of the quinol oxidation. This led to the hypothesis of the so called 
“double  occupancy”  models,  which  proposes  that  the  Qo  site  can  accommodate 
more than just one quinol molecule. According to Ding et al. (124), there are two 
binding sites for quinol, Qos and Qow, to indicate a strong and a weak affinity for the 
substrate. In this way, the two quinol molecules necessary for a complete reduction 
of quinone at the Qi site are already present at the Qo site, and no exchange with the 
Q-pool is needed. According to Brandt (122) in the Qos site, a prosthetic quinone 
binds, and the quinol binding at the Qow site works as the “real” substrate. The latter 
would  be  deprotonated,  and  a  symproportion  share  the  two  electrons  of  the 
substrate with the Qos bound quinone, so that two semiquinone radicals could be 
produced each of them serving as electron donor for the bL (Qow) and the ISP (Qos). 
A different vision of the double occupancy model (73) proposes that only one quinol 
is present in the Qo site but able to move between the proximal and distal pockets 
and deliver electrons to the ISP and to the cytochrome bL, ensuring the bifurcation of 
electrons.  
Another mechanism proposed for the  bc1 complex is the so called “proton-gated 
affinity  change”  mechanism  (56),  according  to  which  after  deprotonation  of  the 
quinol the anion binds one of the liganding histidines of the ISC, and transfers the 
electron to the Rieske center. After being reduced, the ISP would have a high affinity 
for the semiquinone remaining in the proximal position and transferring the second 
electron obligatorily to the  bL  heme. This way, the bifurcation of the electrons is 
maintained, and also provides an explanation why the redox potential of the ISP is 
higher  than  the  one  of  cytochrome  c1  is  given.  This  would  guarantee  that  after 
reduction  of  the  ISC  the  electron  stays  on  the  Rieske  cluster  instead  of  being 
transferred to the cytochrome c1, so that the second electron coming from the quinol 
is forced to enter the low potential chain. Introduction 
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Recently,  from  observations  derived  from  the  structures  and  from  site-directed 
mutagenesis, a new mechanism has been proposed, which is also supported by 
kinetic studies. Two residues are thought to be important in the substrate recognition: 
the Ile
166 and the Pro
270 (bovine numbering) on cytochrome b, the first in the cd1 
helix  and  the  second  in  the  highly  conserved  PEWY  sequence. The first  one  is 
involved  in  binding  to  each  inhibitor  until  now  seen  in  structures  (48),  and  the 
second is hydrogen bonding the quinol in the Qo site. In this model, the ISP head 
domain is constantly scanning the docking position on the cytochrome b, but is not 
fixed in any position (as observed from the structures where inhibitors are bound). 
Upon binding of the substrate in the Qo site, the two residues would sense it and the 
cd1  helix  move,  opening  up  the  docking  site  for  the  ISP  on  cytochrome  b.  The 
Rieske protein is now able to dock on the proximal position. Almost simultaneously, 
the second electron enters the low-potential chain, since the reduced ISP is still in 
the  b  position  and  the  electron  cannot  be  transferred  to  cytochrome  c1.  As  the 
electron from the bL is passed to the bH heme, only then the ISP is free to move and 
deliver its electron to the cytochrome c1 (70, 127). 
The bifurcation is guaranteed by the fixed position the ISP has in the reduced state, 
and the completion of the electron transfer to the bH heme closes the conformation 
of the cd1 helix to set the ISP free to move towards the cytochrome c1. The model is 
supported by the experiments of Zhu et al. (128) where it is shown by stopped-flow 
that the rate of electron transfer from quinol to the ISP and from quinol to the bL is 
the same, and therefore the electron transfer to the high- and low-potential chain is 
thought to occur simultaneously, without the formation of a semiquinone anion at the 
Qo site. Other groups (127, 129, 130) support with their experiments the concept 
that the movement of the ISP happens after electron transfer events in cytochrome 
b have taken place  
The semiquinone in the Qo site was discussed for long time. It is necessary for the 
double occupancy models, either with two or just one quinone in the binding pocket, 
and some groups (131, 132)claimed to have registered an EPR signal attributed to 
the Qo site. A semiquinone has also been postulated by Link et al. (56), but this 
would be not detectable since it is electronically coupled with the ISP and therefore 
EPR-silent.  In  other  studies,  a  highly  unstable semiquinone  would  be  transiently 
present in the Qo site, but be almost immediately oxidized to quinone and therefore 
having  a  concentration  too  low  to  detect  (73).  A  semiquinone  anion  is  certainly Introduction 
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dangerous  for  the  complex,  since  it  can  rapidly  react  with  oxygen  and  create 
reactive oxygen species (ROS). Therefore, a more attractive hypothesis would be a 
simultaneous oxidation of the substrate, to avoid side reactions. More recently, it 
has  been  shown  (133,  134)  that  the  radical  signal  is  insensitive  to  the  Qo  site 
inhibitors myxothiazol and stigmatellin, but it is sensitive to Qi site inhibitors, such as 
antimycin A. This indicates that this signal was wrongly attributed before to the Qo 
site. More investigations lead to the conclusion that the semiquinone is to be found 
at the Qo site, and is derived from the direct reduction of the bH heme in presence of 
quinol.  The  Qi  site  has  a  high  affinity  for  the  quinon  only  when  the  bH  heme  is 
reduced, otherwise quinol would preferentially bind (60). The binding of quinol to the 
Qi site would then lead to the reduction of it and the stabilisation of a semiquinone at 
the Qi site, possibly in both monomers according to the reduction state of the Q pool 
and the electron transfer across monomers over the bH hemes. This hypothesis has 
very strong implications in the formulation of the half-of-the-sites reactivity, which will 
be explained in the section 1.2.4.3. 
The presence of quinone radicals could be, as already observed, detrimental to the 
cell, for the possible formation of ROS, with consequent lipidic peroxidation and cell 
aging. It is therefore important, if any semiquinone is at all present in the complex, 
that it is stabilized or sealed within the reaction site. It is important in that sense that 
the bc1 complex is not inhibited for example by Qi site inhibitors, since blocking the 
low potential chain could possibly bring about a semiquinone in the Qo site able to 
react  with  oxygen.  Studies  with  mutants  lacking  the  bH  or  the  bL  heme  (135) 
indicated that the complexes where the low potential chain was modified to a certain 
extent could produce ROS with the same efficiency as the wild type antimycin A 
inhibited complex. 
Forquer et al. (134) investigated the production of ROS by the  bc1 complex and 
studied the activation energy for the catalytic turnover and for the side reaction with 
oxygen. It resulted that the two processes have the same activation energy, not 
depending on the electron transfer to cytochrome c1 or cytochrome bL, neither on 
the movement of the ISP. The key process is the ISP reduction, since the activation 
energy increases by diminishing the redox potential of the Rieske cluster. These 
results indicate that both the catalytic cycle and the superoxide production share the 
same activation energy and that most likely a semiquinone is responsible for the 
electron transfer to oxygen. Such a finding is in contrast to models supporting a Introduction 
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simultaneous quinol oxidation. In 2007, Cape et al. (131) applied the freeze-quench 
EPR spectroscopy to the antimycin inhibited bc1 complex finding the presence of a 
semiquinone anione at the Qo site which is sensitive to class P inhibitors and is likely 
to be responsible for ROS production. They propose that the redox properties of the 
couple SQ/Q controls the rate of ROS production, and that the structure of the Qo 
site  may  be  involved  since  it  can  probably  act  as  a  barrier  limiting  oxygen 
permeability in the Qo site.  
In  2004  Osyczka  et  al.  (136)  proposed  the  double  gated  model,  by  which  the 
bifurcation of electrons is ensured and side reactions avoided. The quinol oxidation 
would only take place if both ISP and heme bL are oxidized, being regulated by the 
pattern  of  hydrogen  bonding  around  the  Rieske  cluster  and  the  bL  heme  in  the 
oxidized and the reduced state. This model does not exclude the presence of more 
than one quinol in the Qo site participating to the turnover. 
Also  Rich  et  al.  (137)  in  2004  proposed  a  mechanism  which  emphasises  the 
hydrogen bonding pattern of the His and the Glu residues involved in the binding of 
the quinol at the Qo site. Only if the hydrogen bonding pattern is correct, then the 
quinol  oxidation  can  take  place  in  an  “all-or-nothing”  fashion,  in  which  the  two 
electrons are transferred simultaneously to ISP and cytochrome b. 
Mulkidjanan (138) proposed recently the “activated Q-cycle”, in which one Qi site 
contains a stabilised semiquinone and the bH heme in the other monomer is reduced. 
Starting from this “activated state”, a quinol enters the Qo site and makes hydrogen 
bond with the His
161 on the ISP and the Glu
272 (bovine numbering) on cytochrome b. 
After the first coupled electron and proton transfer to the ISC, a semiquinone anion 
is  present  at  the  Qo  site,  and  the  ISP  stays  docked  in  the  proximal  position. 
Thereafter, the second electron is transferred to the oxidised bL heme which then 
reduces the semiquinone to quinol in just one catalytic turnover, without the need of 
any exchange with the Q-pool. In such a model, no interaction between the  bc1 
monomers is expected, in terms of Qo-Qi site interaction as postulated by the half-of-
the-sites mechanism. 
The bc1 complex establishes a proton gradient across the membrane. The proton 
translocation activity originates from the release of four protons from quinol oxidation 
on the positive side of the membrane, and the uptake of two protons on the negative 
side for quinone reduction. The quinol substrate is hydrogen bonded by the His
161, Introduction 
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one of the cluster ligands, and the Glu
272 of the conserved PEWY sequence (59, 66). 
The His
161 shares the hydrogen bond with quinol and as the substrate has been 
oxidized,  the  ISP  moves  in  direction  of cytochrome  c1  releasing the  proton. The 
second proton from quinol is transferred to the Glu
272 after the second electron has 
been passed futher to the bL heme. Then, the Glu side chain rotates 170° to make a 
hydrogen  bond  with  a water  molecule,  itself  in  hydrogen  bond  distance  with  the 
propionate group of heme bL. The proton release to the aqueous solvent is mediated 
by  a  chain  of  hydrogen  bonds  of  water  molecules  stabilised  by  cytochrome  b 
residues Arg
79, Asn
256, Glu
66 and Arg
70 (yeast numbering).  
At the Qi site, two protons are taken up from the matrix side for the reduction of 
quinone to quinol. In yeast, two different pathways have been shown to be important 
for the proton uptake: the E/R pathway and the CL/K pathway. The yeast substrate 
is  UQ6,  which  is  stabilised  at  the  Qi  site  by  the  residue  Asp
229  and  by  a  water 
molecule hydrogen bonded to the His
202. On the Asp
229 side is present the CL/K 
pathway, where the water molecules in the quinone binding pocket are in hydrogen 
bond with the Lys
228, connecting them with the cardiolipin molecule present on the 
surface of the protein (59, 94, 139, 140). Upon reduction of the UQ6, a proton would 
be taken from the Lys
228, which, through the hydrogen bond network, has access to 
the aqueous phase and can replenish the proton. In this way, the cardiolipin is not 
only an important lipid for the structural integrity of the Qi site but also plays a role in 
the protonation pathway for UQ6.  
The second pathway is closer to the residue His
202. In this case, an important Arg 
residue (Arg
218 in yeast) is connected by hydrogen bond with a water molecule and 
involved in a network of interaction with several water molecules and neighbouring 
residues. At the exit of this array, a hydrophilic cavity formed by Qcr 7 and Qcr 8 in 
yeast opens to the solvent, allowing replenishment of the protons when the Arg
218 
donates a proton to the UQ6 (59). 
1.2.4.3  Half-of-the-sites mechanism 
An  important  observation  obtained  from  the  structures  until  now  available  is  the 
dimeric structure of the bc1 complex. The ISP structurally belonging to one monomer 
delivers electrons to the cytochrome c1 of the second monomer (50). Interestingly, 
the distance between the bL hemes is short, comparable to the bL-bH distance in a 
single  monomer,  so  short  to  allow  inter-monomer  electron  transfer  and  electron Introduction 
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equilibration between monomers. This feature is conserved in all structures solved 
so far, and it has been discussed at length whether or not the two monomers are 
both  involved  in  the  catalytic  cycle  of  the  enzyme. The  work  of Trumpower  and 
Covian  opened  the  way  for  the  identification  of  the  so  called  half-of-the-sites 
reactivity  by  using  stopped-flow  measurements  and  computer  simulations.  Their 
work  provided  evidence  for  the  electron  equilibration  and  for  inter-monomer 
communication  able  to  regulate  the  activity  of  the  complex  and  offer  a  base  to 
prevent detrimental electron leakage eventually capable of forming ROS.  
To avoid deleterious electron transfer to oxygen, control on the mechanism of quinol 
oxidation  is  necessary.  With  the  bc1  complex  being  a  dimer,  it  is  theoretically 
possible to oxidize two quinol molecules at the same time. This could eventually 
overload the enzyme with electrons, as is indicated by ischemia studies where the 
physiological membrane potential in the mitochondrion and the reduction of the Q-
pool are altered (60, 141). Kinetic studies with several bc1 inhibitors indicated non-
linear  inhibition  curves  for  the  binding  of  stigmatellin  to  the  Qo  site.  Only  one 
stigmatellin molecule (Pf inhibitor) was necessary per dimer in order to completely 
inhibit the enzyme (142) and the binding of the inhibitor to the complex was found to 
be anti-cooperative. On the other hand, myxothiazol (a class I Pm inhibitor) showed 
a linear inhibition curve, binding tightly to the complex in a homogeneous way in 
respect to the two monomers. The same results were confirmed not only on the 
eukaryotic but also on the bacterial complex (143), hint of a conserved behaviour 
dependent on intrinsic protein properties. Covian et al. (62, 143-145) explained the 
results by proposing a mechanism by which the two monomers could communicate 
and the Qo site of the inhibited monomer would, by a conformational change, block 
the activity of the second one. From the stigmatellin titration curves it was clear that 
the inhibitor could bind to the first monomer in a fast phase, followed by a slow 
phase independent on the inhibitor  concentration,  during which the one inhibited 
monomer could undergo the conformational change needed to impede the quinol 
oxidation on the other monomer. Moreover, in presence of an inhibited Qo site, only 
one Qi site was able to bind antimycin or the substrate quinone, therefore regulating 
the occupancy of the quinone reduction site. The explanation given involved the 
position of head domain of the ISP: in the situation where the two ISP are docked on 
cytochrome  b,  virtually  ready  to  oxidize  quinol,  only  one  Qi  site  is  able  to  bind 
semiquinone.  When  semiquinone  is  bound  to  both  Qi  sites  just  one  ISP  head Introduction 
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domain is able to react with the substrate. Stigmatellin was considered a good mimic 
of the quinol molecule bound at the Qo site, since it resembles both the binding and 
the properties of the substrate right before oxidation, in a situation where the ISP is 
blocked on the b conformation. How exactly the conformational change should cross 
the monomers to get to the second active quinol oxidation site is not yet clear, but 
the authors suggested that the ef loop and the helices D and E could be involved in 
sensing the position of the ISP and, by the N-teminal helix at the cytochrome b, 
transfer  the  blocking  to  the  other  monomer  (62).  Myxothiazol  does  not  directly 
interact with the ISP and its binding is insensitive to the ISP position, and therefore 
does  not  show  the  same  behaviour  as  stigmatellin,  giving  linear  titration  curves, 
expected for the independent inhibitor binding in the two monomers. 
The half-of-the-sites reactivity can be explained also studying the binding properties 
of quinol and quinone at the Qi site. In presence of Qo site inhibitors, the bH hemes 
can be reduced from the quinol at the Qi site. Under these conditions is possible to 
observe an EPR signal, sensitive to antimycin and other class II inhibitors, which 
can be identified with a semiquinone at the Qi site. For the first time it was shown 
that the EPR signal was not localized at the Qo site, possible intermediate of the Q-
cycle, as initially thought (124, 146) but a semiquinone at the Qi site originating from 
the backreaction of the bH hemes from quinol (133, 144, 147). Fig. 6 shows the 
proposed  mechanism  which  regulates  the  Qi  site  occupancy.  Covian  et  al. 
measured the affinity of quinol and quinone for the Qi site and concluded that quinol 
is binding at the Qi site preferentially when the bH heme is oxidized, and quinone 
when it is reduced. This redox specificity is essential to ensure that quinol would 
leave the Qi site each time the heme bH is reduced and ready to reduce a quinone 
molecule (60). From the triphasic cytochrome b reduction kinetics, Covian et al. (145, 
147) identified from the the basis for semiquinone stabilisation at the Qi site: the bH 
heme can interact with quinol and be reduced when its concentration is higher than 
that of quinone; even a few quinone molecules are enough to accept the electrons 
from the turnover of the bc1 complex, such avoiding that electrons could accumulate 
in the high- and low-potential chains; once the turnover has produced again enough 
quinol molecules, they can as well interact with both the Qo and Qi site and be used 
in a normal turnover or as reductant for the bH heme. This way, the dimeric structure 
can use the electron equilibration between monomers in order to have available as 
many oxidized cofactors as possible and avoid the formation of ROS. Introduction 
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Fig.  6:  Semiquinone  stabilisation  at  the  Qi  site.  The  blue  rectangles  represent  the 
cytochrome b subunits, and only the Qi site is shown, for simplicity. The reduction of 
a  b-type  heme  is  shown  with  a  black  circle,  the  oxidized  form  with  a white  circle. 
Semiquinone: SQ; Q: quinone; QH2: quinol (62) After binding of one quinol molecule 
to the Qi site, a semiquinone is formed and the bH heme reduced. At this point, several 
possibilities are open: the electron can be equilibrated to the other monomer and the 
reduced Qi site bind a quinone which is then reduced to semiquinone. The bH hemes 
in both monomers are oxidized (intermediate III´ and IV´). Alternatively, another quinol 
could bind to the free Qi site and give a semiquinone. Both monomers have finally a 
reduced bH heme and a stabilized semiquinone at the Qi site (intermediates III and IV).  
 
Necessary  for  the  semiquinone  stabilisation  at  center  N  is  the  inter-monomer 
electron transfer across the bL hemes. In the yeast complex (62) the edge-to-edge 
distance between the two bL hemes is 13.8 Ǻ, similar to the 12.4 between the bL and 
bH  heme  in  each  monomer.  Intradimeric  electron  equilibration  gains  particular 
importance in situations where the bH hemes are pre-reduced by reverse electron 
transfer at the Qi site, or the low potential chain is inhibited. In the latter case, after 
two turnovers, cytochrome b is fully reduced but the ISP can still oxidize quinol and 
reduce cytochrome c1. In the Qo site a semiquinone anion would remain, eventually 
responsible  of  side  reactions  with  oxygen,  as  indicated  in  the  study  of  Cape  et Introduction 
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al.(131). It is still unclear whether or not a semiquinone is a real intermediate of the 
turnover, but considering the damages derivating from an eventual electron leakage, 
the electron equilibration between monomers may be of critical importance.  
When  antimycin  is  added  in  substoichiometric  amounts  in  respect  to  the  bc1 
complex,  a  fraction  of  dimers  will  bind  only  one  antimycin  molecule.  In  such  a 
scenario, one bH heme is reducible directly by quinol at the Qi site, the second bH 
heme in the inhibited monomer is only available in case of inter-monomer electron 
equilibration. The binding of antimycin (which neither modifies the redox potential of 
the bH hemes, nor can it dissociate easily from the binding site, being a tightly bound 
inhibitor) can be followed by the red shift in the redox spectrum of cytochrome b, 
and by this experiment one of the proofs of the bL-bL electron transport was obtained 
(62). Covian et al. (144, 148) measured pre-steady-state kinetics of cytochrome c1 
and b reduction in the presence of antimycin, showing that one cytochrome c and at 
the same time two cytochromes bH per dimer were reduced by decylubiquinol. If the 
two monomers were both at the same time able to oxidize quinol, two cytochromes 
c1 and two bH would have been expected to be reduced after a single turnover. 
Simulations  presented  in  the  work  could  explain  the  reduction  kinetics  only  if  a 
mechanism was operating by which the two monomers work one at a given time and 
allow for inter-monomer electron transfer. At the same time, the crystal structure of 
the bc1 complex from yeast complexed with the electron acceptor, cytochrome c, 
was published (94) interestingly showing only one cytochrome c bound to the dimer 
and ubiquinone in only one monomer, supporting the half-of-the-site mechanism. 
Taken  together  all  present  data  favour  a  model  as  presented  in  Fig.  7,  which 
summarizes the inhibitor studies, the relationship between the Qi site occupancy, 
the Qi site semiquinone stabilisation and the inter-monomer electron transport. 
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Fig.  7:  Scheme  of  the  half-of-the-sites  mechanism.  The  blue  rectangles  represent 
cytochrome b, with the Qo site as a green oval and the Qi site as an orange oval. In 
yellow, the ISP. This model shows that the occupancy of the Qi  site  regulates the 
activity of the Qo site (62).  
 
The semiquinone is simulated by antimycin in the experiments presented until now. 
In the case of a vacant Qi site, only one ISP domain is able to dock on cytochrome b 
and oxidize quinol. One electron is transferred to the high-potential chain, and the 
second to the low-potential chain. At the bL level, the electron has an approximately 
equal probability to be transferred to the bH of the same monomer or to the other by 
inter-monomer electron transfer. The semiquinone stabilisation at the Qi site (Fig. 6, 
intermediate IV
´) represents a state of the enzyme with the two bLhemes, the two bH 
hemes and two semiquinone ready to accept an electron from the catalysis at the Qo 
site, preventing efficiently any form of electron leakage and oxygen side reaction. In 
the  intermediates  II  and  IV,  the  catalytically  favourable  position  for  the  ISP 
destabilizes the interaction with a semiquinone at the Qi site in the other monomer, 
and the half-of-the-sites mechanism makes sure that electrons are quickly delivered 
to quinone, avoiding them to accumulate in the complex. Since electrons have the 
same probability to be distributed between the two monomers, randomly in a given 
time  span  the  two  monomers  will  swing  between  the  double  active  form 
(intermediates  II  and  IV)  and  the  single  active  form  (intermediates  I  and  III), 
statistically undergoing each the same number of turnovers. Introduction 
31 
Intermediates II and IV are simulated by antimycin titration curves (62, 148), where a 
stimulation of the initial rates, instead of an inhibition, can be observed in presence 
of a substoichiometric amount of antimycin. The inhibitor mimics the presence of a 
semiquinone bound at the Qi site: in the intermediates where just one monomer 
binds antimycin, both Rieske head domains are ready to oxidize quinol, so that the 
stimulation observed is explained as the sum of the activity of the free monomers 
and twice as much the activity of the inhibitor binding monomers (148). If no inhibitor 
is bound at the Qi site, or no semiquinone is stabilized there, only one monomer 
accounts for the activity. For a more detailled discussion on the implication of the 
antimycin titration curves, see the section 3.1.1.6. 
1.3  Cytochrome c552 
Cytochrome  c552  is  the  physiological  electron  acceptor  for  the  bc1  complex  in  
P.  denitrificans.  It  shuttles  electrons  to  the  aa3  oxidase  and  is  only  one  among 
several  cytochrome  c  molecules  involved  in  electron  transfer  in  the  different 
metabolic pathways of this organism. The cytochrome c552 can be divided into three 
domains (118, 149, 150): an N-terminal transmembrane helix, anchoring it to the 
cytoplasmatic  membrane,  a  highly  negatively  charged  llinker  region,  and  a  
C-terminal class I cytochrome domain. It carries a covalently bound c-type heme, 
liganded by a His and a Met.  
Previously the crystal structure of a soluble fragment containing only the cytochrome 
c  binding  domain  has  been  solved  (149)  and recently  a  new  structure  could  be 
achieved,  containing  the  linker  and  the  C-terminal  domain  (150).  A  loop  region 
(residues 1-12) could be identified, followed by the residues 13-31 which lacked any 
electron density. A small helix formed by the residues 34-41 precedes the heme 
binding  domain.  From  the  new  data,  it  was  concluded  that  the  head  domain  of 
cytochrome c552 is flexible to interact with the bc1 complex on the one side and with 
the  cytochrome  aa3 oxidase  on  the  other.  The  region  not  visible  in  the  electron 
density  map  indeed  indicates  a  high  degree  of  mobility,  which  could  be  very 
important since cytochrome c552 is membrane bound and not able to diffuse as does 
the mitochondrial cytochrome c. 
The mobile domain is thus of relevance in the light of a supercomplex, as already 
published (151): in this case, the movements of the C-terminal domain would allow a 
rapid and efficient electron transfer to the oxidase without any lateral diffusion. Introduction 
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1.4  Aim of this work 
The  acidic  domain  deletion  mutant  of  the  bc1  complex  of  P.  denitrificans  is 
investigated, in terms of structural and kinetic properties. During my previous work, I 
achieved  cloning  and  expression  of  the  protein,  and  purified  it  by  affinity 
chromatography.  Due  to  some  problems  encountered  during  purification  (110),  I 
plan to modify and optimise elution condition and to characterise the complex by 
spectral and kinetic analysis. 
By  using  flash  photolysis  kinetics,  I  investigate  the  role  of  the  acidic  domain  in 
cytochrome  c1  in  the  interaction  with  cytochrome  c552,  the  physiological  electron 
acceptor. In fact, the domain resembles the small acidic subunit in the eukaryotic 
complex,  known  to  facilitate  the  interaction  with  the  substrate  (114).  A  similar 
analysis was already performed by Janzon et al. (118) by using soluble fragments of 
the reaction partner. The measurements with whole complexes reflect more closely 
the situation in membranes and offer the possibility to verify the kind of interaction 
between bc1 complex and cytochrome c552. Until now, the interaction mechanism 
has been widely described in yeast, and previous experiments in P. denitrificans 
have shown similarities with that system. 
 With the use of stopped-flow spectroscopy, the internal electron transfer pathway 
will be studied to define the rate of cytochrome c1 reduction from ascorbate and the 
role  that  the  ISP  plays  in  the  complex.  In  particular,  it  should  be  analyzed  how 
electrons can be transferred from the Rieske cluster to cytochrome  c1, the latter 
having a lower redox potential. 
The  second  part  of  my  work  consists  in  structure-function  analysis  and  internal 
regulation in the bc1 complex from P. denitrificans. By using a different experimental 
setup,  flash  photolysis  kinetics  represent  a  powerful  tool  to  measure  internal 
electron transfer and investigate inhibitor effects on specific reactions in the catalytic 
cycle.  Class  P  inhibitors  bind  in  different  positions  at  the  Qo  site  and  lead  to 
inhibition of electron transfer by using different mechanisms. In this work, I analyse 
the position of the head domain of the ISP in presence of different molecules at the 
Qo site, either quinol or inhibitors, to study the mechanism which regulates the ISP 
movement allowing fast electron transfer and catalysis. 
Finally, I plan the construction a heterodimeric bc1 complex in order to prove the 
aforementioned  internal  regulation  system  (half-of-the-sites  mechanism).  This Introduction 
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experiment will be carried out with the deletion mutant of the complex, since it has 
been shown to have a dimeric structure, in contrast with the wild type protein (152). 
One of the two monomers in the complex carries an inactivating mutation in the Qo 
site (153, 154), which does not allow quinol oxidation. The other monomer is fully 
active. A sequential purification due to the differential tagging at the genetic level of 
the  two  halves  will  be  used  to  purify  the  complex.  The  resulting  heterodimer, 
homologously  expressed  in  Paracoccus  denitrificans,  shall  be  analysed  by  time 
resolved stopped slow experiments to demonstrate the regulatory function of the 
dimeric structure. 
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2  Materials and methods 
2.1  Materials 
2.1.1  Chemicals 
All the chemicals, also the ones not explicitly included in this list, were purchased in 
p.a. quality from different companies (AppliChem, Merck, Roche, Roth or Sigma-
Aldrich).  Water  was  desalted  with  an  instrument  from  the  company  Seral  for 
biochemical application, and with a PRO 90 CN apparatus from the same company 
for  molecular  biology  experiments.  In  the  second  case,  water  has  always  been 
autoclaved. 
Acrylamide, Bisacrylamide  Roth 
Antimycin A   Sigma-Aldrich 
Agar-agar  Roth 
Agarose   peqlab 
Ammoniumpersulfate (APS)   Roth 
Ampicillin-sodium salt   Applichem 
Avidin   Gebru 
Bactotryptone   Becton-Dickinson 
Succinic acid  Fluka 
Bromo phenol blue  Sigma-Aldrich 
5-bromo-4-chloro-3-indolylphosphate (BCIP)   Sigma-Aldrich 
Coomassie brilliant blue R250   Roth 
Decylubiquinone   Sigma-Aldrich 
Desoxyribonucleosidtriphosphate (dNTPs)  Fermentas 
Dimethylsulfoxid (DMSO)   Merck 
Ethidium bromide   Gibco BRL 
Folin-ciocalteau   Merck 
Yeast extract   Gibco BRL 
Histidine  Roth 
Imidazole  Applichem 
Isopropyl-β-D-thiogalactopyranoside (IPTG)   Fermentas 
Kanamycinsulfate   Roth 
β-Mercaptoethanol   Sigma-Aldrich Materials and methods 
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Potassium ferricyanide  Fluka 
Sodium ascorbate   Fluka 
Sodium dithionite  Sigma-Aldrich 
Sodium dodecylsulfate (SDS)   Roth 
n-Dodecyl-β-D-maltoside (DDM)   Biomol/Roth 
Bovine serum albumine (BSA)  Roth 
Nicotinamidadenindinucleotide (NADH)   AppliChem 
Nitro blue tetrazolium (NBT)   Sigma-Aldrich 
2-(N-morpholino)ethanesulfonic acid (MES)  AppliChem 
3-(N-morpholino)propanesulfonic acid (MOPS)   Roth 
N,N,N´,N´-Tetramethylethylendiamine (TEMED)   Roth 
Pefabloc SC   Biomol 
Ponceau S   Merck 
Rifampicin  Fluka 
Stigmatellin   Sigma-Aldrich 
Streptomycinsulfate   Applichem 
3,3`5,5`-Tetramethylbenzidine (TMBZ)   Sigma-Aldrich 
 
2.1.2  Proteins 
For  the  enzymes  needed  in  molecular  biology  applications,  were  used  buffer 
delivered from the company.  Enzymes,  antibodies and  cytochrome  c from  horse 
heart were kept at -20 °C, all other proteins at -80 °C. 
2.1.2.1  Enzymes for molecular biology 
Calf intestinal alkaline phosphatase (CIAP)   NEB 
Phusion-DNA Polymerase   Finnzymes 
Ribonuclease A (RNAse)   Roche 
T4-DNA-Ligase   Fermentas 
T4-Polynucleotide kinase (PNK)   Fermentas 
Restriction endonucleases   NEB, Fermentas 
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2.1.2.2  Antibodies 
All antibodies for the respiratory chain of  
Paracoccus denitrificans 
Prof. Ludwig 
Penta-His-Antibody   Novagen 
Protein A-Alkaline Phosphatase   Sigma-Aldrich 
Goat-anti-Mouse IgG / Alkaline Phosphatase-Conjugate   Sigma-Aldrich 
Streptavidin / Protein A- Alkaline Phosphatase -Conjugate  Sigma-Aldrich 
2.1.2.3  Varia  
Cytochrome c from horse heart   Sigma-Aldrich 
Lysozyme   Biomol 
Cytochrome c552 from P. denitrificans   Prof. Ludwig 
Cytochrome c552 N23C from P. denitrificans  Prof. Ludwig 
Isoform 1 cytochrome c from S. cerevisiae  Prof. Millett, Arkansas 
2.1.3  Kits 
Gel extraction/PCR purification  Zymoclean 
2.1.4  Markers 
λ Phage DNA cut with EcoRI/HindIII   Produced in the lab 
Unstained Protein Molecular Weight Marker   Fermentas 
PageRuler Protein Ladder  Fermentas 
2.1.5  Chromatography materials 
Chromatography materials were washed with 20 % ethanol at 4 °C for long time 
storage and with 1 mM sodium azide at 4 °C for short time storage. 
Diethylaminoethyl-(DEAE)-Sepharose CL-6B  GE Healthcare 
Ni
2+-NTA-Agarose Superflow  Qiagen 
StrepTactin-Sepharose  Novagen 
Sephadex G-25  GE Healthcare 
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2.1.6  Instruments 
Analytical balance  Basic Sartorius 
Air-bath shaker  New Brunswick Scientific 
Autoclave  Bioklav Schütt 
Centrifuges Sorvall RC 5B, RC 36  Dupont 
Concentrators   Millipore, Sartorius 
Dialysis tubes 4-6 kDa   Roth 
Drying cupboard   Memmert 
Electrophoresis-Camera Powershot G5   Canon 
FPLC Pharmacia LKB   GE Healthcare 
Freezer  Heraeus 
Ice machine  Ziegra 
Incubator  Heraeus 
Laser flash   Phase R model DL 1400 
flash lamp-pumped dye 
laser 
Manton-Gaulin-Homogenisator   APV Schröder 
Microwave  Hitachi 
Nitrocellulose membrane BA 85   Whatman 
pH-Meter   pH340i WTW 
Pipettes   Eppendorf, Gilson 
Power supplier Powerpac 300   Biorad 
Protein electrophoresis Mini Protean II   BIORAD 
Shaker  New Brunswick Scientific 
Spectrophotometer U-3000   Hitachi 
Sterile bench   Heraeus 
Stopped Flow   Applied Photophysics 
apparatus, Leatherhead, 
UK 
Time resolved Stopped Flow  OLIS Rapid Scanning 
Monochromator 
Table centrifuge Biofuge 13   Heraeus 
Thermocycler   Biorad 
Thermomixer 5436   Eppendorf 
Ultracentrifuge L-70   Beckman 
Ultrasound generator Sonifier 250   Branson Materials and methods 
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Ultra-Turrax-Homogenisator T25   IKA Labortechnik 
UV-Transilluminator   UVP 
Vortex Reax 2000   Heidolph 
Water bath   Bachofer 
 
2.1.7  Softwares and databanks 
2.1.7.1  Softwares 
Adobe Illustrator 9.0  Adobe 
Adobe Photoshop 6.0  Adobe 
Visual Molecular Dynamics  
(VMD) Version 1.8.6 
http://www.ks.uiuc.edu/Resear 
ch/vmd/ (155) 
Clone Manager   Scientific & Educational Software 
Origin 8.0   OriginLabCorporation 
2.1.7.2  Databanks 
NCBI Entrez Pubmed  http://www.ncbi.nlm.nih.gov/entrez/query.fcgi
?db=PubMed 
Expasy Swissprot  http://www.expasy.org/sprot/ 
Kazusa Codon-usage Databank  http://www.kazusa.or.jp/codon/ 
Protein Data Bank (PDB)  http://www.rcsb.org/pdb/home/home.do 
Elektronische Zeitschriften 
Bibliothek 
http://rzblx1.uni-
regensburg.de/ezeit/fl.phtml?bibid=UBFM 
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2.1.8  Plasmids 
2.1.8.1  Available plasmids 
Plasmids  Description  Resistance  Origin 
pBluescript   cloning vector, f1 ori, lacZʱ  Amp  Stratagene 
(Heidelberg) 
pRI2  broad host range vector, pBBR1MCS 
derivative, expression vector 
Sm, Cm  (156)  
pRI2 (436)  fbc operon HindIII/SacI in pRI2, 
expression vector for wt complex III 
Sm, Cm  M. Korn 
(Institute) 
pSL1180   Cloning vector, superlinker, pMB1 ori, 
M13 ori, lacZʱ 
Amp  Pharmazia 
pUC18   Cloning vector, lacZʱ  Amp  (157) 
pEG400  incP, broad host range-vector, 
expression vector 
Sm  (109) 
pBBR1-MCS5  broad host range-vector, expression 
vector 
Gm  (158) 
pMC1  expression vector for the fbc operon 
with N-terminal fbcC deletion and C-
terminal fbcB 10x His tag 
Sm, Cm  (110) 
pTK33   pRI2 (436) derivative (HindIII/SacI) + 
fbcB  C-terminal 10x His tagged 
fbc operon  
Sm, Cm  (152) 
pTK44  pTK33 derivative (Eco147I+Pfl23II) 
with a Y147S mutation in fbcB with a 
Eco24I restriction site) +  
fbcB C-terminal 10x His tag 
Sm, Cm  (152) 
pTK56  pMC1 derivative, + fbc B C-terminal 
Strep tag,  
Gm  Kleinschroth 
(institute) 
pTSP1  pAlter with fbc operon from  
P. denitrificans with S157A mutation 
in fbcF 
Amp, Tet  (85) 
pTSP2  pAlter with fbc operon from  
P. denitrificans with Y159F mutation 
in fbcF 
Amp, Tet  (85) 
pEC86  Heme maturation plasmid, 
pACYC184, ccmABCDEFGH 
Cm  (159) 
pBR2  P. denitrificans cycM (cyt. c552 
functional domain) NcoI/HindIII in 
pET22b(+) 
Amp  (160) Materials and methods 
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2.1.8.2  Plasmids produced in this work 
Plasmid  Description  Resistance 
pMC8  pMC1 with Pfl23II/SacI fragment from pTSP2 
contains the mutation Y159F in the fbcF gene 
Sm, Cm 
pMC9  pTK33 with Pfl23II/SacI fragment from pTSP1 
contains the mutation S157A in the fbcF gene 
Sm, Cm 
pMC10  pTK33 with Pfl23II/SacI fragment from pTSP2 
contains the mutation Y159F in the fbcF gene 
Sm, Cm 
pMC11  pMC1 with Pfl23II/SacI fragment from pTSP1 
contains the mutation S157A in the fbcF gene 
Sm, Cm 
pMC12 a  fbc operon from pMC1 HindIII/SacI in pUC18  Amp 
pMC12 b  pMC12 a with Pfl23II/SacI from pTK44 in pUC18 
contains the Y147S mutation in fbcB 
Amp 
pMC12  HindIII/SacI fragment from pMC12 b in pEG400 
contains the fbc operon with N-terminal 
cytochrome c1 domain deletion and Y147S 
mutation in fbcB 
Sm 
pMC13  HindIII/SacI fragment from pTK33 in pUC18 
Contains the 10X His tagged fbc operon 
Amp 
pMC14  fbc operon from pMC12 a with a S157C mutation 
in fbcF 
Amp 
pMC15  fbc operon from pMC13 a with a S157C mutation 
in fbcF 
Amp 
pMC16  HindIII/SacI fragment from pMC14 in pRI2 
contains the fbc operon with N-terminal fbcC 
domain deletion and S157C mutation in fbcF 
Sm 
pMC17  Pfl23II/SacI fragment from pMC14 in pTK33 
contains the fbc operon with C-terminal fbcB 10X 
His tag and S157C mutation in fbcF 
Sm 
pMC18  Pfl23II/SacI fragment from pMC14 in  
pRI2(436) contains the fbc operon from  
P. denitrificans with S157C mutation in fbcF 
Sm 
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2.1.9  Microorganisms 
2.1.9.1  Escherichia coli K12 
Strain  Genetic markers  Origin 
DH5ʱ  SupE44, ΔlacU169 (ʦ80lacZΔM15), 
hsdR17, recA1, endA1, gyrA96, thi-1, 
relA1 
(161-163) 
pMC8  DH5ʱ, transformed with pMC8  this thesis 
pMC9  DH5ʱ transformed with pMC9  this thesis 
pMC10  DH5ʱ transformed with pMC10  this thesis 
pMC11  DH5ʱ transformed with pMC11  this thesis 
pMC12 a  DH5ʱ transformed with pMC12 a  this thesis 
pMC12 b  DH5ʱ transformed with pMC12 b  this thesis 
pMC12  DH5ʱ transformed with pMC12  this thesis 
pMC13  DH5ʱ transformed with pMC13  this thesis 
pMC14  DH5ʱ transformed with pMC14  this thesis 
pMC15  DH5ʱ transformed with pMC15  this thesis 
pMC16  DH5ʱ transformed with pMC16  this thesis 
pMC17  DH5ʱ transformed with pMC17  this thesis 
pMC18  DH5ʱ transformed with pMC18  this thesis 
2.1.9.2  Paracoccus denitrificans 
Strain  Genetic marker  Origin 
Pd1222  Spc
R, Rif
R, „enhanced mating frequency“  (164) 
MK6  Pd1222 derivative chromosomal deletion mutant 
for the fbc-Operon Δ(fbc::Km
R), Spc
R, Rif
R 
(85) 
MC1  MK6 derivative contains pMC1  (110) 
pMC8  MK6 derivative contains pMC8  this thesis 
pMC9  MK6 derivative contains pMC9  this thesis 
pMC10  MK6 derivative contains pMC10  this thesis 
pMC11  MK6 derivative contains pMC11  this thesis 
pMC12  MK6 derivative contains pMC12  this thesis 
pMC16  MK6 derivative contains pMC16  this thesis 
pMC17  MK6 derivative contains pMC17  this thesis 
pMC18  MK6 derivative contains pMC18  this thesis Materials and methods 
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2.1.10  Oligonucleotides 
Oligonucleotides for PCR applications were purchased from Biospring.  
Oligonucleotide  Sequence 
fS157C_III  5´- CCGTGCCACGGGTGCCATTACGACACC -3´ 
fS157C_III_reverse  5´- GCAGAACCAGCCGCCGAAATCGC -3´ 
ende_cytb_rev_seq  5´- GCAACAGCCGTGAGCGAT -3´ 
Seq_cytb_mitte  5´- CCCTTCGTCATCGCGGCG -3´ 
Seq_ISP_mutagenese  5´- ATTTGATCGCTAGAACCGCG -3´ 
 
2.1.11  Solutions 
All  the  solutions  were  prepared  with  the  described  water.  Solutions  for  protein 
purification  were  sterile  filtered.  All  the  solution  for  molecular  biology  application 
were sterile filtered or autoclaved. 
 
DNA Agarose gel electrophoresis  
DNA sample buffer  0.02 % bromo phenol blue, 30 mM EDTA,  
5 % glycerol in TBE buffer 
TBE buffer (10x)   1 M Tris,1 M boric acid, 25 mM EDTA, pH 8 
Ethidium bromide stock 
solution 
10 mg/ml ethidium bromide in H2O 
 
Activity measurements   
bc1 dilution buffer  50 mM MOPS/NaOH pH 7.5, 100 mM NaCl, 
0.04 % DDM, 5 % glycerol, 0.05 % BSA 
bc1 measurement buffer  50 mM MOPS/NaOH pH 7.5, 100 mM NaCl,  
0.04 % DDM, 1 mM EDTA, 1 mM KCN 
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Kinetic measurements 
Stopped Flow    50 mM MOPS/NaOH pH 7.5,  0.04 % DDM,   
1 mM EDTA, 1 mM KCN 
Time resolved Stopped 
Flow 
100 mM Tris-HCl, pH 8.0, 2 mM sodium azide,  
0.2 mM EDTA, 0.05% dodecylmaltoside 
Laser flash RuZ-H39C-Cc  20 mMTris/HCl pH 8.0,  0.02% DDM,  
2 mM sodium ascorbate,  
2 µM N, N, N’,N’ tetramethylphenylendiamine (TMPD) 
Laser flash Ruz-N23C-c552F  10 mMTris/HCl pH 8.0,  0.02% DDM,  
2 mM sodium ascorbate,  
2 µM N, N, N’,N’ tetramethylphenylendiamine (TMPD) 
 
Purification bc1 complex from P. denitrificans (ion exchange column) 
Solubilisation buffer (2x)  100 mM MES/NaOH pH 6, 600 mM saccharose,  
2,4 M NaCl 
Equilibration buffer  50 mM MES/NaOH pH 6, 350 mM NaCl 
Low salt buffer  50 mM MES/NaOH pH 6, 350 mM NaCl, 0.02 %DDM 
High salt buffer  50 mM MES/NaOH pH 6, 600 mM NaCl, 0.02 % DDM 
Wash buffer  50 mM MES/NaOH pH 6, 1 M NaCl 
 
Purification bc1 complex from P. denitrificans  
(affinity chromatography, Ni
2+-NTA with imidazole) 
Solubilisation buffer (2x)  100 mM NaPi pH 8, 600 mM saccharose, 2.4 M NaCl, 
20 mM imidazole 
Equilibration buffer  50 mM NaPi pH 8, 300 mM NaCl 
Low imidazole buffer  50 mM NaPi pH 8, 300 mM NaCl, 0.02 % DDM,  
10 mM imidazole 
High imidazole buffer  50 mM NaPi pH 8, 300 mM NaCl, 0.02 % DDM,  
250 mM imidazole 
Wash buffer  50 mM NaPi pH 8, 500 mM imidazole, 1 M NaCl 
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Purification bc1 complex from P. denitrificans 
(affinity chromatography, Ni
2+-NTA with histidine) 
Solubilisation buffer (2x)  100 mM NaPi pH 8, 600 mM saccharose, 2,4 M NaCl 
Equilibration buffer  50 mM NaPi pH 8, 300 mM NaCl 
Low histidine buffer  50 mM NaPi pH 8, 300 mM NaCl, 0,02 %DDM 
High histidine buffer  50 mM NaPi pH 8, 300 mM NaCl, 0,02 % DDM  
250 mM histidine 
Wash buffer  50 mM NaPi pH 8, 500 mM histidine, 1 M NaCl 
 
Purification bc1 complex from P. denitrificans 
 (Strep-Tactin column) 
Solubilisation buffer (2x)  100 mM NaPi pH 8, 600 mM saccharose, 2.4 M NaCl, 5 
mg avidin 
Equilibration buffer  50 mM NaPi pH 8, 300 mM NaCl, 0.02 % DDM 
Elution buffer  50 mM NaPi pH 8, 300 mM NaCl, 0.02 % DDM, 
2.5 mM desthiobiotin 
 
Purification c552F from E.coli cells 
Q-Sepharose washing 
buffer  
50 mM Tris/HCl pH 8, 1 mM EDTA 
Q-Sepharose gradient 
buffer 
50 mM Tris/HCl pH 8, 350 mM NaCl, 1 mM EDTA 
Q- Sepharose high salt 
buffer 
50 mM Tris/HCl pH 8, 2 M NaCl, 1 mM EDTA 
Gel filtration buffer  50 mM Tris/HCl pH 8, 150 mM NaCl, 1 mM EDTA 
 
Coomassie staining 
Staining solution  0.2 % Coomassie brilliant blue R 250,  
10 % acetic acid, 20 % methanol 
Destaining solution  10 % acetic acid, 20 % methanol 
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Plasmidic DNA isolation (Miniprep) 
Mini II  50 mM glucose, 0,2 M NaOH, 1 % SDS 
Mini III  potassium acetate solution 3 M,  
11.5 % acetic acid, pH 5 (4 °C) 
Chloroform/Isoamylic alcohol  24:1 (v/v) 
 
Competent cells 
TFB-I-Puffer  30 mM potassium acetate pH 5.8, 
10 mM CaCl2, 50 mM MnCl2,  
100 mM RbCl, 15 % glycerol 
TFB-II-Puffer  10 mM MOPS/KOH pH 6.8, 10 mM RbCl, 
75 mM CaCl2, 15 % glycerol 
TE-Puffer  10 mM Tris/HCl pH 7.5, 1 mM EDTA 
 
Membrane preparation 
Lysis buffer  100 mM KPi pH 8, 1 mM EDTA 
Membrane buffer  20 mM KPi pH 8, 1 mM EDTA 
bc1 membrane buffer  50 mM MES/NaOH pH 6, 300 mM saccharose, 
1 mM EDTA 
bc1 membrane buffer NaPi  50 mM NaPi pH 8, 300 mM saccharose,  
1 mM EDTA 
Membrane spectrum buffer  50 mM KPi pH 8, 0.5 % Triton X-100 
 
 
Protein concentration (Lowry) 
Lowry A  2 % Na2CO3, 0.1 M NaOH 
Lowry B1  1 % CuSO4·* 5H2O 
Lowry B2  2 % potassium sodium tartrate 
SDS solution  20 % SDS 
Folin solution  50 % (v/v) Folin-ciocalteau in H2O 
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Periplasma prep   
Periplasma buffer   100 mM Tris/HCl pH 8, 0,5 M saccharose, 
1 mM EDTA 
 
SDS polyacrylamide gel electrophoresis (Tricine-System from Schägger) 
Anode buffer (10x)  1 M Tris/HCl pH 8.9 
Cathode buffer (5x)  0.5 M Tris/HCl, 0.5 M tricin, 0.5 % SDS, pH 8,3 
Acrylamide solution  48 % acrylamide, 1.5 % Bis-acrylamide 
Gel buffer  3 M Tris/HCl pH 8.5, 0.3 % SDS 
Sample buffer  100 mM Tris pH 6.8, 4 % SDS, 200 mM DTT,  
20 % glycerol, 0.02 % bromo phenol blue 
 
Trace element solution for succinate medium 
Trace element solution  15g CaCl2 * 2 H2O, 24.5g FeCl3 * 6 H2O,  
10g MnCl2 * 4 H2O, 3.4 g ZnCl2,  
2.4 g CoCl2 *6 H2O, 1.25 g CuSO4 * 5 H2O, 
0.6 g H3BO3 * 6 H2O, 2.4 g Na2MoO4 * 2 H2O, 
resuspend in 250 ml HClconc. and 250 ml H2O, to 
1 L with H2O 
 
Western Blot solutions   
Semidry buffer   11.64 g Tris, 5.86 g glycine,  
3.75 ml SDS 20 %, 400 ml methanol, 
to 2 L with H2O 
Ponceau solution  0.2 % Ponceau, 3 % TCA 
BSA solution  3 % BSA in TBS 
TBS   50 mM Tris/HCl pH 7.5, 150 mM NaCl 
TBS-TT   0.05 % (v/v) Tween-20, 0.2 % Triton X-100,  
20 mM Tris/HCl pH 7.5, 500 mM NaCl 
TNM   100 mM Tris/HCl pH 9.5, 100 mM NaCl,  
50 mM MgCl2 
BCIP   BCIP 25 mg/ml in dimethylformamide (DMF) 
NBT   NBT 50 mg/ml in 70 % DMF 
Stop solution  50 mM EDTA pH 8 
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2.1.12  Antibiotics 
Antibiotic  Stock solution 
Ampicillin (Amp)  50 mg/ml in 50 % (v/v) glycerol 
Gentamycin (Gm)  10 mg/ml in 50 % (v/v) glycerol (E. coli) 
20 mg/ml in 50 % (v/v) glycerol (P. denitrificans) 
Kanamycin (Km)  25 mg/ml in 50 % (v/v) glycerol 
Rifampicin (Rif)  15 mg/ml in methanol 
Streptomycinsulfat (Sm)  25 mg/ml in 50 % (v/v) glycerol 
 
Antibiotics have been (except rifampicin) sterile filtered and stored at -80 °C. After 
opening an aliquot, it was stored at -20 °C and used between 4 and 6 weeks. The 
dilution in the medium is 1:250 for rifampicin, and 1:1000 for all the other antibiotics. 
 
2.1.13  Medium 
 
Medium   Protocol 
Luria-Bertani (LB)-Medium 
(Sambrook et al., 1989) 
Pepton 1 % (w/v), yeast extract 0.5 % (w/v), 
NaCl 0.5 % (w/v) 
Succinate medium 
(Ludwig, 1986) 
50 Mm K2HPO4, 10 mM NH4Cl, 1mM citrate,  
1 mM MgSO4, 40 mM succinate,  
0.2 ‰ (v/v) trace elements solution, 
pH with KOH to 6.2 
Frozen cultures medium, 
(Sambrook et al., 1989) 
Pepton 1.6 % (w/v), yeast extract 1 % (w/v), 
NaCl 1 % (w/v), 20 % glycerol 
 
To prepare Agar plates, 1,5 % (w/v) Agar-Agar has been added to the mediums. 
The plates are stored at 4 °C four to six weeks. Rifampicin plates were stored in a 
dry and dark place, since rifampicin is light sensitive. 
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2.2  Molecular biology methods 
2.2.1  Growth and storage of microorganisms 
2.2.1.1  Escherichia coli 
E. coli liquid cultures were obtained by shaking the inoculated LB medium at 37 °C 
in air bath shaker (Multitron Shaker, type Aerotron, 37 °C, 240 rpm). The cells can 
be streaked on a plate and kept in the incubator over night. After that, the plate can 
be stored at 4 °C for six weeks. For frozen cultures, the colony from the backup 
plate was inoculated in 2 ml LB medium with the correspondent antibiotic and grown 
over night. The cells are then harvested, resuspended in frozen cultures medium, 
vortexed and frozen in liquid nitrogen before storing them at -80 °C 
2.2.1.2  Paracoccus denitrificans 
P. denitrificans cells can be grown in LB medium or in succinate medium. For small 
amounts, the cells are grown in the shaker (Multitron shaker, Typ Aerotron, 32 °C, 
240  rpm)  over  night, similar  to  E.coli. To grow  them  on  a  plate, the strains  are 
normally streaked on the corresponding antibiotic plates and kept over night in a 
incubator at 32 °C (Heraeus B 6120). It is then possible to store the plates at room 
temperature for one week. 
For a preparative scale (10 to 50 L), a frozen culture is streaked out on a plate and 
left  over  night  in  the  incubator  at  32  °C.  The  so  obtained  cell  layer  was  then 
resuspended in 2 ml and used to inoculate a 2 L pre-culture flask. After 24 hours of 
growth, 50 ml of it are inoculated in each 2.5 L succinate medium flask. The cells 
can be harvested after 18-22 hours of growth, at an OD600 value of 3-5.  
For P. denitrificans frozen cultures, see the protocol described for E.coli.  
2.2.2  Isolation of plasmidic DNA in small scale (Miniprep) 
1.5 ml of a 2 ml overnight culture were harvested using a table centrifuge (13.000 
rpm, 2 minutes at room temperature). The supernatant is discarded and the cell 
pellet completely resuspended in 100 µl water. 200 µl from the Mini II solution are 
added and the Eppendorf cup inverted several times, to mix the two solutions and 
lyse the cells. This will make the solution viscous. It is important not to vortex or to 
shake  the  Eppendorf  cup,  since  this  can  lead  to  problems  in  the  separation  of Materials and methods 
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genomic DNA from the plasmidic one. After 5 minutes incubation on ice, 150 µl of 
the  Mini  III  solution  are  added,  and  the  cup  again  mixed  by  inversion.  After  5 
minutes incubation on ice, white flakes of complexes containing SDS, genomic DNA, 
protein and membrane lipids are visible, which are pelletted by centrifugation (13000 
rpm, 10 min, 4 °C). The supernatant will be transferred to a new Eppendorf cup 
avoiding the white pellet and mixed with an equal volume of chloroform/isoamylic 
alcohol (24:1) and vortexed for a minute. After centrifugation (13000 rpm, 5 min, RT) 
the aqueous phase is again mixed with an equal volume of chloroform/isoamylic 
alcohol and again vortexed and centrifuged as before. 
The  aqueous  phase  is  transferred  to  a  new  Eppendorf  cup  and  mixed  with  2 
volumes  of  cold  ethanol  100%,  and  incubated  for  30  minutes  at  -20  °C.  After 
centrifugation  (30  minutes  at  4  °C,  the  supernatant  is  discarded  and  the  pellet 
washed with 1 ml 70 % ethanol, without resuspending it, and again centrifuged 10 
minutes, 13000 rpm, at 4 °C. The supernatant is discarded and the pellet kept 5 
minutes at 37 °C in the opened Eppendorf cup to let ethanol evaporate completely. 
The pellet is then completely resuspended in 50 µl water and incubated with 1 µl 
from a 2 mg/ml RNAse A stock, to remove RNA from the preparation. 
2.2.3  Plasmid DNA restriction 
DNA restrictions have a final volume of 20 µl. This includes the 10X buffer supplied 
with the enzyme from the company, in a 1X final concentration, and 100-300 ng 
plasmidic DNA for an analytic restriction. If requested, 2 µl 10X BSA are also added 
if not included in the supplied buffer. For a preparative restriction, it is necessary to 
calculate the enzyme amount according to the indications of the supplier and to the 
amount of DNA. For a standard restriction, 2.5 U of the enzyme are added. The 
mixture  is  vortexed  and  incubated  for  an  hour  at  the  optimal  temperature.  Most 
reactions can be stopped by heat-inactivation of the enzyme or by addition of 5 µl of 
DNA sample buffer, and the mixture stored at -20 °C or directly analyzed on an 
agarose gel.  
2.2.4  Electrophoretic separation of DNA 
The separation of DNA is achieved in 0.7 to 2 % agarose gels, according to the 
expected  fragment  size.  The  smaller  the  fragments,  the  higher  has  to  be  the 
percentage of the gels. To prepare the gels, the calculated agarose amount has to Materials and methods 
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be cooked in the microwave, until the powder is solved. When the solution is hand-
warm, 5 µl ethidium bromide (10 mg/ml) can be added pro 100 ml of liquid agarose 
solution and carefully mixed by gentle shaking. The solution is then poured into a 
casting chamber with the combs where the sample has to be loaded afterwards.  
The agarose is put in a running chamber filled with TBE buffer so that it stays wet 
during the electrophoretic run. The probe is pipetted in the pockets and the run 
started using a constant voltage (5 V / cm). At the end of the run, the gel is taken out 
from the chamber and put on a transilluminator (TMW 20, Firma UVP) to reveal the 
DNA fragments using the fluorescence of ethidium bromide at 254 nm when it is 
intercalated in DNA. To reveal fragments which should be recovered from the gel, a 
UV light at 365 nm is used, to avoid the formation of thymin dimers in the DNA, 
which could lead to mutations. At the end of the observation, a picture is taken to 
document the gel. 
2.2.5  DNA extraction from agarose gels 
The bands of interest can be cut out the gel using a scalpel and transferred to an 
Eppendorf cup. To extract them from the gel, the Zymoclean Gel Extraction kit from 
the  company  Zymo  Reasearch  has  been  used.  At  the  end,  the  desired  DNA  is 
purified from the gel and resuspended in water (30 µl or 10 µl, according to further 
use). 
2.2.6  Ligation of DNA fragments 
Ligations  are  pipetted  to  a  final  volume  of  10  µl,  adding  1  µl  of  ligation  buffer 
supplied  by  Fermentas  together  with  the  enzyme,  1  µl  of  DNA  ligase  (1  U), 
equimolar amounts of vector and insert (at least 25 ng for a sticky end ligation, and 
200 ng for a blunt end one) and the rest filled with water uo tp 10 µl. The reactions 
takes place at least for an hour (overnight for blunt end ligations) at 22 °C, and 
subsequently the ligase is inactivated at 65 °C for 10 minutes. To improve the yield 
of the ligation in case of a blunt end ligation or ligation with two identical sticky ends, 
or  to  avoid  the  insertion  of a  chain  of inserts into  the  vector,  the  vector  can  be 
dephosphorylated with the Calf Intestinal Alkaline Phosphatase (CIAP). Materials and methods 
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2.2.7  Production E.coli competent cells 
2 ml of an E.coli overnight culture are prepared from a frozen culture. The next day 
50 ml LB medium are inoculated to have a 0.5 % culture. The culture is shaken at 
37 °C until an OD550 of 0,45/0,5 is reached, and kept for 10 minutes on ice. Then the 
cells  are  pelletted  (Megafuge  3400  rpm,  at  2000  g  and  0  °C,  10  min).  The 
supernatant is thrown away carefully, and any remaining medium is pipetted away. 
The pellet is then resuspended in 1 ml cold TFB I buffer, and again 6.5 ml of the 
same buffer added and mixed by inverting it. The cell suspension is incubated one 
hour on ice and afterwards pelletted (BIORAD Megafuge 4800 rpm, bei 3000 g und 
0 °C). The pellet is then carefully resuspended in 2 ml cold TFB II buffer. The cell 
suspension is aliquoted (100 µl) and frozen in liquid nitrogen. Afterwards, the cells 
can be stored at -80 °C. 
2.2.8  Transformation of E.coli competent cells 
An aliquot of competent cells is thawn on ice (20 minutes) and 20-50 ng DNA from 
the ligation or 1 ng from the plasmidic DNA which is needed to be retransformed 
added, and carefully mixed with the pipette tip. After 20 minutes incubation on ice, 
follows the heat shock at 42 °C for one minute, 900 ml of fresh LB medium are then 
added and the cell suspension left 1 h at 37 °C in an Eppendorf Thermomixer under 
shaking. At the end, the cells can be plated (100% or splitting them in two  aliquots, 
90 % and 10 %) on plates with the appropriate antibiotics. 
2.2.9  Conjugation: Triparental Mating 
The  P.  denitrificans  strains  used  in  this  works  possess  no  natural  or  chemical 
competence. Therefore conjugation is normally used. The plasmids and the strains 
used  in  the  normal  laboratory  work  possess  no  tra  functions,  necessary  for  the 
conjugation. These genes are present in a helper strain, E. coli MM294, having a 
mobile plasmid (pRP4-7) which will be transferred in the donor strain (DH5ʱ), now 
made able to transfer the desired vector into the recipient strain (MK6: bc1 deletion 
mutant).  The  three  strains  are  inoculated  in  a  2  ml  overnight  culture  with  the 
corresponding antibiotic. The next day, 300 µl of the recipient strain and 100 µl from 
the helfer and the donor strains are mixed together and the cells pelletted with a 
table  centrifuge  (6000  rpm,  3  minutes,  room  temperature).  The  supernatant  is 
discarded and the cells resuspended in 100 µl fresh LB medium and in a single drop Materials and methods 
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transferred to a LB plate without any antibiotic. The plate is incubated overnight at 
32 °C, and the next day the cells scratched away and resuspended in 500 µl LB 
medium.  This  suspension  is  diluted  in  a  row  from  1:4  to  1:32  and  plated  on 
Rif/Km/Sm  or  Rif/Km/Gm20  or  Rif/Km/Sm/Gm20  plates,  according  to  the  desired 
selection.    Km,  Sm  and  Gm  select  P.  denitrificans  cells  which  have  received  a 
plasmid  after  conjugation.  Rif kills the  E. coli  cells. The plates  are incubated 24 
hours at 32 °C and single colonies are picked and transferred to a backup plate for 
further analysis. 
2.2.10  Phosphorilation of oligonucleotides 
In an Eppendorf cup 2 μl PNK 10x reaction buffer supplied from the company are 
pipetted, plus 4 μl of a 5 mM ATP solution, 1 μl T4-Polynucleotid-Kinase, 100 pmol 
of the oligonucleotide and destilled water up to 20 µl final volume. After 30 minutes 
at 37 °C, the mixture is inactivated at 70 °C for 10 minutes. 
2.2.11  Polymerase Chain Reaction  
The  polymerase chain reaction, PCR, is used to amplify DNA. The polymerases 
used  are  thermostabile,  and  this  makes  possible  to  achieve  several  cycles  of 
amplification  without  adding  after  each  denaturation  step  new  enzyme.  An 
amplification cycle starts with a denaturation step at 98 °C, during which the two 
DNA  strands  are  separated.  In  the  annealing  step,  oligonucleotides  anneal 
specifically  to  the  complementary  sequence  on  the  DNA  strand.  The  melting 
temperature for the primers is calculated in silico with the software Clone Manager 
and  the  annealing  temperature  calculated  by  subtracting  10  °C.  During  the 
elongation  step,  the  primer  is  elongated  in  direction  5´  to  3´  at  72  °C  by  the 
thermostabile polymerase. The cycles duration and number can vary, according to 
the different application of the PCR and the kind of polymerase used. In this work, 
the  Phusion  polymerase  from  Finnzymes  has  been  used,  which  has  a 
polymerisation  rate  of  3500  bp*min
-1.  For  a  PCR  reaction,  20-50  ng  of 
oligonucleotide are used and 1-2 ng of template DNA. For a 50 µl reaction, 2.5 U of 
enzyme and 100 µM dNTPs are required. Annealing temperatures and protocols are 
adapted to each application and polymerase. 
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Cycles  Steps  Time [min]  Temperature [°C]  Function 
1  1  1  95  Pre-denaturation 
30  1  0:30  95  DNA strands separation 
30  2  0:30  5060  Annealing 
30  3  0:1560  72  Elongation 
         
2.2.12  Site directed mutagenesis 
The mutation of a specific amino acid in a protein is achieved by changing the DNA 
sequence which codes for that rest, using the directed mutagenesis. In this work, 
directed  mutagenesis  was  achieved  by  inverse  PCR.  With  this  technique,  the 
plasmid which has to be mutagenised is used as template in a PCR which uses two 
primers: the forward contains the mutation, and the reverse without the mutation 
binds exactly where the forward starts and runs in the opposite direction. Therefore, 
are  produced  copies  of  the  plasmidic  DNA  which  contains  the  mutation  in  the 
desired position and are open. The PCR product is run on a preparative gel, and 
purified using the DNA Gel Extraction kit and eluted using 20 µl of water. Then, 5 µl 
of the eluted DNA are phosphorylated and ligated at the same time and after 2 
hours of ligation transformed into DH5ʱ competent cells. The next day, colonies are 
picked from the plate, inoculated in LB medium with the corresponding antibiotic and 
the plasmidic DNA analyzed by restriction and sequencing.  
2.2.13  DNA Sequencing 
DNA has been sequenced from the company Scientific Research and Development 
GmbH (SRD GmbH) Köhlerweg 20 D-61440 Oberursel, with the chain termination 
method (165) 
2.3  Protein biochemistry 
2.3.1  Analytic membrane preparation 
Initially, a 2 ml culture of the desired P. denitrificans strain is grown over night at 
32 °C with the needed antibiotics. The pre-culture is then inucolated in a 2 L flask 
containing  400  ml  of  succinate  medium  with  antibiotics  and  grown  over  night  at 
32 °C and 250 rpm. The next day, the cultures are cooled down on ice and the cells Materials and methods 
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harvested  in  a  Sorvall  centrifuge  at  6000  rpm  and  4  °C.  The  supernatant  is 
discarded and the cell pellet resuspended in 5-10 ml of 50 mM KPi buffer pH 7, 10 
mM EDTA. Cells are lysated using lysozyme (0.1 mg/ml) and incubated 30 minutes 
on ice. The solution is now viscous, due to the cell disruption and the release of 
genomic DNA. To achieve a complete cell disruption, the solution is schock frozen in 
liquid nitrogen creating so water crystals which help disrupting completely the cells. 
After thawing the sample at room temperature, it follows a 5-10 minutes treatment 
with a Branson Sonifier 250 (duty cycle 30 %, output 40 %) on ice, until the solution 
is  not  anymore  viscous  since  the  genomic  DNA  is  completely  destroyed.  The 
sample is afterwards centrifuged (Sorvall Centrifuge SS34-Rotor in 10 ml tubes, 10 
minutes at 10000 rpm and 4 °C) and the supernatant transferred in ultracentrifuge 
tubes to be again centrifuged (Beckman ultracentrifuge, Ti-70-Rotor, 1 hour, 35000 
rpm at 4 °C). Membranes are present in the pellet fraction, which is then recovered 
from the ultracentrifuge tubes and resuspended using a Teflon pistil in 200 µl 20 mM 
KPi pH 8, 1 mM EDTA. Membranes are frozen in liquid nitrogen and stored at -80 °C 
2.3.2  Membrane preparation (preparative scale) 
2.5 L flasks of P. denitrificans cells are prepared as previously described. Cells are 
then harvested at an OD600 of 3-5 in a Sorvall RC36 for 20 min at 5000 rpm and  
4 °C after cooling down the flasks. The cell pellett is resuspended in 100-200 ml of 
cold 100 mM KPi, pH 8, 1 mM EDTA buffer and frozen at -80 °C. This helps also the 
cell disruption later. To lysate the cells, after thawing, the protease inhibitor Pefabloc 
SC is added to a 100 µM final concentration and a Monton-Gaulin homogenisator 
(APV  Schröder,  Lübeck)  used  for  5  minutes  at  400  bar  pression.  The  warmth 
generated from the homogenisator is compensated by the presence oa ah ice bath. 
The instrument is washed with buffer in order to recover all the cell material and 
subsequently with 20 % ethanol to eliminate any cell rest. The sample is centrifuged 
in a Sorvall RC36 centrifuge at 5000 rpm for 15 min in order to sediment big cell 
fragments and granules. The supernatant is centrifuged again over night in a Sorvall 
centrifuge,  GS3  Rotor  at  8000  rpm,  presenting  the  next  day  a  hard,  white  core 
(granules) and a soft, red external part where the membranes are. This red pellett is 
transferred  to  a  becker  and  resuspended  in  50  mM  MES/NaOH  pH  6,  300  mM 
Saccharose (or 50 mM NaPi pH 8, 300 mM Saccharose according to the desired 
applications) using an Ultra Turrax Homogenisator. It follows the last centrifugation Materials and methods 
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step (Beckmann ultracentrifuge Ti 45-Rotor, 1 hour, 35000 rpm at 4 °C) to better 
separate the membranes from the storage ganula. The so obtained membranes are 
then resuspended in a small volume of the same buffer previously used, aliquoted 
and frozen at -80 °C. 
2.3.3  Membrane solubilisation 
2.3.3.1  Classic purification of the cytochrome bc1 complex  
Membrane aliquots are thawn and the protein concentration is set to 35 mg/ml using 
the membrane  buffer. Membranes  are  solubilised  upon  addition  of  Pefabloc  SC,  
100 µM final concentration, and one volume of solubilisation buffer 2X, 1.2 times 
DDM compared to the protein amount (w/w) and water to final volume. The solution 
is then stirred one hour at 4 °C. The solubilisate is then centrifuged (Beckmann Ti 
45 Rotor 35000 rpm, 1 hour at 4 °C) and the supernatant, which now has a NaCl 
concentration  of  600  mM,  diluted  to  350  mM  NaCl  using  the  dilution  buffer  and 
filtered using a paper filter. 
2.3.3.2  Purification by affinity chromatography (Ni
2+-NTA)  
Membrane aliquots are thawn and the protein concentration is set to 35 mg/ml using 
the membrane buffer NaPi. Membranes are solubilised upon addition of Pefabloc 
SC, 100 µM final concentration, and one volume of solubilisation buffer imidazol or 
histidine 2X, 1.2 times DDM compared to the protein amount (w/w) and water to final 
volume.  The  solution  is  then  stirred  one  hour  at  4  °C.  The  solubilisate  is  then 
centrifuged (Beckmann Ti 45 Rotor, 35000 rpm, 1 hour at 4 °C) and the supernatant 
filtered using a paper filter. 
2.3.3.3  Purification by affinity chromatography (StrepTactin) 
Membrane aliquots are thawn and the protein concentration is set to 35 mg/ml using 
the membrane buffer NaPi. Membranes are solubilised upon addition of Pefabloc 
SC, 100 µM final concentration, and one volume of solubilisation buffer with avidin 
2X, 1.2 times DDM compared to the total protein amount (w/w) and water to final 
volume.  The  solution  is  then  stirred  one  hour  at  4  °C.  The  solubilisate  is  then 
centrifuged (Beckmann Ti 45 Rotor 35000 rpm, 1 hour at 4 °C) and the supernatant 
filtered using a paper filter. Materials and methods 
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2.3.4  Chromatography 
All the chromatographic experiments are done at 4 °C 
2.3.4.1  Classic purification of the cytochrome bc1 complex 
The  column  (DEAE-Sepharose  CL-6B,  ca.  250  ml,  FPLC  Pharmacia  LKB)  is 
equilibrated with 4 column volumes (CV) equilibration buffer and 2 CV low salt buffer. 
The  solubilisate  is  applied  to  the  column  with  a  flow  rate  of  3.5  ml/min,  and 
afterwards washed with 1 CV of low salt buffer. All proteins not tigthly bound to the 
column are washed away. The bc1 complex is eluted with a 6 CV NaCl gradient 
(350-600 mM NaCl). The elution profile is registered with a detector (Pharmacia 
Optical Unit UV-1, 280 nm) and a writer (Pharmacia Rec 102). The elution of the red 
fractions containing the bc1 complex happens around 420-450 mM NaCl, and the 
fractions are analysed spectroscopically and by SDS-PAGE and Western Blot. The 
fractions containing no undesired protein are collected and concentrated to a factor 
of 150-200 (Satorius Vivaspin cutoff 100 kDa). 
2.3.4.2  Purification by affinity chromatography (Ni
2+-NTA) 
The column (Ni
2+-NTA-Superflow, ca. 20 ml, FPLC Pharmacia LKB) is equilibrated 
with  4  column  volumes  (CV)  equilibration  buffer  and  2  CV  low  imidazole  or  low 
histidine buffer. The solubilisate is applied to the column  with a flow rate of 1 ml/min, 
and  afterwards  washed  with  1  CV  of  low  imidazole  or  low  histidine  buffer.  All 
proteins not tigthly binding to the column are washed away. The bc1 complex is 
eluted with a 5 CV gradient (10-250 mM imidazole or 10-200 mM histidine). The 
elution profile is registered with a detector (Pharmacia Optical Unit UV-1, 280 nm) 
and a writer (Pharmacia Rec 102). The elution of the red fractions containing the bc1 
complex happens about 150 mM imidazole and 80 mM histidine. The fractions are 
analysed spectroscopically and by SDS and Western Blot. The fractions containing 
no undesired protein are collected and concentrated to a factor of 150-200 (Satorius 
Vivaspin cutoff 100 kDa). 
2.3.4.3  Purification by affinity chromatography (StrepTactin) 
The column (Core-Streptavidin, 5 ml, FPLC Pharmacia LKB, 0,5 ml/min) is washed 
with 6 CV equilibration buffer. The solubilisate is loaded and the column washed 
with  1  CV  equilibration  buffer  to  wash  away  the  protein  not  tightly  bound.  The Materials and methods 
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complex  is  eluted  with  2  CV  elution  buffer  in  a  single  step.  The  fractions  are 
analysed  spectroscopically  and  by  SDS-PAGE  and  Western  Blot.  The  fractions 
containing no undesired protein are collected and concentrated to a factor of 150-
200 (Satorius Vivaspin cutoff 100 kDa). 
2.3.4.4  Purification of the cytochrome c552F 
Two  different  columns  are  used  to  purify  the  cytochrome  c552F  heterologously 
expressed in E.coli, an ion exchange (Q-Sepharose) and the gel filtration (Sephacryl 
S-100). The first column is equilibrated with the 4 CV Q-Sepharose washing buffer, 
and the periplasma loaded on it. After loading the column, it is washed with 1 CV of 
the same buffer. The protein is eluted with 5 CV NaCl gradient (0-350 mM). The 
fractions (ca. 5 ml) are analyzed with SDS PAGE, and where no impurity has been 
found, collected and concentrated. The concentrated sample is run on the second 
column, previously equilibrated with 4 CV of the gel filtration buffer. The run occurs 
with the same buffer. The protein is eluted in 0.5 ml fractions, analyzed by SDS 
PAGE and collected to be concentrated 
2.3.5  Lowry 
The solution for the Lowry measurement has always to prepared fresh. It contains 
20 ml Lowry A, 0.5 ml Lowry SDS solution, 0.2 ml Lowry B1 and 0.2 Lowry B2. The 
standards are prepared with BSA in the following amounts: 0.0, 2.0, 4.0, 6.0, 8.0, 
1.0 and 1.5 mg/ml. Standards and samples have a total volume of 50 µl. To these, 
850 µl from the Lowry solution are added, vortexed well and incubated in the dark 
for 10 minutes. Next, 100 µl of the Folin solution are added and kept 30 minutes in 
the dark. Reading the OD750 of the standards and making a linear regression, is then 
possible to determine the protein concentration of the sample (166). 
2.3.6  Polyacrylamide gel electrophoresis (PAGE) 
2.3.6.1  Tricine system (Schägger) 
For the SDS PAGE has been used the Schägger sistem, specific for proteins with a 
Mr < 1-100 kDa (167). The 10 % lower gel is prepared pipetting 2 ml acrylamide 
solution, 3.5 ml H2O, 3.3 ml Gel buffer, 1 ml Glycerol, 20 μl TEMED and 100 μl of a 
10 % APS solution, mixing and quickly pouring in the casting chamber (Mini Protean Materials and methods 
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II, BIORAD).  After polymerisation, the upper gel is prepared (0.5 ml acrylamide 
solution, 6 ml H2O, 1.5 ml Gel buffer, 20 μl TEMED und 100 μl 10 % APS) and 
poured over it, using a comb for the pockets. The samples are mixed with Sample 
buffer (1:1) and kept 30 minutes at 37 °C to allow denaturation of the proteins. The 
gel apparatus is then put in a running chamber and the inside of it is filled with 
catode buffer while the rest with anode buffer. The probes are loaded onto the gel 
using  a  Hamilton  syringe;  the  gel  runs  with  a  constant  voltage  (100  V  for  100 
minutes). 
2.3.7  Gel staining 
2.3.7.1  Coomassie staining 
The  gel  is  kept  in  the  Coomassie  staining  solution  for  20  minutes  at  room 
temperature. The extra Coomassie bound to the gel can be washed away until the 
desired background is obtained with the Coomassie destaining solution. 
2.3.8  Westernblot (semidry) 
Three pieces filter paper wet with some semidry buffer are put in the semidry blot 
apparatus  (BIORAD),  upon  them  a  layer  of  nitrocellulose  membrane  (Whatman) 
also previously wet with the same buffer and the acrylamide gel on it. It is important 
to avoid air bubbles which can lead to an improper protein transfer during the Blot. 
Upon the gel, again wet filter paper is put, ad the “sandwich” is then closed in the 
Blot apparatus. The upper part of it is the negative pole, and the negatively charged 
proteins are forced, by applying voltage (15 V, 1 hour) to move in the direction of the 
positive pole, meaning to the nitrocellulose membrane.  After one hour, the gel and 
the filter paper are discarded and the nitrocellulose membrane is washed with some 
distilled water in order to wash away ions which would interfere with the Ponceau 
staining. The membrane is then stained with the Ponceau solution for five minutes. 
The protein bands will appear on it, since Ponceau binds reversibly to proteins when 
no ions are present and can be easily and totally be washed away with destilled 
water. The marker bands are marked with a pen and the membrane destained. Materials and methods 
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2.3.8.1  Western blot protocol 
The membrane is “blocked” with BSA 3 % in TBS for one hour. BSA binds onto the 
membrane and occupies all the positions were no proteins are bound, avoiding that 
the antibody later could bind on unspecific position and give background staining.  
The  primary  antibody  (monoclonal from  mouse  against the  His tag,  or  policlonal 
from rabbit for the protein of the respiratory chain from Paracoccus denitrificans) is 
diluted 1:1000 in BSA solution and incubated shaking with the membrane for two 
hours or over night. Subsequently, the membrane is washed three times with TBS-
TT  and  again  with  TBS  to  wash  away  restiduals  of  the  antibody  not  specifically 
bound to the protein of interest. The membrane is then incubated with the secondary 
antibody (also diluted 1:1000 in BSA solution) for one hour. The secondary antibody 
can be, in the case of the anti His-tag Blot, a goat anti mouse IgG directed against 
the primary one, or a Protein A-Alkaline Phosphatase conjugate (AAP) in the case of 
policlonal antibody from rabbit. In the case of the anti Strep-tag Blot, a mouse IgG is 
used  to  bind  the  Strep-tag,  directly  coupled  to  the  Alkaline  Phosphatase,  and 
therefore, after 30 minutes incubation with the first antibody, the membrane can be 
washed with TBS-TT and directly stained. 
After the secondary antibody incubation, the membrane is then washed three times 
with TBS-TT, once with TBS and with TMN buffer. TMN is a buffer with pH 9.5, 
which equilibrates the membrane at the right pH to let the Alkaline Phosphatase 
work in presence of the two substrates.  
The staining solution is 20 µl TMN buffer and 90 µl NBT and BCIP. After puring it on 
the membrane, it is incubated in the dark to avoid unspecific background and the 
reaction is then stopped, when the bands are visible, using 10 ml 50 mM EDTA. By 
keeping the membrane wet, is now possible to document it 
2.4  Biophysics methods 
2.4.1  Enzymatic activity tests 
To measure the activity of the cytochrome bc1 complex, the change in absorption at 
550 nm is detected, which shows the change in the redox state of the cytochrome c 
from  horse  heart.  For  the  measurements  with  cytochrome  c552F,  the  absorption Materials and methods 
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change at 552 nm has been recorded. The electron donor is decylquinol, analog to 
the native substrate, ubihydroquinone. 
2.4.1.1  Decylubiquinone reduction 
To reduce the substrate, 50 mg decylquinone are solved in 3 ml ethanol and 1 ml 
water is added. The solution is deep yellow. 100 µl of 1 M HCl are added to regulate 
the pH. Decylubiquinone is reduced by the careful and slow addition of KBH4, which 
can be optically seen since the solution becomes transparent. Bubbles are produced 
during the reduction process. Afterwards, in 20 µl steps, 1 M HCl is added until no 
more bubbles are visible, since the excess of KBH4 has been removed. The pH has 
to be checked with pH indicators and has to be kept below 4. Then, 2 ml of water 
are added and the sample is mixed 3 times with 5 ml cyclohexane. The organic 
phases are then collected and again washed 2 times with water. The sample is then 
aliquoted  in  150  µl  aliquots  in  small  Eppendorf  cups  and  the  organic  phase  is 
evaporated using a SpeedVac. The aliquots are stored at -80 °C, and resuspended 
in 40-60 µl ethanol mit 100 µM HCl give a solution of about 50 mM. To check the 
amount  of  reduction,  a  spectrum  from  the  sample  is  measured,  afterwards  it  is 
oxidized  with  some  µl  of  a  fresh  1  M  NaOH  solution,  and  again  messed.  The 
difference spectrum allows the calculation of the decylubiquinol concentration (168, 
169) using the extinction coefficient : ε275, oxred = 12,5 mM
-1cm
-1. 
2.4.1.2  Measurements 
The complex III activity can be measured by following the increasing of absorption at 
550 nm (for the measurement with horse heart cytochrome c) or 552 nm (for the 
case of cytochrome c552F. In a 1 ml disposable cuvette, 1 ml of the measuring buffer 
is pipetted together with 10 µl of a 2.5 cytochrome c from horse heart stock solution 
and 2 µl of the aforementioned decylubiquinol stock solution (ca 50 µM). When the 
spectrophotometer shows a stable baseline, the previously diluted protein sample 
(1:100 for membranes, 1:1000 for purified proteins) is then added, quickly mixed 
and  the  absorption  change  is  measured. The activity  is  normally  measured  in  a 
window between 40 and 120 mOD. The initial rate is measured in a time  of 10 
seconds and the slope calculated by linear regression. In the case of steady-state 
kinetics, different concentrations of cytochromes c and c552F are used instead of a 
fixed one Materials and methods 
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2.4.1.3  Redox spectra  
Redox  spectra  can  be  made  directly  with  purified  proteins.  In  the  case  of 
membranes,  it  is  necessary  to  solubilise  the  protein from  the  lipids.  This  occurs 
using the Spectra buffer, which is then mixed in ratio 20:1 with 25 % Triton X-100. 
The sample is afterwards vortexed and centrifuged (30 min at 4 °C in Heraeus table 
centrifuge at 13000 rpm). Thereby the solubilized proteins are separated from the 
lipid portion and a spectra can be measured. (In the case of purified protein, some µl 
of the concentrated sample are diluted in the elution buffer and measured.) The 
supernatant  is  transferred  to  a  glas  cuvette,  and  the  sample  is  first  completely 
oxidized with potassium ferricyanide(III), to record an oxidized spectrum (Hitachi U-
3000 Photometer, wavelengths 500-650 nm) which serves as baseline. The sample 
is afterwards reduced with sodium ascorbate (to reduce especially c-type hemes) 
and/or with sodium  dithionite (to reduce all the cofactors) and again a spectrum 
recorded. The result is a typical redox spectrum which shows the kind of cofactors 
present and allows an estimation of their concentration by measuring the hight of the 
single peaks (normally the ʱ- and β- bands between 500 und 650 nm are used for 
this aim). 
Protein  Heme  Wavelength 
[nm] 
Extinction coefficient 
ε [mM
-1cm
-1] 
Reference 
cyt b  b  560-574  28.5 / 29.3  (170, 171) 
cyt c  c  550  19.4  (172) 
cyt c1  c1  553-540  20.1 / 23.2  (170, 173) 
 
2.4.1.4  Pre steady-state cytochrome c1 reduction: Stopped-flow  
To  measure  the  rate  of  cytochrome  c1  reduction  in  the  bc1  complex  from 
P.  denitrificans  the  Stopped  Flow  has  been  used  in  collaboration  with  Prof. 
Francesco  Malatesta  in  the  lab  of  Prof.  Maurizio  Brunori  at  the  university  “La 
Sapienza” in Rome. A fixed amount of cytochrome bc1 complex (ca. 5 µM) has been 
mixed with increasing amounts of sodium ascorbate (1, 2, 4, 7 and 10 mM before 
mixing) and the signal at 420 nm recorded. The syringes with the samples were kept 
on ice until used, and the experiments made at 10 °C. The buffer used was 50 mM 
MOPS/NaOH pH 7.5, 100 mM NaCl, 0.04 % DDM, 1 mM EDTA and 1 mM KCN.  Materials and methods 
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The conditions used are  Pseudo First Order conditions (PFO), meaning that the 
concentration of sodium ascorbate is so high compared to the bc1 concentration that 
it can be considered constant during the reaction, since it does not vary much. This 
approximation  is  normally  used  to  simplify  the  calculation  of  constant  from 
bimolecular  reactions,  which  would  be  otherwise  calculated  using the η-equation 
(174)  in  conditions  were  the  PFO  approximation  cannot  be  assumed.  The  PFO 
approximation  can  be  described  as  follows,  for  the  reaction  in  equation  2. 
 
C B A     Equation 2 
 
In this case, the concentration of the product C in the time is: 
     B A k
dT
C d
ET
   Equation 3 
 
If the concentration of one of the reagent (in this example B) is much higher than the 
concentration of A, it can be considered as constant.  
 
OBS ET
k B k     Equation 4 
 
The 2.1 can be then also written as follows:  
    A k
dT
C d
OBS
   Equation 5 
 
The kOBS is a PFO constant, from which it is possible to calculate the second order 
kinetic constant by plotting the kOBS against the concentration of B. 
After recording the signals, they were fitted to a mon- or bi-exponential mathematic 
model described in Equations 6 and 7. 
 
offset e a y
t k  
 * *  Equation 6 
 
 t k e a y
* 1 * 1 offset e a
t k 
 * 2 * 2  Equation 7 
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2.4.1.5  Time resolved stopped-flow  
The  measurements  were  performed  in  collaboration  with  Prof.  Bernard  L. 
Trumpower  and  Dr.  Raul  Covian  at  the  Dartmouth  Medical  School  in  
New Hampshire, USA.  
2.4.1.6  Pre  steady  state  reduction  of  cytochrome  c1  and  cytochrome  b  
in presence of antimycin  
Pre-steady state reduction of cytochrome c1 and cytochrome b was followed at room 
temperature by stopped flow rapid scanning spectroscopy using the OLIS Rapid 
Scanning Monochromator. For the experiments 2 µM of enzyme were used, with 
and without 2.5 µM antimycin, in the measuring buffer (100 mM Tris-HCl, pH 8.0, 2 
mM sodium azide, 0.2 mM EDTA, and 0.05% DDM). The cytochrome bc1 complex 
was measured against an equal volume of buffer containing several concentrations 
of decylubiquinol. The traces were exported using software from OLIS and fitted to a 
monoexponential or a biexponential mathematical model using the software Origin 
5.0.  
2.4.1.7  Steady-state cytochrome c reduction with and without antimycin 
The electron acceptor used in these experiments is the horse hearth cytochrome c, 
whose  reduction  was  followed  at  room  temperature  using  OLIS  Rapid  Scanning 
Monochromator. 100 nM enzyme and horse heart cytochrome c have been mixed 
against an equal volume of buffer with different concentrations of decylubiquinol. 
The  absorbance  change  between  550  and  539  nm  has  been  extracted  using  a 
software  from  OLIS  and  exported  to  Origin  5.0,  where  the  initial  absorbance 
increase  has been fitted to a linear regression and expressed as turnover numbers 
(mol cytochrome c reduced/mol bc1 monomer/s),using an extinction coefficient of  
21.5  mM
-1cm
-1  (63).  The  calculated  initial  rates  are  then  fitted  to  the  Michaelis-
Menten equation. The enzyme (100 µM) was kept on ice. Several concentrations of 
inhibitor were added to this stock solution and left 2 minutes on ice to let the binding 
occurr. After this incubation, the enzyme has been diluted to a final concentration of 
100 nM, and 20 µM cytochrome c were added. The sample was then mixed against 
an equal volume of buffer containing 80 µM decylubiquinol. The absorbance change 
at 550 versus 539 nm has been extracted and rates calculated as described above. Materials and methods 
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Six individual data sets per antimycin concentration are shown in the results and 
fitted to a model already described (148). 
2.4.1.8  Flash photolysis experiments  
For the laser flash experiments a Phase R model DL 1400 Laser has been used, 
which generates an excitation pulse of 480 nm and 0.4 µs period using a Coumarin 
LD 490 dye. The detection system used is the one described from Heacock et. al. 
(175).  In  a  micro-glass  cuvette  were  mixed  300  µl  of  buffer  (according  to  the 
different c-type cytochrome used), 5 µM cytochrome c552F (or isoform 1 of the yeast 
cytochrome  c)  coupled  to  ruthenium,  5  µM  cytochrome  bc1  complex  from  
P. denitrificans, 2 mM sodium ascorbate, 2 µM TMPD. Also a sacrificial oxidant was 
used  according  to  the  experiment,  [Co(NH3)Cl]
2+  and  pentaamine  osmium  for, 
respectively, the cases of Ruz-H39C-Cc and Ruz-N23C-c552F. The salt concentration 
has been increased using a 2 M KCl stock solution and each time a new spectrum 
recorded in order to check the redox state of the bc1 complex in the cuvette. The 
experiments were carried out at 10 °C, and each condition has been tested with 
different time scales and 2 different wavelengths (550 or 552 nm for the reduction of 
the substrate cytochromes and 558 nm for the oxidation of cytochrome c1 (176), to 
make  sure  that  the  reaction  was  observed  in  each  component.  The  transient 
obtained  from  the  meaurements  were  fitted  using  the  program  SIFitting  5.0  and 
mathematically fitted to a mono- or a bi-exponential equation and a kOBS obtained 
which describes the electron transfer process between the two reaction partners. 
The kOBS calculated from the transients have been plotted against the square root of 
the  ionic  strength  to  obtain  the  Brønsted  plot  which  describes  the  interaction 
observed between the cytochrome bc1 complex and the substrates. 
2.4.1.9  Flash photolysis internal kinetics  
With the same system, using a ruthenium dimer, it is possible to determine the rate 
for the reduction of cytochrome c1 from the ISP. In this case, the same experimental 
setup as in 2.4.1.8 has been used, but instead of the cytochromes c coupled with 
ruthenium, a ruthenium dimer in solution takes an electron away from cytochrome c1 
and lets the ISP deliver an electron to the cytochrome c1. The measurements were 
performed with several inhibitors. The transients obtained from these measurements 
were fitted as previously described to a single or a double exponential equation. Results 
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3  Results 
The results presented in this work will be divided into four sections, dealing with the 
dimeric  nature  of  the  complex,  the  interaction  with  its  substrate,  the  internal 
regulation facilitated by the substrate and the electron transfer pathway 
3.1  Dimeric nature of the complex 
The aim of this section is to analyse the dimeric structure of the  bc1 complex in  
P. denitrificans and prove the regulation mechanism already presented by Covian et 
al. (145) in the past. For the analysis, a deletion mutant of the acidic domain in 
cytochrome c1 has been used, since the wild type protein is a “dimer of dimers” (177) 
and this posed several problems, as already discussed by (152). 
3.1.1  Purification and characterization of the deletion mutant  
In a previous work (110), the fbc operon with a deletion in the fbcC gene and a C-
terminal 10X His tag has been cloned and homologously expressed (MC1). The 
purification was obtained with Ni
2+-NTA affinity chromatography and eluted with an 
imidazole  gradient  (0-200  mM).  The  complex  normally  eluted  around  150  mM 
imidazole  and  the  eluate  was  concentrated  using  100  kDa  cut  off  ultrafiltration 
membranes (Fig. 8). 
 
Fig. 8: Chromatogram of the purification of the deletion mutant of the cytochrome bc1 
complex from P. denitrificans by a Ni
2+-NTA column. The elution is obtained with an 
imidazole gradient. On the right, the concentrated protein on a SDS PAGE, silver 
stained (chromatogram from (152)). 
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From redox spectra, it was clear that the reducibility of the mutated cytochrome c1 
was strongly impaired. In Fig. 9 static spectra are shown where the complex has 
been  reduced  with  increasing  amounts  of  ascorbate  to  selectively  reduce 
cytochrome c1, and finally with dithionite to achieve a complete reduction of all redox 
cofactors. As control, the wild type complex (WT) and its His tagged version (TK33) 
were  measured  as  well.  Cytochrome  c1  in  the  wild  type  complex  is  completely 
reduced by ascorbate at 1 mM concentration, and later addition of reductant does 
not increase the signal in the spectra. On the other hand, a shoulder at 560 nm 
appears, speaking for reduction of cytochrome b. Ditionite reduces completely all 
the  redox  cofactors.  In  the  His  tagged  and  the  mutant  complex  only  a  partial 
reduction of the c1 heme can be observed, even with excess of reductant. At the 
same time, a more definite signal at 560 nm can be recorded, indicating cytochrome 
b reduction. 
 
 
Fig. 9: Static spectra from the wild type (A), the His tagged (B) and the deletion mutant 
(C)  bc1  complexes  from  P.  denitrificans.  In  panel  A,  the  wild  type  complex  is  well 
reduced at 1 mM ascorbate. In panels B and C, even 10 mM ascorbate is not enough 
to  achieve  complete  reduction  of  cytochrome  c1.  Dithionite,  on  the  other  hand, 
reduces completely all redox cofactors. In black, the oxidized spectrum; red: 1 mM 
ascorbate; green: 5 mM ascorbate; blue: 10 mM ascorbate; light blue: dithionite. Results 
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The wild type complex is purified by ion exchange chromatography (DEAE), since 
the acidic domain, with its strong negative charge, binds the protein to the positively 
charged resin. The His tagged wild type and the mutant complex are both purified by 
a Ni
2+-NTA column and eluted with an imidazole gradient. It was already reported in 
the  literature  that  imidazole  is  detrimental  to  cytochrome  c1  (for  example  in 
Rhodobacter  sphaeroides  cytochrome  bc1  (178,  179)),  impairing  the  turnover 
number of the complex and the reducibility of the c1 heme. This effect, in the case of 
the  P.  denitrificans  cytochrome  bc1  complex  was  unknown.  Thereafter,  the  His 
tagged proteins have been purified using a buffer containing histidine for  elution 
instead  of  imidazole.  The  purification  protocol  remains,  nevertheless,  the  same. 
Membranes are solubilised as described in section 2.3.3, ultracentrifuged and the 
column  (equilibrated  with  50  mM  sodium  phosphate,  pH  8,  350  mM  NaCl  and 
0.02 %  dodecylmaltoside)  loaded  with  the  supernatant.  A  washing  step  with  the 
equilibration buffer follows until the 280 nm trace reaches baseline, to wash away 
unbound proteins. Elution is obtained by a histidine gradient from 0 to 200 mM in the 
equilibration  buffer.  The  chromatogram  shows  two  peaks:  the  first  has  a  green 
colour and contains the cytochrome  c  oxidase,  the second one is deep red and 
contains the cytochrome bc1 complex. The elution point is slightly shifted from 150 
mM imidazole to 120 mM histidine but the peak containing the complex is very well 
separated from the rest of the membrane proteins (Fig. 10)  
 
 
Fig.  10:  Purification  of  MC1  by  affinity  chromatography  (Ni
2+-NTA)  and  elution  in 
presence  of  histidine.  The  chromatogram  resembles  the  one  obtained  with  the 
imidazole elution, with a slightly shifted elution point.  Results 
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Spectra have been measured also for the complexes purified using the histidine 
elution,  showing  that  the  redox  properties  are  restored,  as  indicated  in  Fig.  11. 
Cytochrome  c1  is  already  fully  reducible  with  1  mM  ascorbate.  No  reduction  of 
cytochrome b is now visible. 
 
Fig. 11: Static spectra of the His tagged wild type (A) and the mutant (B) bc1 complex. 
Small  amounts  of  ascorbate  fully  reduce  cytochrome  c1,  with  dithionite  also 
cytochrome b is reduced. In black, the oxidized spectrum; red: 1 mM ascorbate; green: 
5 mM ascorbate; blue: 10 mM ascorbate; light blue: dithionite. 
 
To characterize the newly obtained mutant complex and to check possible effects of 
the  mutation  on  the  interaction  with  the  substrate,  steady  state  kinetics  were 
performed. Two different substrates were tested, horse heart cytochrome c and the 
physiological  electron  acceptor,  cytochrome  c552F.  Being  the  latter  a  membrane 
bound cytochrome, for all the experiments reported in this work a soluble fragment 
of it has been cloned and expressed (160) containing only the heme binding domain, 
from now on referred to as cytochrome c552F. Steady-state kinetics were performed 
at  room  temperature  measuring  the  initial  velocity  of  the  reaction  at  several 
substrate  concentrations,  repeating  each  measurement  three  times  for 
reproducibility.  In  a  disposable  cuvette,  the  appropriate  amount  of  horse  heart 
cytochrome c or cytochrome c552F has been mixed with 25 µM decylubiquinol and 
buffer added up to 1 ml final volume. By addition of nanomolar amounts of enzyme, 
the  absorbance  increases  at  550  nm  (horse  heart  cytochrome  c)  or  552  nm 
(cytochrome c552F), showing cytochrome c reduction. The obtained initial velocity has 
been  plotted  against  several  cytochromes  c  concentrations,  and  the  catalytic 
constant (kCAT) and the Michaelis constant (KM) calculated by using the software Results 
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Origin 8.0. Table 2 reports the results for the three complexes with both substrates. 
The  catalytic  constant  is  not  influenced  by  the  deletion,  even  though  an  entire 
domain  (150  residues)  is  missing.  The  KM  does  not  show  substantial  changes 
between the wild type and the mutant protein, the latter exhibiting wild type kinetic 
properties. These results will be analysed in more detail in the section 1.2.3, where 
the interaction between the bc1 complex and its substrate is discussed.  
 
  Horse heart cytochrome c  Cytochrome c552F 
kCAT [s
-1]  KM [µM]  kCAT [s
-1]  KM [µM] 
WT  273 ± 25 
  2,3 ± 0,5   251 ± 13 
  2,7 ± 0,3  
TK33  328 ± 22 
  3,4 ± 0,3   322 ± 25 
  4,8 ± 0,9  
MC1  357 ± 19 
  3,1 ± 0,3   315 ± 13 
  3,8 ± 0,2  
 
Table 2: Steady-state kinetics with two different substrates. WT: wild type bc1 complex; 
TK33: wild type His tagged complex; MC1: His tagged acidic domain deletion mutant. 
 
In collaboration with the group of Prof. Petra Hellwig in Strassbourg redox potentials 
of the three complexes were measured, to be sure that the introduction of the His 
tag  and  the  deletion  of  the  acidic  domain  did  not  affect  the  redox  potential  of 
cytochrome b and c1. The results are shown in Table 3, clearly meaning that neither 
the affinity tag nor the deletion have influence on the redox potential of the hemes. 
 
  cyt bL  cyt bH  cyt c1 
Wild type  -175 mV  80 mV  211 mV 
Wild type His 
tagged 
-141 mV  90 mV  227 mV 
His tagged deletion 
mutant 
-178 mV  95 mV  223 mV 
Table  3:  Redox  potentials  of  the  wild  type,  wild  type  His  tag  and  the  His  tagged 
deletion mutant. The insertion of the His tag and the deletion of an entire domain do 
not affect the redox potentials of the two b hemes and the cytochrome c1. 
 
In previous experiments, LILBID MS (177) was used to analyse the oligomerization 
state  of  the  wild  type  and  the  deletion  mutant  protein.  The  wild  type  complex 
appears to be a “dimer of dimers”, where two dimeric structures stably associate. Results 
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The reason for such an association is unknown. The same analysis on the deletion 
mutant gave unexpected results, since the association of dimers is not visible at all, 
and  the  spectra  obtained  clearly  indicate  the  presence  of  dimeric  structures  in 
solutions. The results are confirmed by the crystallographic structure obtained by 
Thomas  Kleinschroth  in  collaboration  with  the  group  of  Prof.  Carola  Hunte 
(Kleinschroth et al., manuscript submitted). 
The deletion mutant of the P. denitrificans cytochrome bc1 complex shows kinetic 
properties like the wild type protein, but the deletion of the acidic domain influences 
the oligomerisation state. Being a dimer and not an association of two dimers, the 
newly obtained complex was chosen as substrate for the studies to investigate the 
dimeric nature of the bc1 complex and to validate the half-of-the-sites mechanism. 
3.2  Heterodimeric cytochrome bc1 complex  
The  half-of-the-sites  mechanism  describes  an  internal  regulation  mechanism 
(section  1.2.4.3)  influencing  the  activity  of  the  two  monomers  in  the  dimeric  bc1 
complex. According to the results observed by Covian et al. (60, 62, 143, 144, 148), 
the Qi site occupancy in one monomer can regulate the activity of the other one. 
Intermonomeric  electron  transfer  between  the  bL  hemes  enables  the  complex  to 
maximize the presence of electron acceptors in order to avoid the formation of ROS. 
One  way  to  prove  this  mechanism  is  the  inactivaton  of  just  one  monomer  by 
inserting a mutation in its Qo site. The second monomer carries no mutation and is 
fully active. In this way, the stimulation observed in presence of antimycin should not 
be visible, with the second quinol oxidation site inactive. Still, the reduction of two 
cytochrome  bH  per  dimer  can  be  achieved  by  bL-bL  electron  transfer  between 
monomers. The protein needed for this approach is a heterodimeric bc1 complex, as 
schematically indicated in Fig.  12. The heterodimeric cytochrome  bc1  complex is 
composed of a monomer which carries a mutation at the Qo site inactivating quinol 
oxidation without affecting the KM for the substrate. The second monomer shows full 
wild type properties. To be able to analyze the presence of the two monomers, they 
have been labelled with affinity tags, associating the inactivating mutation with the 
His tag and the wild type monomer with the Strep tag II. This allows performing a 
sequential purification, to isolate the heterodimeric complex. Results 
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Fig. 12: Heterodimeric bc1 complex from P. denitrificans. One monomer  carries an 
inactivating mutation in the Qo site, so that only one fully active quinol oxidation site 
is present in the dimer. The two monomers are separately cloned on two expression 
plasmids,  each  of  them  with  a  different  tag.  After  homologous  expression,  the 
heterodimer is obtained by sequential purification.  
 
The  mutation  used  for  the  Qo  site  has  been  described  first  by  Saribas  et  al.  in  
Rhodobacter (153): mutation of the Tyr
147 to a Ser impairs electron transfer to the 
heme bL from the quinol oxidation, with a remaining activity of about 10 %, without 
modifying the affinity for the substrate (see 4.1, Fig 70). In this way, any effect on 
the activity of the second Qo site is due only to the presence of the half-of-the-sites 
mechanism and not to changes in the KM for quinol. To obtain the heterodimeric 
complex, it was necessary to clone two different versions of the fbc operon: one 
modified with the mutation in cytochrome b and the His tag at the C-terminus of 
cytochrome  b, and the other carrying a Strep tag II, at the same position. Each 
operon was cloned in an expression vector and mated into P. denitrificans MK6 cells, 
where the fbc operon has been substituted with the Km resistance. 
The plasmids used were a pEG400 (109), which was used with the mutated, His 
tagged version of the operon, and a pBBR1-MCS5 (158) with the wild-type, Strep Results 
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tagged  version  of  it.  The  two  plasmids  have  different  origins  of  replication.  The 
vectors were chosen in order to avoid loss due to incompatibility. In fact, two vectors 
having the same origin of replication (oriV) are incompatible, meaning that just one 
of them is replicated and passed on to the daughter cells (180). The two copies of 
the  operon  cloned  in  the  expression  vectors  are  represented  in  Fig.  14.  The 
resulting plasmids were pMC12 (S147Y mutation in cytochrome b and C-terminal 
10X  His  tag)  and  pTK56  (wild  type  cytochrome  b  and  C-terminal  Strep  tag  II), 
respectively 11 kb and 8.1 kb. In the cell, the expressed subunits are able to freely 
associate and form three different kinds of dimers: one containing only monomers 
carrying the His tag (and therefore the mutation), one being just wild type and only 
Strep tagged, and the heterodimer. To separate heterodimers from the other two 
combinations,  a  sequential  purification  strategy  has  been  developed,  including  a 
Ni
2+-NTA column followed by a StrepTactin, to first separate the only Strep tagged 
dimers and then the just His tagged ones. The purification strategy is exemplified in 
Fig. 13.  
 
Fig. 13: Schematic representation of the purification strategy developed to obtain the 
bc1 heterodimer. The pink monomers carry a Strep tag, whereas the green ones a His 
tag.  After  membrane  solubilisation,  three  different  combinations  of  the  tags  are 
possible (1). With the Ni
2+-NTA, the only Strep tagged monomers are washed away (2), 
and  the  eluate  from  the  first  column  is  loades  onto  the  StrepTactin  (3).  Here, 
monomers carrying only a His tag are separated (4) from the heterodimers (5). Results 
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3.2.1  Genetic background, mating and purification 
As already mentioned, the protein used in this project is the deletion mutant of the 
Paracoccus denitrificans wild type complex. Two different versions of the fbc operon 
have been cloned, TK56 and MC12, as indicated in Fig. 14.  
 
 
Fig. 14: fbc operon wild type and the Δac fbc operon (MC1). TK56 is the fbc operon 
with the Strep tag and MC12 is the His tagged one containing also the Y147S mutation 
in cytochrome b. Graphics from (152). 
 
pTK56 (8132 bp) is a pBBR1-MCS5 derivative (158), containing the Δac fbc operon 
with a Strep tag at the C-terminus of cytochrome b, inserted by using a SOEing PCR 
(Splicing  by  Overlap  Extension)  [111,  124,  125].  pMC12  (11000  bp)  is  pEG400 
derivative (109) with a His tagged Δac fbc operon and the mutation Y147S cloned 
by Pfl23II/SacI restriction from the plasmid pTK44 (152). pTK56 and pMC12 carry 
the  resistance  for  Gm  and  Sm,  respectively.  Since  the  efficiency  for  chemical 
transformation or electroporation in P. denitrificans is not high, the strategy chosen 
to  transfer  the  plasmids  was  conjugation.  Vectors  used  in  the  laboratory  do  not 
possess tra functions, which would allow the bacterium to freely transfer genetic 
material to other bacterial cells. For conjugation to occur, it is necessary to use a 
helper strain, (E. coli RP4-4, Amp
R), which carries the plasmid-encoded tra genes 
necessary to transfer genetic material. The donor strains (containing each pTK56 
and pMC12), the helper strain and the recipient P. denitrificans strain (MK6, Rif
R and 
Km
R) are mixed and pipetted in a single drop on a LB agar plate. This allows the 
helper  strain  to  transfer  its  vector  containing  the  tra  functions  to  the  two  donor Results 
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strains,  which  are  now  able  to  carry  over  the  vectors  to  P.  denitrificans  cells. 
Selection occurs by pipetting a dilution series and streaking the cells on agar plates 
containing four antibiotics (Sm, Gm, Km and Rif) to select specifically P. denitrificans 
clones containing both expression vectors. After two days of incubation at 32° C, 
few clones were visible on the plates, with a much lower efficiency than the one 
normally  observed  for  the  conjugation  of  a  single  plasmid.  The  clones  were 
inculated and plasmid DNA prepared from them. The presence of the plasmid is the 
confirmation  of  the  successful  mating,  since  the  strain  used  for  the  conjugation 
normally lacks plasmid DNA.  
 
 
Fig. 15: Agarose gel from the plasmid DNA prepped from colonies 1 to 15 obtained 
after P. denitrificans conjugation with pTK56 and pMC12. The DNA was digested with 
Bpu1102I (single cutter in the Sm resistance gene) and BglII (single cutter in the Gm 
resistance gene). Ladder: λ phage DNA cut with EcoRI/HindIII.  
 
The agarose gel in Fig. 15 shows the digestion of the plasmid DNA obtained from 
the colonies after conjugation. The enzymes used, Bpu1102I and BglII, are single 
cutters for the antibiotic resistances, Sm and Gm respectively. In lanes 2, 11, 13 and 
15 the two bands at the top of the gel are respectively the linearized pMC12 and 
pTK56,  followed  by  two  more  bands  corresponding  to  supercoiled  plasmids. 
Paracoccus  denitrificans  DNA  has  a  high  GC  %  content  and  a  high  degree  of 
methylation, which leads sometimes to incomplete digestion.  
From  the  colonies  3,  11,  13  and  15  cultures  were  used  for  the  preparation  of 
membranes on an analytical scale. Membranes with a total protein content of 150 
µg were applied on SDS PAGE. Western blot analysis using an antibody directed 
against the His tag and the Strep tag II indicated the presence of a band reacting Results 
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with the two antibodies, at an apparent molecular weight of about 40 kDa, being 
most likely cytochrome b. Unexpectedly, also two unspecific bands appeared, in the 
Western  blot  for  the  Strep  tag  II,  at  low  molecular  weights,  being  with  high 
probability biotinylated small proteins. The antibody directed against the Strep tag II 
binds with a high efficiency biotinylated proteins: to avoid this, traces of avidin are 
added to the blocking solution. In this way, avidin reacts promptly with biotin, leading 
to less unspecific bands. In order to obtain a much cleaner result, cells were grown 
on a preparative scale (50 L) and membranes prepared. For the purification, the 
same  protocol  was  used  as  for  the  purification  of  the  deletion  mutant.  The 
cytochrome bc1 complex was solubilised using a 1.15 : 1  ratio detergent to total 
membrane protein in a 50 mM sodium phosphate buffer pH 8, containing 600 mM 
NaCl, and stirred for one hour on ice. After solubilisation, the sample was loaded 
onto the Ni
2+-NTA column (Fig. 16). The flow rate was set to 1 ml/min, to allow 
efficient binding to the column. Not only the His tagged cytochrome bc1 complex 
binds  to  the  Ni
2+-NTA,  but  also  the  cytochrome  c  oxidase  from  
P.  denitrificans,  in  an  unspecific  manner.  The  column  was  washed  with  1  CV 
equilibration buffer, which washes away all the unbound protein, among these, also 
the Strep tagged dimers. The elution is performed with a 5 CV histidine gradient, 
from 0 to 200 mM, to elute first the unspecifically bound oxidase and finally the bc1 
complexes containing at least one His tag (heterodimeric complex and homodimer 
with the Y147S mutation in both monomers). In Fig 16, peak 1 shows a green colour, 
typical for the cytochrome aa3 oxidase, and appears to be well separated from the 
peak number 2, red coloured, containing the cytochrome bc1 complex. The eluate 
from the Ni
2+-NTA column (peak 2) is loaded onto the StrepTactin column without 
concentrating  the  fraction.  After  loading,  the  StrepTactin  column  is  washed  with 
buffer until the chromatogram goes back to baseline, to avoid any contamination of 
the homodimer containing the mutation in both monomers. After the washing step, 
the  protein  bound  on  the  StrepTactin  (heterodimeric  bc1  complex)  is  eluted  in  a 
single step with a buffer containing 2.5 mM desthiobiotin (lower chromatogram in Fig. 
16). Results 
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Fig. 16: Chromatograms of the sequential purification. Upper panel: Ni
2+-NTA column. 
Two peaks are visible, the first one is the aa3 oxidase which binds unspecifically on 
the column and elutes early as the gradients starts. When the gradient reaches 90 mM 
histidine, the bc1 complex elutes. The eluate is directly loaded onto the StrepTactin 
column, where only the heterodimer binds. The column is washed until the absorption 
reaches  baseline  and  eluted  in  a  single  step  with  a  buffer  containing  2.5  mM 
desthiobiotin.  
 
The eluate has been concentrated and tested by redox spectra, SDS PAGE and 
Western blot (Fig. 17 and 18). 
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Fig. 17: Mixed dimer redox spectra. In the figure the absorbance peaks for cytochrome 
c1 and cytochrome b are indicated. Inset, a redox spectrum of the Δac bc1 complex 
(MC1) from P. denitrificans as comparison. 
 
 
Fig. 18: anti His tag blot (top left) and anti Strep tag II blot (top right). Bottom: SDS 
PAGE with fractions from the purification. 1: solubilisate; 2: flowthrough Ni
2+-NTA; 3: 
wash  Ni
2+-NTA;  4:  flowthrough  StrepTactin;  5:  wash  StrepTactin;  6:  mixed  dimer 
(TK56/MC12);  7:  Δac  bc1  complex  (MC1);  8:  WT Strep  tagged  bc1  complex  from  P. 
denitrificans.  In  the  red  rectangle,  the  wild  type  cytochrome  c1;  in  the  green  one, 
cytochrome b; in magenta the deletion form of the cytochrome c1 and in yellow the 
ISP.  The  latter  appears  typically  in  two  bands,  most  likely  representing  different 
unfolded states of the head domain. Results 
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The  redox  spectra  confirm  that  the  mixed  dimer  presents  no  differences  in 
comparison to the Δac bc1 complex, and that the mutation at the Qo site shows no 
effects on the cytochrome bL spectrum. As can be seen from the SDS PAGE in Fig. 
15, the bands for the ISP, cytochrome c1 and cytochrome b are visible (respectively 
20 kDa, 30 kDa and 35 kDa), and the ISP presents two bands, as already described 
for the complex from P. denitrificans (152). Two additional bands are visible, most 
likely due to incomplete denaturation: around 65 kDa a band formed by cytochrome 
b and cytochrome c1 associated, and around 130 kDa a complex dimer missing the 
ISP, as confirmed by Western blots with antibodies directed against the two tags 
both  at  the  C  terminus  of  cytochrome  b.  Notably  the  difference  in  the  running 
behaviour  between  the  wild  type  cytochrome  c1  and  the  one  from  the  Δac  bc1 
complex: the presence of the acidic domain makes the subunit run at an apparent 
mass of about 65 kDa (calc. mass 47 kD), whereas without the domain it runs as 
expected. In summary, from the redox spectra, SDS PAGE and Western blots it is 
obvious that a complex has been purified, which shows wild type spectra and a 
signal for both the His tag and the Strep tag II. Therefore, it is possible to procede 
with the kinetic studies to address the half-of-the-sites mechanism. As controls, two 
complexes  were  analysed:  a  dimer  in  which  both  monomers  carry  a  C-terminal 
Strep tag II and cytochrome b is wild type, and a dimer with His tagged, mutated 
monomers.  This  permits  to  follow  the  behaviour  of  each  monomer  in  the 
heterodimer. 
3.2.2  Pre steady-state ubiquinol oxidation by the cytochrome bc1 
complex in absence of antimycin 
After purification, the heterodimer (TK56/MC12) and the two controls (TK56/TK56 
and MC12/MC12) have been tested by stopped flow analysis, in order to prove the 
composition of the heterodimer and to characterize it.  
The first kinetic study was to follow cytochrome c1 reduction. In the stopped flow 
apparatus, a volume of buffer containing 2 µM of each complex was mixed with an 
equal  volume  of  buffer  containing  40  µM  ubiquinol.  Eight  different  signals  were 
averaged after subtracting the oxidized spectrum. The results are shown in Fig. 19. 
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Fig.  19:  Pre  steady-state  cytochrome  c1  reduction.  Upper  trace,  wild  type  Δac 
homodimer.  Middle  trace:  heterodimer.  Lower  trace:  Y147S  Δac  homodimer. 
Cytochrome c1 reduction was recorded at 554 nm and corrected by subtracting the 
oxidized spectrum.  
 
The upper trace corresponds to the wild type Δac bc1 complex, and the lower to the 
mutated  Δac  complex.  Both  of  them  are  single  phase  traces,  with  a  rate  of, 
respectively, 30 s
-1 and 5 s
-1. The heterodimeric complex shows, on the contrary, a 
biphasic kinetic, with rates corresponding to the upper trace (fast phase) and to the 
lower trace (slow phase). The two phases have the same amplitude (about 50% 
each). This result indicates clearly the presence of a heterodimer, and confirmes 
what already the Western blot analysis showed. In the heterodimer, one monomer 
carries the Y147S mutation at the cytochrome b, which reduces the activity of the 
complex to a residual 10 % without influencing the KM for the substrate. The other 
monomer is a Δac wild type complex, and able to faster oxidize ubiquinol. The two 
phases are a reflection of the heterodimer composition: both monomers have the 
same affinity for ubiquinol, but the kinetic of the mutated monomer becomes visible 
only when the high potential chain of the wild type half starts accumulating electrons 
due  to  the  faster  turnover.  At  that  point,  the  cytochrome  c1  from  the  wild  type 
monomer cannot be reduced anymore, since no electron acceptor is present. The 
high potential chain is then blocked and the mutated monomer is now visible, due to 
its slower kinetic. Results 
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At the beginning of the traces, a short lag phase is observable, better visible in the 
case  of  the  mutant  homodimer.  This  might  be  due  to  partitioning  between  the 
detergent micelles of the substrate after rapid mixing, which becomes more evident 
in the case of MC12 due to the slower turnover rate. 
3.2.3  Steady-state kinetics  
According to the half-of-the-sites mechanism, only one monomer is able to oxidize 
ubiquinol in a given turnover. In this way the production of ROS is minimized, since 
the production of a semiquinone at a single Qo site allows having up to six electron 
acceptors in the dimer (see 1.2.4.3). This means that only one monomer at a time 
accounts for the activity of the complex. In the heterodimer, where one Qo site has 
only a small residual activity, the turnover number is expected not to change, nor the 
affinity for ubiquinol. Therefore, Michaelis-Menten kinetics can verify two important 
aspects:  first,  that  the  heterodimer  has  the  same  affinity  for  ubiquinol,  second 
whether there is any change in the vMAX due to the insertion of the mutation. 
In the stopped flow apparatus, one volume of buffer with 100 nM enzyme and 20 µM 
cytochrome  c  from  horse  heart  is  mixed  against  an  equal  volume  of  buffer 
containing increasing concentrations of decylubiquinol. Six traces for each quinol 
concentration were recorded and the time course of absorbance change between 
550 nm and 539 nm used to obtain the turnover numbers expressed as moles of 
cytochrome c reduced per moles of cytochrome bc1 complex. The resulting turnover 
numbers have been plotted against the substrate concentration. As shown in Fig. 20 
and indicated in Table 4, the upper trace (Δac bc1 complex) and the middle trace 
(heterodimer) do not show any significal difference. The vMAX is the same for the two 
complexes, meaning that the inactivation of one monomer does not influence the 
kinetics  of  the  dimer.  The  Michaelis  constant  is  also  not  changed:  the  apparent 
affinity for the substrate is not influenced from the mutation, as already described 
elsewhere (153). In the case of MC12/MC12, the vMAX is about 10 fold lower than the 
wild type and the heterodimer; on the other side, the KM is decreased, meaning a 
higher apparent affinity for the substrate. Actually, this could be due to the smaller 
contribution  of  kCAT  to  the  KM  of  the  mutant  homodimer,  which  represents  an 
apparent dissociation constant. 
 Results 
81 
 
Fig.  20:  Michaelis-Menten  kinetics  with  the  three  complexes.  Upper  trace:  Δac  bc1 
complex; middle trace: heterodimer; lower trace: Δac Y147S bc1 complex.  
 
  vMAX [s
-1]  KM [µM] 
TK56/TK56  294.6 ± 14  77.5 ± 6.6 
TK56/MC12  279.3 ± 7.4  78.8 ± 3.7 
MC12/MC12  28.2 ± 1.6  31.7 ± 2.9 
Table  4:  vMAX  and  KM  values  for  the  three  complexes.    As  indicated,  no  signficant 
difference can be seen between TK56/TK56 and the heterodimer TK56/MC12, meaning 
that only one monomer is working at a time in the dimeric complex. 
 
The results from the steady-state kinetics represent a first confirmation of the half-of-
the-sites mechanism, since they show that inactivating one of the monomers does 
not  change  the  vMAX  of  the  enzyme.  In  the  case  of  the  two  monomers  working 
indipendently of each other, one would expect the heterodimer to be 50 % slower 
than the wild type homodimer, which is clearly not the case. Results 
82 
3.2.4  Pre steady-state ubiquinol oxidation by the cytochrome bc1 
complex in presence of antimycin 
According  to  the  half-of-the-sites  mechanism,  the  cytochrome  bc1  complex 
equilibrates  electrons  between  monomers  in  the  dimer,  in  order  to  reduce  the 
possibility of ROS production. When, for instance, antimycin is bound at the Qi site, 
electrons are stuck in the high potential chain and may readily react with oxygen. 
Electron equilibration between monomers plays an important role by passing them 
to  the  other  monomer  in  order  to  maximize  the  number  of  potential  electron 
acceptors in the complex, to transfer them fast and avoid the side reaction with 
oxygen. 
In presence of antimycin, a Qi site inhibitor, electrons can enter the complex only 
through the Qo site. Center N is blocked by the inhibitor, so quinol, semiquinone and 
quinone  do  not  bind  the  complex.  In  the  stopped  flow  apparatus,  
2 µM cytochrome bc1 complex inhibited with 2,5 µM antimycin have been mixed 
against 40 µM decylubiquinol and the absorbace changes followed up to 800 ms at 
554-539 nm for the cytochrome c1, and 563-578 nm for cytochrome bH. The results 
can be seen in Fig. 21, 22 and 23. The Δac bc1 complex (TK56/TK56) shows the 
reduction of one cytochrome c1 and two cytochrome bH per dimer. The reduction of 
cytochrome bH is on the left panel, corresponding to the spectra taken at 20, 50, 100, 
200 and 400 ms: only a peak at 560 nm (representing 70% of the total cytochrome b 
present in the observation chamber) can be seen (cytochrome bH) and no shoulder 
at 566 (cytochrome bL) is visible. The heterodimeric Δac bc1 complex shows the 
same results: even if one of the two Qo sites is inactivated, there is still reduction of 
two cytochrome bH and one cytochrome c1. This supports the results obtained from 
the steady-state kinetics, according to which only one monomer is working at a time 
(if the monomers were working independently from each other it should be expected 
to see, in the first panel, reduction of two cytochromes c1). It also shows that even in 
the case of inactivation of one center P, two cytochromes bH are still getting reduced 
per  dimer.  The  only  way  to  achieve  this  is  electrons  to  equilibrate  between 
monomers. In the case of TK56/TK56 electrons can enter the complex through two 
centers P, but in the heterodimeric complex only one center P is able to oxidize 
quinol.  The  rates  of  reduction  of  cytochrome  bH  in  the  two  complexes  are  very 
similar, as indicated in table 5, whereas in the case of MC12/MC12, the Δac Y147S 
bc1 complex, they are at least 7 times slower. At the given timescale, the reaction is Results 
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far from being completed. If the two bH hemes were reduced from electrons coming 
from  two  different  centers  P,  slower  cytochrome  b  reduction  kinetics  should  be 
observed  in  the  heterodimer,  due  to  the  much  slower  ubiquinol  oxidation  at  the 
mutated center P. This result validates the occurrence of intermonomeric electron 
equilibration. 
 
  Cyt bH reduction 
[s
-1] 
Cyt c1 reduction 
[s
-1] 
TK56/TK56  20  7.4 
TK56/MC12  20.9  8.2 
MC12/MC12  3.1  1.3 
Table 5: Rates for the reduction of ctochromes bH and c1 in the three complexes in 
presence of antimycin. Errors are within 10% of the measurements. 
 
 
Fig. 21: Pre steady-state oxidation of ubiquinol at the Qo site in presence of antimycin 
for the homodimeric Δac bc1 complex. Two cytochrome bH and one cytochrome c1 are 
reduced per dimer, when antimycin is bound at both Qi sites in the dimer. 
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Fig. 22: Pre steady-state oxidation of ubiquinol at the Qo site in presence of antimycin 
in the heterodimeric complex. The inactivation of one Qo site still allows the reduction 
of both cytochromes bH in the dimer and only one cytochrome c1 is reduced. 
 
 
Fig. 23: Pre steady-state oxidation of ubiquinol at the Qo site in presence of antimycin. 
In the homodimeric mutant complex, due to the mutation, the rate of cytochrome bH 
and cytochrome c1 reduction is much slower than the wild type complex.  
 
3.2.5  Antimycin titrations 
As shown with the yeast enzyme, substoichiometric amounts of antimycin increase 
the cytochrome c reduction. When the ratio antimycin : bc1 monomer reaches 25 %, 
the  activity  of  the  complex  increases,  and  decreases  slowly  as  the  inhibitor  : 
monomer ratio increases further. This is a paradoxical effect, considering antimycin 
as an inhibitor, but can be explained by the half-of-the-sites mechanism, in which Results 
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dimers  having  semiquinone  bound  at  one  center  N  are  both  able  to  react  and 
oxidize quinol. On the other hand, when none or both centers N are occupied, only 
one monomer can oxidize the substrate. In other words, the occupancy of the Qi site 
in the complex can stimulate the second, otherwise inactive monomer to react with 
quinol  and  participate  in  turnover.  Antimycin  simulates  quite  well  a  semiquinone 
bound  at  the  Qi  site,  so  that  titrating  the  enzyme  with  antimycin  shows  the 
aforementioned  stimulation.  In  the  case  of  the  heterodimer,  the  second  quinol 
oxidation site is almost totally inactivated due to the introduced mutation, so that the 
stimulation observed in the wild type complex should not be seen. 
In order to test this, a 10 µM solution of enzyme kept on ice was incubated with the 
indicated  amount  of  antimycin  for  two  minutes,  before  diluting  it  to  a  final 
concentration  of  100  nM  with  the  buffer  used  for  the  measurements  at  room 
temperature. The final dilution used for the experiments contained also 20 mM horse 
heart  cytochrome  c.  A  volume  of  the  diluted  enzyme-inhibitor  solution  has  been 
mixed  with  an  equal  volume  of  buffer  containing  80  µM  decylubiquinol,  and  the 
absorbance between 550-539 nm used to calculate the turnover number at a given 
inhibitor : monomer ratio. The results are shown in Fig. 24 for the Δac bc1 complex 
(TK56/TK56) and the heterodimer (TK56/MC12).  
In the left panel, the titration with the Δac bc1 complex (TK56/TK56) is shown. The 
stimulation is visible (solid curve), due to the activation of the second monomer in 
response  to  the  inhibitor  binding  to  one  of  the  Qi  sites  in  the  dimer.  As  a 
consequence to the inhibitor binding on one monomer, the second, otherwise silent, 
center  P  is  activated,  and  the  enzyme  is  able  to  recycle  electrons  and  reduce 
quinone  to  quinol  through  a  single  Qi  site,  thanks  to  the  intermonomer  electron 
equilibration.  Results 
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Fig.  24:  antimycin  titrations.  Left:  wild  type  Δac  bc1  complex;  right:  heterodimeric 
complex. The inset curves indicate the percentages of the inhibitor-free dimer (solid 
line) and the dimer where one Qi site is liganded varying with increasing antimycin 
concentrations. 
 
In the case of the heterodimeric complex, the second otherwise inactivated Qo site 
cannot oxidize quinol, at least not as efficiently as the wild type monomer at the 
timescale used for the measurements, so a stimulation is not observed. The solid 
curve  in  the  right  panel  represents  the  expected  behaviour  in  the  case  of  the 
monomers with one inhibitor molecule bound having the same activity of the free 
ones. The dotted straight line in the right panel represents the simulation of the 
expected  inhibition  curve  assuming that  no  intermonomer  electron  transfer  takes 
place and no electron equilibration between the cytochromes bL is possible. 
In the inset, the curves represent how the concentrations of different intermediates 
vary  by  increasing  the  antimycin  concentration.  The  free  dimer  concentration 
diminishes  constantly.  On  the  other  side,  the  concentration  of  the  intermediate 
where only one Qi site binds the inhibitor increases in the beginning, to diminish in 
favour of the dimer with both Qi sites occupied by the ligand. 
An important feature of the half-of-the-sites mechanism is the electron equilibration 
between monomers. The solid curves simulate the activation of the second quinol Results 
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oxidation site, given that electrons taken up from quinol oxidation at one Qo site are 
able to be used for quinone reduction in the Qi site of the other monomer. If this was 
not  be  the  case,  then  the  inhibitor  bound  monomer  could  oxidize  quinol,  but 
electrons coming into the low potential chain would be blocked at the cytochrome bH 
in  the  same  monomer  without  the  possibility  to  reduce  quinone  (being  the  site 
occupied  by  antimycin).  Assuming  no  electron equilibration,  the  antimycin  bound 
monomer would have to be considered fully inactive, so that only free monomers 
could contribute to the activity. This would be the situation depicted in the absence 
of the half-of-the-sites reactivity. 
It is interesting to note that even a 100 % ratio antimycin : bc1 monomer does not 
give full inhibition of the cytochrome c reduction. The binding of antimycin leads to 
electrons  accumulating  in  the  low  potential  chain,  blocking  the  electron  flow  to 
quinone or semiquinone. At the Qo site, quinol can still be oxidized, but semiquinone, 
eventually present after the first electron has entered the high potential chain, stays 
at the Qo site, unable to deliver its electron to the bL heme, and reacts fast with 
oxygen increasing the concentration of superoxide in solution. The latter is a very 
good reductant for cytochrome c by itself, so that the absorbance change seen at 
high inhibitor concentration is dependent on the cytochrome c reduction in presence 
of ROS. This activity is sensitive to superoxide dismutase, which can abolish up to 
50 % of the activity seen at high antimycin concentration (63). This depends on the 
fact that one electron coming from quinol oxidation reduces the ISP and cytochrome 
c1 and finally the electron acceptor cytochrome c. The second electron bypasses 
cytochrome  b  and  reacts  directly  with  oxygen  to  produce  ROS,  part  of  which 
indirectly reduces cytochrome c (Fig. 25).  Results 
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Fig. 25: With antimycin bound at the Qi site, the low potential chain is blocked. When 
quinol  is  oxidized,  electrons  flow  normally  through  the  ISP  and  cytochrome  c1  to 
cytochrome c, but they are stuck in the low potential chain since no quinone is bound 
at the Qi site. Therefore, after two turnover cytochrome b is fully reduced (red stars). If 
this  is  the  case,  subsequent  quinol  oxidations  at  the  Qo  site  will  produce  a 
semiquinone  radical,  which  reacts  readily  with  oxygen  and  produces  superoxide  
(O2
-*). 
3.3  Interaction between cytochrome bc1 of P. denitrificans and  
its cytochrome c substrate  
In this part of the work will be analysed the interaction between P. denitrificans bc1 
complex  and  its  substrate,  cytochrome  c552.  As  already  described  (1.2.2.2),  
P.  denitrificans  is  the  only  organism  with  an  acidic  domain  fused  with  the 
cytochrome  c1  protein.  The  acidic  domain  has  a  very  peculiar  composition, 
reminiscent of the hinge protein in the bovine complex and of the acidic part of thr 
Qcr6p  in  the  yeast  enzyme,  even  if  there  is  no  direct  homology.  In  the  two 
mentioned systems, kinetic studies showed that these subunits are involved in the 
electron  transfer  to  cytochrome  c,  the  electron  acceptor  in  mitochondria.  The 
interaction is driven by opposite charges on the two interaction partner (cytochrome 
c1  and  cytochrome  c)  and  the  acidic  subunits  help  pre-orienting  the  electron 
acceptor versus the donor. The interaction surface is rather hydrophobic, and this Results 
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leads to a two-step model with long-range electrostatic interactions and short range 
hydrophobic ones tightening the transient interaction and making it specific (94, 96, 
111,  114,  140). Crystal structures  (111)  showed that the Qcr6p in yeast has no 
direct interaction with cytochrome c, but the deletion affects the complex activity, 
probably since the pre-orientation effect is missing.  
In most bacterial complexes, only the three catalytically active subunits are present. 
All the additional subunits present in the eukaryotic complexes are missing, but in  
P.  denitrificans  the  acidic  domain  in  cytochrome  c1  most  likely  resembles  the 
eukaryotic situation. Previous investigations (118) using soluble fragments indicated 
that no specific role could be assigned to the acidic domain in the interaction with 
cytochrome  c552F.  Soluble  fragments  are  free  to  diffuse  and  to  interact  with  the 
reaction  partner,  whereas  the  whole  membrane  protein  complex,  embedded  in 
detergent micelles, are limited in this respect. This means a different experimental 
setup which is, on the other hand, similar to the situation in the membrane. For this 
reason, a new investigation was performed with the full membrane complex in order 
to analyze the kind and modality of interaction, and verify the previously obtained 
results. 
3.3.1  Pre-steady-state laser flash kinetic studies 
The interaction between the bc1 complex and its native electron acceptors has first 
been analysed by stopped flow spectroscopy. The dead time of the instrument, i. e. 
the  time  occurring  between  the  start  of  the  mixing  and  the  beginning  of  the 
measurement, is 1 ms. Since the reaction starts already in the dead time, the initial 
part  of  the  kinetic  traces  was  lost,  so  that  only  partial  measurements  could  be 
obtained, not allowing a complete analysis. One way to overcome this problem was 
the use of laser flash kinetics. With this method,  one of the reaction partners is 
covalently bound via a cysteine residue to a photoactive ruthenium  complex. By 
flashing with an appropriate laser, the excited ruthenium is able to oxidize or reduce 
the  redox  center  of  the  protein  to  which  it  is  bound,  according  to  the  reaction 
conditions (structure and redox properties of the photoactive complex). This method 
is  known  as  metal  to  ligand  charge  transfer;  in  this  experiments  Ru(2,2’-
bipyrazine)2(4-bromomethyl-4’-methyl-2,2’-bipyridine) (from now on referred as Ruz) 
has been used as a photoactive complex. Ruz-H39C-Cc is the yeast isocytochrome 
c with Cys
102 mutated to Thr (C102T) and a surface Cys introduced in position 39 Results 
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(H39C),  covalently  attached  to  Ruz.  Ruz-N23C-c552F  is  the  P.  denitrificans 
cytochrome  c552F  with  the  surface  Asn
23  mutated  to  Cys  (N23C)  and  covalently 
attached  to  Ruz.  Two  cytochromes  c  have  been  used  to  better  investigate  the 
interaction with the cytochrome bc1 complex: the yeast cytochrome c is known to 
have a very strong interaction with complex III (116), and this helps having a more 
complete picture of the effects the deletion brings. 
In  the  following  sections,  the  coupling  between  redox  partner  and  ruthenium 
complex, as well as the reaction protocol and the results obtained will be discussed. 
3.3.2  Preparation of the ruthenium coupled electron acceptors 
The  preparation  of  ruthenium  labeled  cytochrome  c552F  was  performed  by  Lois 
Geren at the University of Arkansas. The position of the cysteine residue for the 
ruthenium coupling was devised by Julia Janzon in her PhD thesis (116). 5 µl of 
N23C  mutant  cytochrome  c552F  were  treated  with  a  10-fold  molar  excess  of 
dithiothreitol  (DTT)  to  reduce  the  cysteines,  then  concentrated  and  buffer-
exchanged three times using a Centricon Ultracel YM-10 concentrator. The sample 
was then diluted to 0.1 mM in a volume of 2.0 mL of 50 mM sodium borate buffer 
(pH 9.0). A 2-fold molar excess of DTT was added to the anaerobic solution of the 
protein and stirred for 15 minutes, followed by the addition of a 3-fold molar excess 
of  Ru(2,2′-bipyrazine)2(4-bromomethyl-4′-methyl-2,2′-bipyridine)  while  stirring  and 
under light protection. Ruthenium labeling was continued for 12−18 h in the dark 
under  anaerobic  conditions  at  room  temperature.  The  reaction mixture  was  then 
dialyzed  extensively  against  5 mM  sodium  phosphate  buffer (pH  7.0)  to remove 
excess ruthenium reagent and to lower the ionic strength, then applied to a 5 mm × 
50 mm DE53 (DEAE Cellulose) column equilibrated with 5 mM sodium phosphate 
(pH 7.0). Only unlabeled N23C cytochrome c552F bound to the column while most of 
the multiple and singly labeled oxidized protein was eluted with 5 mM phosphate 
buffer in that order. The eluted sample was then again concentrated low salt buffer 
and minimal DTT (or ascorbate) was added to reduce the Ruz-N23C-c552F which was 
further purified by HPLC on a 1.5 cm × 30 cm high-resolution DEAE-52. Multilabeled 
protein eluted with a 5 mM sodium phosphate buffer washing step. Immediately after 
the start of a slow salt gradient, a single peak eluted off the DEAE-52 column which 
had a UV−visible spectrum equal to the sum of one equivalent of N23C cytochrome 
c552F  and  1  equivalent  of  ruthenium  reagent,  followed  by  a  peak  assigned  to Results 
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unlabeled  N23C  cytochrome  c552F.  The  purified  Ruz-N23C-c552F  was  exchanged 
three times with 5 mM sodium phosphate buffer (pH 7.0), then concentrated, and 
frozen at −80 °C. The overall yield of Ruz-N23C-c552F was 10-30%. 
3.3.3  Redox mediators and reaction conditions 
The  laser  flash  system  is  regenerated  after  each  flash,  so  that  several 
measurements can be performed with the same sample. This allows reducing the 
variability  in  the  experiments.  In  Fig.  26  is  represented  the  scheme  of  the 
measurements. For the regeneration of the initial conditions, the redox centers have 
to be re-reduced after electron transfer. In the cuvette, the  bc1 complex and the 
ruthenium labeled electron acceptor are mixed, and reduced by using ascorbate and 
TMPD  (N,N,N’,N’  tetramethyl-phenylendiamine)  as  a  redox  mediator.  The  redox 
state of the c-type hemes was checked by recording spectra, resulting in a complete 
reduction.  Therefore,  before  each  measurement,  the  c-type  hemes  are  reduced. 
After flashing, one electron is transferred from the excited ruthenium photoactive 
complex to a sacrificial oxidant (step 1), stabilizing the electron vacancy by avoiding 
back-reactions. The electron acceptor transfers one electron to the ruthenium (step 
2), which is then reduced and relaxes to the initial state. At this point, the electron 
acceptor  can  receive  one  electron  from  the  cytochrome  c1,  and  its  reduction 
followed  at  550  nm  for  the  RuZ-H39C-Cc  or  at  552  nm  for  Ruz-N23C-c552F.  The 
oxidation  of  cytochrome  c1  was  followed  at  557  nm,  the  isosbestic  for  
Ruz-N23C-c552F.  The  wavelengths  have  been  chosen  according  to  the  work  of 
Janzon, who analyzed the spectral properties of the electron acceptors used also in 
this work (116). 
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Fig. 26: Mechanism of the laser flash experiments to study the interaction between 
cytochrome c1 and several electron acceptors. The red arrows represent the electron 
transfer steps after flashing and initiating the reaction. The blue arrow indicates the 
ISP movement to reach cytochrome c1 (graphic from Castellani et al., 2011, submitted). 
 
After the laser pulse, ruthenium is in the excited state and the c-type heme in the 
electron acceptor is oxidized. Recording this signal, in absence of the bc1 complex 
in the cuvette, gives a so called “step function” (Fig. 27), which reflects the oxidation 
of  the  acceptor  protein  in  the  photoactive  complex.  Since  no  electron  donor  is 
present in solution, no absorbance changes should be recorded. If this is the case, 
then the ruthenium labeled cytochrome is stable, and efficiently being oxidized after 
the laser pulse. If any absorbance change is recorded, or no step function at all can 
be seen, the system is not stable and the conditions have to be optimized or new 
photoactive complex prepared. As visible in Fig. 27, in the case of the ruthenium 
labeled  cytochrome  c552F,  a  buffer  containing  pentaammineosmium  nitrile 
([Os(NH3)5(CH3CN)](CF3SO3)
3+) as sacrificial oxidant has been tried. After flashing, 
the signal goes down (cytochrome c552F oxidation, yellow arrow) and stays stable 
(black arrow), with no absorbance changes in the time. This is a typical step function, 
meaning that the system was stable and cytochrome c552F successfully oxidized.  Results 
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Normally,  [Co(NH3)5Cl]
2+  is  the  preferred  sacrificial  oxidant,  since  it  rapidly 
decomposes after reaction with ruthenium. This avoids back-reactions which could 
bring about unwanted reactions with hemes (see 3.3.1). In previous experiments, by 
Janzon  et  al.  (116),  was  found  out  that  the  [Co(NH3)5Cl]
2+  precipitates  the 
cytochrome c552F, so they used Paraquat and aerobic conditions for the studies with 
the  soluble  fragments.  For  the  experiments  presented  in  this  work,  it  was  not 
possible to work under aerobic conditions, since small amounts of contaminating 
oxidase  left  from  the  protein  preparation,  not  visible  on  the  SDS  PAGE  or 
spectroscopically, could still be present and falsify the measurements. The use of 
Paraquat  (Fig.  28)  is  not  compatible  with  anaerobic  conditions,  since  when  it  is 
reduced it is strongly coloured and interferes with the absorption between 540 and 
570 nm. Therefore, the only sacrificial oxidant suitable for these experiments was 
the osmium complex, even if some backreactions could take place (see 3.3.5). For 
the  experiments  with  Ruz-H39C-Cc,  [Co(NH3)5Cl]
2+  was  the  best  experimental 
condition. 
 
 
Fig. 27: Step function observed from the  Ru-N23C-c552F in presence of the osmium 
complex as sacrificial oxidant. After the flash (yellow arrow), the signal goes down in 
respect  to  the  initial  baseline  (black  arrow).  This  indicates  the  oxidation  of  the 
electron acceptor. Since no cytochrome bc1 complex is present in this measurement, 
the signal remains constant. This means the photoactive complex can be oxidized, is 
stable and can be used for further experiments. Results 
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Fig. 28: Step function observed from the Ru-N23C-c552F using Paraquat as sacrificial 
oxidant. After the flash, the signal goes up to decay slowly almost back to baseline. 
This is due to the absorption Paraquat has under anaerobic conditions as tested in 
this work. Therefore, it was not the sacrificial oxidant of choice for these experiments. 
 
Flash photolysis experiments were carried out using a phase R model DL 1400 flash 
lamp-pumped dye laser and a detection system described by Heacock et al. (175). 
Solutions contained about 5 µM Ruz-N23C-c552F or Ruz-H39C-Cc and approximately 
6 μM cytochrome bc1 in 300 µl of Tris/HCl buffer (20 mM in the case of RuZ-39-Cc 
and 10 mM for Ruz-23-c552F) pH 8.0 with 0.02% dodecylmaltoside in semimicro glass 
cuvettes at 10 
oC. 2 mM sodium ascorbate, and 2 µM TMPD were added to fully 
reduce the heme groups, as verified by recording the visible spectra before flash 
photolysis.  In the photooxidation experiments with Ruz-H39C-Cc, [Co(NH3)5Cl]
2+ was 
added (5mM) as the sacrificial oxidant (Fig. 26), whereas in the case of Ruz-N23C-
c552F,  1  mM  pentaammineosmium  nitrile  was  used.  To  establish  and  maintain 
anaerobic  conditions,  the  cuvette  was  closed  with  an  appropriate  septum  and 
flushed with N2.  
To test the dependence of the electron transfer reaction of the ionic strength [I], 
several  amounts  of  a  2  M  KCl  stock  solution  were  added  to  the  sample  before 
flashing in a sequential experiment series, spectra collected to check the cofactors 
reduction and eventually ascorbate added. The [I] was increased up to 430 mM, and 
for  each  increment  was  measured  the  rate  of  electron  transfer  to  the  accepting Results 
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cytochrome c. Plotting the logarithm (log) of the rate constant against the square 
root of the [I] (Brønsted plot) allows to analyse the kind of interaction between the 
two proteins. 
The wild type, the His tagged wild type and the His tagged deletion mutant were 
used  in  this  study.  The  cytochrome  bc1  complex  from  P.  denitrificans  requires 
relatively high amounts of salt for the purification, and in the classical procedure 
(ionic exchange, DEAE) the protein elutes from the column at a concentration of 450 
mM NaCl. As a consequence, a condition with zero mM ionic strength cannot be 
tested. On one side, this might appear as a limitation since the reaction cannot be 
studied in the absence of salt, but has the advantage that the complex is stable and 
does not show self oxidation. Janzon (116) showed that in absence of salt it was not 
possible  to  achieve  a  complete  and  stable  reduction  of  the  hemes.  In  these 
experiments,  the  hemes  appeared  to  be  fully  reduced  before  the  flash  and 
maintained  their  state  throughout  the  measurements.  In  the  case  of  the  intact 
complex, the cytochrome c1 can be reduced directly by ascorbate (see the section 
3.5.1) or via the ISP, which is easily reduced by ascorbate due to its redox potential 
(higher than that of the cytochrome c1) at the pH used for the experiments. The 
kinetics of cytochrome c1 reduction by the ISP will be discussed in section 3.5. This 
double reduction pathway ensures that the c1 heme is fully reduced before flash, as 
subsequent additions of ascorbate did not change its spectrum.  
3.3.4  Salt titrations with the Ruz-H39C-Cc 
Fig. 29 shows a trace recorded in the salt titration involving the Ruz-H39C-Cc and 
the cytochrome bc1 complex (in this case, the wild type complex). The black upper 
trace recorded at 550 nm represent the reduction by cytochrome c1 of the electron 
acceptor after fast oxidation due to the laser flash. At the same time and with the 
same rate, cytochrome c1 is oxidized (grey transient).  Results 
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Fig. 29: Example of the kinetics between the wild type cytochrome  bc1 complex of  
P.  denitrificans  and  the  Ruz-H39C-Cc.  Upper  trace:  signal  at  550  nm  showing  the 
reduction of the photoactivated complex. Lower trace: isosbestic at 557 nm for the 
Ruz-H39C-Cc indicating the oxidation of cytochrome c1.  
 
The signal at 550 nm shows two phases: a fast one, immediately after the flash, and 
a slower one on a long time scale, which is not present in the signal at 557 nm. This 
reaction  mechanism  is  similarly  observed  in  the  three  sets  of  measurements 
involving the wild type, the His tagged wild type and the His tagged deletion mutant 
complex. The rates for the fast phase are indicated in Table 6 and are very similar in 
the three experiments. 
 
  WT 
[s
-1] 
WT His-tagged 
[s
-1] 
His-tagged deletion 
mutant [s
-1] 
550 nm   16,600
  9,300
  14,600
 
557 nm  16,700
  8,400
  11,200
 
Table  6:  Rates  recorded  in  the  salt  titrations  obtained  using  the  Ruz-H39C-Cc  as 
electron acceptor. The two transient reported here, at 550 nm and 557 nm, indicate the 
reduction  of  the  ruthenium  labeled  cytochrome  c  from  yeast  and  the  oxidation  of 
cytochrome c1 respectively. Errors are within 10 % of the measured values.  Results 
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The fast phase represents the fast electron transfer between the cytochrome c1 and 
the  Ruz-H39C-Cc,  and  finds  correspondence  in  the  signal  recorded  for  the 
cytochrome  c1  oxidation.  These  rates  are  compatible  with  the  previous  results 
shown by Janzon et al., which indicated a bimolecular reaction between the soluble 
fragments (118). The slow phase, on the other hand, shows very small amplitudes 
during the whole titration and is very slow, being completed in millisecond time scale 
and not microsecond as the electron transfer reaction between the bc1 complex and 
the ruthenium labeled yeast cytochrome c. Moreover, it is not present in the 557 nm 
transient, suggesting a slow reduction of the photoactive complex by ascorbate. The 
amplitude of the 557 nm signal is slightly lower than the one recorded from the 550 
nm transient. This is due to the fast reduction of cytochrome  c1 from the ISP, a 
process almost as fast as the electron transfer to the photoactive yeast cytochrome 
c (see 3.3.4-5). 
The signal at 550 nm after flashing does not go back to baseline. This is due to the 
fact  that  550  nm  is  not  an  isosbestic  point  for  the  ruthenium  labeled  yeast 
cytochrome c, so a small contribution in the absorbance from the cytochrome  c1 
heme is also present. The signal could go back to the starting absorption value after 
complete re-reduction of all the cofactors operated by ascorbate and TMPD (see the 
slow kinetic in Fig. 29, upper trace).  
By  increasing  the  salt  concentration,  the  rate  observed  for  the  electron  transfer 
process is stable until a total ionic strength of 90 mM is reached. At higher salt 
concentrations, the rate starts becoming slower. This behaviour, shown in Fig. 30, 
reflects also what was already observed for the soluble fragments.  
According to the Brønsted equation, the dependence of the observed rate constant 
from the [I] is defined by: 
 
                                        log kOBS = log k0+ 2B ZAZB log [I]
1/2              Equation 8 
 
where the log kOBS is dependent on the log of the rate constant at [I]=0, and on the 
square root of the [I] multiplied by a term called ZAZB which is the product of the total 
charges involved in the interaction between two partners. B is a parameter derived 
from the Debye-Hückel theory keeping into account the dielectric constant of the Results 
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medium  and  the  temperature  For  buffers  made  in  water  and  at  temperatures of 
10 °C, the parameter B is equal to 0.5.  
The Brønsted parameter ZAZB for the aforementioned electron transfer reaction is 
reported in Table 7.  
 
WT  WT His-tagged  His-tagged deletion 
mutant 
-5.57±0.5  -5.68 ± 0.4  -4.59 ± 0.3 
Table 7: Brønsted parameters for the three sets of experiments with the ruthenium 
labeled yeast cytochrome c.  
 
 
Fig. 30: Brønsted plot for the reaction between the cytochrome bc1 complex and the 
photoactivated isoform 1 of the yeast cytochrome c. The slopes of the three 
experiments are very similar, indicating a similar reaction mechanism for the wild type 
and the deletion mutant. 
 
The kinetics indicate that the electron acceptor and the bc1 complex interact stably 
when  the  total  ionic  strength  is  low,  forming  a  complex  showing  very  high 
intramolecular transfer rates. This is a situation where cytochrome c1 can transfer an 
electron to the ruthenium labeled cytochrome c very fast, since they do not have to Results 
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diffuse and find each other. By increasing the ionic strength,  above 90 mM,  the 
association between the two reaction partners is less strong and they separate, so 
they diffuse and move to encounter each other for the electron transfer event (Fig. 
31). The higher the ionic strength, the less probable is a successful encounter which 
leads to the transfer of an electron, so the observed rate decreases.  
 
 
Fig.  31:  Scheme  showing  the  formation  of  stable  complex  with  the  photoactive 
complex  in  conditions  of  low  ionich  strength  (left  side).  As  the  KCl  concentration 
increases  (blue  triangle)  the  two  reaction  partners  tend  to  separate  and  have  to 
diffuse and encounter each other in the correct orientation to react. The long range 
interactions are shielded by the high ionic strength so that the successful collisions 
for electron transfer become more rare. 
3.3.5  Salt titrations with the Ruz-N23C-C552F 
The same experiment has been repeated with the ruthenium labeled substrate from 
P.  denitrificans.  Also  here,  the three  complexes  were  tested  with  increasing  salt 
concentrations, and the logarithm of the rate observed rate constant (kOBS) plotted 
against the square root of the ionic strength. Fig. 32 shows an example of kinetics 
obtained in presence of the Ruz-N23C-c552F.  
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Fig.  32:  Example  of  the  kinetics  between  the  cytochrome  bc1  complex  of  
P. denitrificans and the Ruz-N23C-c552F, showing the reduction of the photoactivated 
substrate.  
 
The rates observed for the electron transfer reaction between the P. denitrificans 
cytochrome bc1 complex and the Ruz-N23C-c552F are 1900 s
-1, 1500 s
-1 and 1000 s
-1 
for  the  wild  type,  the  His  tagged  wild  type  and  the  deletion  mutant  complex, 
respectively. The reaction is slower than what previously observed with the yeast 
cytochrome c, and the signal at 552 nm is monophasic, indicating that ascorbate is 
not able to re-reduce the photoactive complex as fast as in the previous experiments. 
In this case, the signal after  the flash goes back to  baseline. The reason is the 
choice of the sacrificial oxidant: the osmium complex was the only possibility for the 
experiments with the ruthenium labeled c552, but it can back-react with cytochrome 
c1 being positively charged, and reduce it, whereas it shows no interaction with the 
cytochrome c552 (otherwise to be observed in the step function). The latter repels the 
osmium complex due to the charges around the heme crevice. As cytochrome c1 is 
oxidized  by  reaction  with  the  ruthenium  labeled  cytochrome  c552F,  it  is  rapidly 
reduced from the sacrificial oxidant, and therefore the signal goes back to baseline. 
This effect was not observed in the previous experiment, since the sacrificial oxidant 
chosen was the cobalt complex.  
The  Brønsted  plot  (Fig.  33)  shows,  for  the  bc1  complex  interaction  with  the 
physiological  substrate,  that  there  is  almost  no  formation  of  a  stable  complex Results 
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between the enzyme and its substrate. The plot starts rapidly going down after 60 
mM, so the reaction with the ruthenium labeled cytochrome c552F is more sensitive to 
the ionic strength. Moreover, the Brønsted parameters (shown in Table 8) indicate 
that no charge interaction is lost by the deletion of the acidic domain, not only in the 
aforementioned experiments nor with the native substrate. Therefore, these results 
confirm the observations obtained with the soluble fragments. The interaction model 
driven by long range electrostatic forces is also valid here, clearly showing no role of 
the  charges  of  the  acidic  domain  in  interactions  with  the  substrate.  The  acidic 
domain, similar (but not homologous) to the small acidic subunit of the eukaryotic 
complex, does not play any role in the interaction with the electron acceptor. 
 
WT  WT His-tagged  His-tagged deletion mutant 
-2.78 ± 0.08  -3.36 ± 0.26  -3.35 ± 0.17 
Table 8: Brønsted parameters for the three sets of experiments with the ruthenium 
labeled cytochrome c552F. 
 
 
Fig. 33: Brønsted plot for the reaction of the cytochrome  bc1 complex and the Ruz 
labeled substrate. The slopes of the three experiments are very similar, indicating a 
similar reaction mechanism for the wild type and the deletion mutant. 
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3.4  Rapid flash kinetics for the internal electron transfer 
The laser flash technique can be also used for the investigation of internal electron 
transfer steps. In this case, a ruthenium dimer is used, which is not coupled to any 
electron acceptor. Its positive charge (+4) directs it to the cytochrome c1 heme and 
allows its specific oxidation, creating an electron vacancy which is rapidly filled by 
the ISP. The reduction of cytochrome c1 heme followed at 552 nm (ʱ peak) permits 
an estimation of the internal electron transfer to the cytochrome c1. This electron 
transfer is governed by the movements of the ISP head domain, and several models 
have  been  developed  so  far  (74,  127,  130)  to  explain  the  trigger  of  the  ISP 
movements  in  direction  to  cytochrome  c1.  Measurements  in  the  R.  sphaeroides 
system have been carried out (181), describing a very fast electron transfer to the 
cytochrome c1 with signals showing a single phase and rates of about 80000 s
-1 
(182).  Until  now,  no  data  were  available  for  the  important  model  of  the  P. 
denitrificans enzyme. In this part of the work, the complexes used in the previous 
experiment (wild type, His tagged wild type and His tagged deletion mutant complex) 
were  tested  in  order  to  study  the  electron  transfer  reaction  from  the  ISP  to  the 
cytochrome  c1,  and  to  investigate  possible  effects  of  the  deletion  of  the  acidic 
domain for this interaction 
3.4.1  Experimental setup and protocol description 
The bc1 complex (5 µM of each of the three aforementioned complexes) is mixed in 
300  µl  of  a  20  mM  TRIS/HCl  buffer  at  pH  8.0,  additionally  containing  0.02% 
dodecylmaltoside and 5 mM of [Co(NH3)5Cl]
2+ as the sacrificial oxidant. Moreover, 2 
mM succinate and 50 nM succinate dehydrogenase were added to ensure reduction 
of  the  low  potential  chain  and  regenerate  the  oxidized  substrate  (100  µM 
decylubiquinone) after flashing. To maintain the redox cofactors oxidized and avoid 
loss of reduction after several flashes (as observed already in (182)), 20 µM TMPD 
and 1 mM ascorbate were also added in the cuvette. The photoactive complex is the 
binuclear  ruthenium  complex,  [Ru(bpy)2]2(qpy)(PF6)4;  qpy,  2,2′:4′,4′′:2′′,2′′′-
quaterpyridine Ru2D, in 20 µM concentration. The sample was made anaerobic by 
flushing with N2 and using appropriate septa; the measurements were carried out at 
10°C.  
After  a  flash,  one  electron  is  abstracted  from  the  excited  ruthenium  dimer  and 
transferred to the sacrificial oxidant, which decomposes after reduction and thus Results 
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avoids backreactions (see 3.3.4-5). In a timescale of 1 µs, the cytochrome  c1  is 
rapidly oxidized, and can take up an electron from the ISP (k1). After ISP oxidation, 
a turnover can take place at the Qo site, since now the ISP is available to accept an 
electron from quinol  (k2).  At  this  point,  an  increase  in the  absorption at  560  nm 
(isosbestic for cytochrome c1) is observed, followed by a slower oxidation (k4). The 
rate constant k3 cannot be calculated, since the electron transfer from the bL to the 
bH is extremely fast due to the high redox potential of the latter and its short distance 
to the latter and, therefore, not rate limiting.  
In Fig. 34 the experimental setup used for the experiments is depicted.  
 
 
Fig. 34: Schematic representation of the experimental setup for the internal kinetic 
studies. In the cuvette, ascorbate and TMPD directly reduce the ISP and cytochrome 
c1,  and  the  quinol  reduces  the  low  potential  chain.  After  flashing,  one  electron  is 
abstracted from the ruthenium dimer and subsequently transferred to the sacrificial 
oxidant.  At  this  point,  cytochrome  c1  is  oxidized  transferring  its  electron  to  the 
photoactive complex and the ISP can move to the c1 heme and reduce it (k1). As the 
ISP is oxidized, one turnover can take place and a quinol molecule is oxidized at the 
Qo site. The ISP is then available to be reduced again (k2) and reduction of a b-type 
heme is observed. The electron transfer between bL and bH is a fast process, driven by 
the high redox potential of the bH heme, and k3 cannot be resolved. k4 represents the 
oxidation  of  bH  to  reduce  a  quinone  or  a  semiquinone  at  the  Qi  site.  SQR  is  the 
succinate dehydrogenase which regenerates with succinate the quinol pool after the 
turnover. 
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Two different sets of experiments were tried: in the first one, the complexes were 
reduced by TMPD and ascorbate, so that only the high potential chain could be 
reduced. This implies no electron transfer processes at the level of the low potential 
chain, and permits to define wether or not the mobility of the ISP is affected from the 
presence of the substrate at the Qo site. Several inhibitors were tested (stigmatellin, 
myxothiazol, MOA-stilbene, and JG-144) to study eventual effects in the cytochrome 
c1 reduction in presence of Pm and Pf inhibitors. In the second set, the reduction of 
the  complex  was  obtained  by  using  ascorbate  and  TMPD  and  decylubiquinol, 
continuously  regenerated  by  the  presence  of  succinate  and  catalytic  amounts of 
SQR. In this way, it is possible to observe also the kinetics at the low potential chain. 
3.4.2  Internal kinetics using TMPD and ascorbate to reduce the 
 cytochrome bc1 complex 
In the following tables the kinetics observed in presence of ascorbate and TMPD to 
reduce  the  high  potential  chain  are  reported.  After  flashing,  the  Ru2D  is  able  to 
oxidize  cytochrome  c1  and  the  ISP  transfers  an  electron  to  the  c-type  heme.  In 
absence of quinol at the Qo site, it is feasible to analyze the movements of the head 
domain  of  the  ISP  without  any  restriction  due  to  possible  interaction  with  the 
substrate. The Qo site is, indeed, partially composed of the head domain of the ISP. 
Quinol forms a hydrogen bond with residues coordinating the Rieske cluster (His
155 
in the P. denitrificans enzyme). 
For  each  sample,  three  different  inhibitors  were  tested  and  in  all  cases  a 
measurement  without  inhibitor  was  included  as  reference.  The  transients  were 
recorded at 552 nm to follow reduction of cytochrome c1 and fitted to a mono- or bi-
exponential equation. The wild type complex (Table 9) shows biphasic kinetics, with 
a fast phase of 9100 ± 883 s
-1 and a slow phase of 910 ± 112 s
-1. Upon addition of 
MOA-Stilbene to the sample, the fast phase is not considerably changed but the 
slow phase is two times faster than observed before (1800 ± 189 s
-1 in the wild type 
complex).  The  amplitude  of  the  two  phases  (expressed  as  percentage  of 
cytochrome c1 reduced to the total amount of cytochrome c1 oxidized) is sensibly 
increased,  meaning  that  more  cytochrome  c1  is  reduced  than  in  absence  of 
inhibitors (Fig. 35) 
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  k1 
(s
-1) 
Amplitude  
(%) 
k2 
(s
-1) 
Amplitude  
(%) 
no inhibitor  9100 ± 883  9  910 ± 112  15 
MOA-stilbene  9900 ± 65  33  1800 ± 189  26 
myxothiazol  8900 ± 1006  30  1700 ± 146  30 
JG-144  1289 ± 94  17  257 ± 75  45 
Table 9: Results from the experiments obtained using ascorbate and TMPD to reduce 
the wild type bc1 complex from P. denitrificans. The amplitude shown is expressed as 
a percentage of the total heme c1 flash-oxidized.  
 
. 
Fig. 35: Effect of Pm inhibitors on the electron transfer from the ISP to the cytochrome 
c1 in the cytochrome bc1 complex of P. denitrificans. In black, the transient obtained 
without inhibitors; in red and green the kinetics after addition of MOA-stilbene and 
myxothiazol respectively. The amplitude of the signal is increased, meaning a much 
higher reduction of cytochrome c1 in presence of Pm inhibitors. The rate of reduction 
measured for the fast phase does not increase significantly, but the slow phase is two 
times faster than observed previously.  
 
This result allows assigning the fast phase to the reduction of cytochrome c1 when 
the ISP is in the so called c1 position, and the electron transfer to the c1 heme is not 
limited by the movements of the cluster. The slow phase represents the reduction of 
cytochrome  c1  by  the  ISP  being  in  the  b  position,  closer  to  the  cytochrome  b, 
therefore having to reach the c1 heme and then to initiate electron transfe event. 
MOA-stilbene displaces the ISP from the  b  position, and makes the slow phase Results 
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faster since the inhibitor forces the ISP to move towards the cytochrome c1. Hereby 
the distance the head domain has to transit before transferring an electron is lower 
than without inhibitor. The fast phase is not considerably faster than in absence of 
inhibitor, but the total amplitude increases (as visible in Fig. 35), as a consequence 
of the displacement of the ISP head domain. Myxothiazol shows an effect similar to 
the one of MOA-stilbene: the slow phase is 2-fold faster and the amplitude increases, 
meaning more cytochrome c1 reduced.  
The situation changes in presence of JG-144 (Fig. 36), a Pf type of inhibitor which 
was shown in crystal structures to keep the ISP head domain close to cytochrome b, 
even if no hydrogen bonding can be identified between the inhibitor molecule and 
the Rieske cluster as in the case of stigmatellin (48). JG-144 slows down both fast 
and slow phase observed, meaning that the ISP head domain is not able to interact 
anymore with the cytochrome c1 as in absence of inhibitor, but not fixed in the b 
conformation  since  electron  transfer  to  the  c1  heme  is  still  observed  (Table  9). 
Notably, the total amplitude is increased, indicating a higher amount of cytochrome 
c1 reduced. This could indicate that a Qo site occupied with a ligand allows a major 
portion of the ISP to be mobile compared to the situation where only endogenous 
quinone/quinol is bound in cytochrome b (see 3.4.2 and 3.4.3).  
Stigmatellin, on the other side, completely blocks electron transfer, also when added 
in  substoichiometric  amounts  (0.5  molecules  per  complex  dimer).  The  hydrogen 
bond with the His
155 (P. denitrificans numbering) coordinating the cluster fixes the 
ISP head domain, as shown by the flat step function in Fig. 36. The electron transfer 
observed in presence of JG-144 can not be due to the re-reduction of cytochrome c1 
from ascorbate present in the reaction, since ascorbate only slowly reduces the c1 
heme in the P. denitrificans bc1 complex, as confirmed by stopped-flow experiments, 
on a completely different timescale (seconds instead of microseconds). Therefore, 
such a slow electron transfer can not be observed in flash photolysis experiments, 
being far too slow for the considered timescale.   Results 
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Fig. 36: Effect of the Pf inhibitors on the electron transfer to the cytochrome c1 heme. 
In black, the transient obtained without inhibitors, and in red and green respectively 
the  effects  of  JG-144  and  stigmatellin.  JG-144  slows  both  phases  down,  whereas 
stigmatellin blocks completely the electron transfer.  
 
The  results  are  similar  also  in  the  case  of  the  His  tagged  wild  type  complex, 
although the observed rates are generally slower than those of the wild type. This 
could be due to variability of the samples, but also to the small amplitude of the 
phases in absence of inhibitor that making an accurate fitting difficult. Nevertheless, 
the behaviour observed upon binding of inhibitors is similar to the one observed with 
the wild type complex (Table 10 and Fig. 37). 
 
  k1 
(s
-1) 
Amplitude 
(%) 
k2 
(s
-1) 
Amplitude 
(%) 
no inhibitor  5200 ± 488  9  600 ± 73  14 
MOA-stilbene  9427 ± 509  33  1422 ± 127  24 
myxothiazol  9736 ± 537  33  1714 ± 93  34 
JG-144  733 ± 85  22  175 ± 19  26 
Table 10: Results from the experiments obtained using ascorbate and TMPD to reduce 
the His tagged wild type bc1 complex from P. denitrificans.  
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Fig. 37: Effects of the inhibitor on the electron transfer from the Rieske cluster to the 
c1 heme for the His tagged wild type cytochrome bc1 complex from P. denitrificans. In 
black,  the  complex  reduced  with  ascorbate  and  TMPD  and  without  any  inhibitor. 
Following, in red the kinetics with myxothiazol, in green with MOA-stilbene, and in 
blue with the Pf inhibitor JG-144. 
 
In the case of the deletion mutant complex, there is a significant increase of the fast 
phase in presence of inhibitors, with an increase also in the slow phase. The effect 
on the fast phase is unexpected and is present as well in the experiments where 
also the substrate quinol is used to reduce the complex (see 3.4.3). Moreover, a 
signal is visible also for the b hemes at 560 nm, which is not present in the wild type 
complexes (Fig. 38, 39). Results 
109 
 
 
Fig. 38: Electron transfer from the ISP to the cytochrome c1 in the deletion mutant of 
the cytochrome bc1 complex from P. denitrificans. Upper panel, transient recorded 
oinly  in  presence  of  ascorbate  and  TMPD  to  reduce  the  complex.  A  signal  is  also 
evident at 560 nm, completely unexpected since electrons flow only through the ISP 
and cytopchrome  c1. Lower panel: adding  stigmatellin to the sample  shown in the 
upper panel, no change can be observed. Stigmatellin is, though, expected to quence 
the signal. 
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Fig.  39:  Wild  type  cytochrome  bc1  complex  from  P.  denitrificans,  reduced  with 
ascorbate and TMPD and blocked with stigmatellin. The black transient represent the 
electron transfer events at 552 nm and the red one at 560 nm. Both data indicate that 
in presence of stigmatellin, the electron flow to cytochrome c1 is blocked and that no 
unexpected signal at 560 nm is recorded.  
 
This is an indication for electron transfer taking place at the level of cytochrome b, 
which should not be observed since the complex is reduced only by ascorbate and 
TMPD,  allowing  only  the  reduction  of  ISP  and  cytochrome  c1.  In  presence  of 
stigmatellin,  which  locks  the  ISP  away  from  the  cytochrome  c1,  reduction  of 
cytochrome b is still observed, as shown in Fig. 38 (lower panmel). Fig. 39 shows 
the behaviour of the wild type complex upon binding of stigmatellin, with a flat step 
function  indicating  fixation  of  the  ISP  head  domain  onto  cytochrome  b.  This 
unexpected feature in the deletion mutant complex could indicate that the inhibitor is 
not locking anymore the ISP and still allows electron transfer. This hypothesis looks 
quite improbable, since the introduced mutation is on cytochrome c1, not changing 
the inhibitor binding properties of the complex whereas the binding pocket is made 
up of cytochrome b and ISP. To check this, a test experiment has been performed, 
reducing the mutant complex using decylubiquinol and TMPD as redox mediator. 
After flashing, electrons are transferred to cytochrome c1 and to cytochrome b, as 
shown in Fig. 40. Results 
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Fig.  40:  Transients  for  the  electron  transfer  to  the  cytochrome  c1  in  the  mutant 
cytochrome bc1 complex from P. denitrificans, reduced with decylubiquinol and TMPD 
as redox mediator. 
 
Addition of stigmatellin blocks the electron transfer, as expected, giving flat signals 
at both wavelengths. In Fig. 41, at 552 nm and at 560 nm the signals indicate that 
no electron is transfered, and therefore, that the inhibitor is binding and correctly 
inhibiting the electron flow through the complex, as expected.  
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Fig. 41: Effect of stigmatellin on the ISP-cytochrome c1 electron transfer kinetics on 
the mutated cytochrome bc1 complex from P. denitrificans. In black, the transient at 
552 nm and in red at 560 nm, both showing a flat line and indicating the inhibition of 
the complex by stigmatellin.  
 
When  ascorbate  is  added  to  the  same  sample,  reduction  of  cytochrome  c1  and 
cytochrome b is again visible, even if the ISP is firmly docked on the Qo site (Fig. 42). 
Therefore  is  possible  to  conclude  that  ascorbate  is  responsible  for  the  artefact 
observed in the case of the mutated complex. As shown from Fig. 40, the complex 
could be reduced also using quinol and avoiding artifacts, but the use of ascorbate 
allows analysing the behaviour of the ISP with no external added substrate. This is 
important since the occupancy of this site is thought to have a regulatory role in 
defining  the  gating  of  the  ISP  head  domain  movement  (see  4.2).  Moreover,  the 
behaviour of the mutant in response to the inhibitor binding is the same as the wild 
type, even if the measured rate constants are faster as a result of the presence of 
ascorbate.  
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Fig.  42:  Effects  of  ascorbate  on  the  mutant  cytochrome  bc1  complex  from  
P. denitrificans. Adding ascorbate to the sample in Fig. 41 restores the reduction of 
cytochrome c1 and cytochrome b even if the complex is blocked with stigmatellin. 
This shows that ascorbate is responsible for the artefact observed at 560 nm and for 
the faster electron transfer rates measured for the complex.  
 
The reduction of cytochrome b recorded in these experiments was not observed in 
redox spectra using ascorbate to reduce the complex (see Fig. 11) and the steady-
state kinetics showed values comparable with the wild type. Probably, the deletion 
of the acidic domain and the change in the oligomerisation state (see 4.4) render the 
complex  more  accessible  for  small  molecules  such  as  ascorbate,  showing  the 
aforementioned effects.  
Even though the rates appear to be faster, the effects of inhibitors are similar: MOA-
stilbene and myxothiazol increase the rate of electron transfer to the cytochrome c1, 
whereas  JG-144,  by  constraining  the  ISP  close  to  cytochrome  b,  affects  both 
phases, still allowing slow electron transfer.  
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  k1 
(s
-1) 
Amplitude 
(%) 
k2 
(s
-1) 
Amplitude 
(%) 
no inhibitor  9400 ±939   26  1300 ± 560  14 
MOA-stilbene  22138 ± 514  41  3005 ± 87  24 
myxothiazol  21776 ± 842  51  4197 ± 159  43 
JG-144  5889 ± 137  64  818 ± 25  15 
Table 11: Results from the experiments obtained using ascorbate and TMPD to reduce 
the His tagged deletion mutant bc1 complex from P. denitrificans.  
 
 
Fig. 43: Effects of the inhibitor on the electron transfer from the Rieske cluster to the 
c1  heme  for  the  His  tagged  deletion  mutant  cytochrome  bc1  complex  from  
P. denitrificans. In black, the complex reduced with ascorbate and TMPD and without 
any  inhibitor.  Following,  in  red  the  kinetics  with  myxothiazol,  in  green  with  MOA-
stilbene, and in blue with the Pf inhibitor JG-144. 
 
3.4.3  Internal kinetics using TMPD, ascorbate, decylubiquinol, 
 succinate and SQR to reduce the cytochrome bc1 complex 
In a further set of experiments, the electron transfer from the ISP to the cytochrome 
c1 has been measured reducing the complex also in presence of quinol. This allows 
to observe effects on the kinetics in presence of substrate bound at the Qo site. 
Moreover, quinol starts the turnover of the enzyme and, therefore, electron transfer Results 
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at the level of the cytochrome b which can be followed at 560 nm. Ascorbate is still 
present in the reaction, to achieve complete reduction of the high potential chain and 
achieve good start conditions prior to flashing. In Table 12 the results for the three 
complexes are summarized, reduced with quinol and ascorbate, compared to what 
previously observed where the complexes were reduced by ascorbate and TMPD 
only. Again, cytochrome c1 is reduced in two phases, with a scheme similar to what 
was observed in the experiments where only the high potential chain was reduced. 
The rates are comparable to the previous experiments, indicating that the binding of 
substrate does not influence the rates of electron transfer to the c1 heme. On the 
other hand, the amplitude of the signals changes upon binding of inhibitor. This does 
not hold true for the fast phase of the cytochrome c1 deletion mutant complex, but 
this  effect  might  be  due  to  the  atypical  reaction  of  the  complex  in  presence  of 
ascorbate described in the previous chapter. 
Wild type complex 
  k1 
[s
-1] 
A1 
[%] 
k2 
[s
-1] 
A2 
[%] 
k3 
[s
-1] 
A3 
[%] 
Ascorbate and 
TMPD 
9100  9  1000  15  0  0 
Ascorbate, TMPD 
and quinol 
9200  17  900  45  600  83 
His tagged wild type complex 
Ascorbate and 
TMPD 
5200  9  600  14  0  0 
Ascorbate, TMPD 
and quinol 
5900  17  400  46  300  88 
His tagged deletion mutant complex 
Ascorbate and 
TMPD 
9400  26  1300  14  5600  17 
Ascorbate, TMPD 
and quinol 
17700  26  1000  46  2200  67 
Table  12:  Results  from  the  experiments  obtained  using  TMPD,  ascorbate,  quinol, 
succinate  and  SQR  to  reduce  the  cytochrome  bc1  complex  from  P.  denitrificans. 
Errors are within 10 % of the measured values.  
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The  presence  of  quinol  in  the  assay,  nevertheless,  changes  the  distribution  of 
amplitudes:  the  amount  of  cytochrome  c1  reduced  increases,  and  especially  the 
slow phase amplitude increases almost three fold compared to the experiments with 
no quinol added. This is consistent with the presence of substrate: the ISP docks 
onto cytochrome  b to form the complete pocket for the binding and oxidation of 
quinol, and this increases the amplitude of the slow phase, since most electrons 
reducing  cytochrome  c1  now  come  from  the  oxidation  of  quinol  at  the  Qo  site. 
Turnover at the Qo site is confirmed by the transients recorded at 560 nm, showing 
reduction of cytochrome b (Fig. 44) with a rate comparable to the one of the slow 
phase, consistent with electron bifurcation after quinol oxidation.  
 
 
Fig. 44: Transients obtained from the wild type complex in presence of ascorbate and 
quinol to reduce both the high and the low potential chain. Upper panel, redox events 
at the cytochrome c1 (552 nm); lower panel: cytochrome b reduction (560 nm). Results 
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This  result,  taken  together  with  the  previous  investigation  where  only  the  high 
potential  chain  is  reduced,  indicate  that  the  ISP  head  domain,  in  absence  of 
substrate,  is  not  fixed  in  a  single  position  but  most  likely  continuously  scanning 
between the Qo site and the cytochrome c1, being randomly distributed. Binding of 
Pm  inhibitors  brings  the  ISP  head  domain  closer  to  the  the  cytochrome  c1  and 
increases the amount of cytochrome  c1  reduced.  Binding of Pf inhibitors, on the 
other side, forces the ISP in the b position with different efficiencies: stigmatellin 
blocks the electron transfer to cytochrome c1, whereas JG-144 lowers the rate of the 
process  still  allowing  electron flow..  Binding  of  quinol  at  the  Qo  site  leads  to  an 
increase of the amplitude of the slow phase, indicating that the ISP head domain 
assumes preferentially the b position in order to bind and oxidize the substrate. Most 
important is that binding of ligands at the Qo site (inhibitors or substrate) increases 
considerably  the  amount  of  cytochrome  c1  reduced  compared  to  the  total  flash 
oxidized c1 heme. The informations obtained with these experiments give evidence 
for a regulatory role for the ligand at the Qo site, as proposed by Di Xia et al. (127). 
The mechanism seems to be controlled from the “sensory” cd1 helix of cytochrome 
b, which allows the docking at the Qo site when the substrate is bound. This will be 
discussed more in detail in section 4.2. 
3.5  Interaction between the ISP and the cytochrome c1  
by stopped flow kinetics 
3.5.1  Experimental setup 
In the previous section, the kinetics of the cytochrome c1 reduction by the ISP has 
been analysed on a very short time scale (µs range), by using ascorbate and TMPD 
to pre-reduce the high potential chain. In the following experiments, the cytochrome 
c1 reduction has been followed in the stopped flow apparatus by rapid mixing the 
oxidized protein against increasing amounts of ascorbate in pseudo-first-order (PFO) 
conditions. As visible in Fig. 45, a fixed amount of cytochrome bc1 complex (3 µM) 
has  been  mixed  agaist  a  large  excess  of  ascorbate,  in  order  to  achieve  PFO 
conditions  and  determine  the  bimolecular  rate  constant  for  the  cytochrome  c1 
reduction. The FeS cluster has a redox potential close to the one of cytochrome c1 
(85), so that also the ISP is reduced in presence of ascorbate. This implies that the 
reduction  of  cytochrome  c1  is  not  only  achieved  by  direct  electron  transfer  from 
ascorbate to the c1 heme, but also by the electron transfer from the Rieske cluster. Results 
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The  picture  is  more  complicated  since  it  is  necessary  to  consider  also  the 
movements the ISP head domain has to undergo in order to reduce the cytochrome 
c1  as  described  in  the  previous  chapter.  A  mechanism  describing  the  electron 
transfer according to the experimental setup is described in section 3.4.2. 
 
 
Fig.  45:  Scheme  of  stopped  flow  experiments.  A  fixed  amount  of  cytochrome  bc1 
complex is mixed, under PFO conditions, with increasing concentrations of ascorbate. 
Cytochrome c1 reduction can be followed at 418 nm, as a result of two processes: the 
direct reduction by ascorbate and the reduction by the Rieske cluster. 
 
 
Fig. 46: Double sector cuvette (DSC) experimental setup. In a double sector cuvette 
two solutions are carefully pipetted: in one side 3 µM cytochrome bc1 complex and in 
the other side 1 mM ascorbate. A spectrum is recorded (before mixing). After that, the 
cuvette  is  inverted  to  mix  the  two  solutions  and  another  spectrum  recorded  (after 
mixing). The difference spectrum (am-bm) allows identifying the wavelength at which 
the change in absorption occurs; this wavelength is then used for the SF experiments.  
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In the stopped flow apparatus, one syringe contained a protein solution (in some 
experiments  incubated  over  night  with  Qo  site  inhibitors)  with  3  µM  oxidized 
cytochrome bc1 complex, and the other one a solution containing 1 mM, 2 mM, 4 
mM, 7 mM or 10 mM ascorbate in the same buffer. The two solutions were rapidly 
mixed and the absorption recorded at 418 nm. The wavelength has been chosen by 
double sector cuvette experiments, as depicted in Fig. 46. These cuvettes with two 
sectors have been used, in which one sector contains the oxidized cytochrome bc1 
complex and the second one a solution of 1 mM ascorbate. A spectrum is recorded 
before  mixing  the  two  solutions.  After  that,  the  cuvette  is  inverted  and  the  two 
solutions  can  mix,  reducing  the  protein.  After  waiting  for  five  minutes  to  reach 
complete reduction, an after-mixing spectrum is recorded, and subtracted from the 
previous one. This gives a difference spectrum (Fig. 47): the peaks at 418 nm and 
552 nm can be used to follow the spectral changes due to the complex reduction. 
The 418 nm peak is higher than the 552 nm one, indicating that the signal in the 
stopped flow will be more intense at 418 nm than at 552 nm. 
 
 
Fig. 47: DSC difference spectra. Here are represented the difference spectra from the 
three  complexes,  indicating  that  the  same  wavelength  can  be  used  for  the 
experiments at the Stopped Flow. The peak at 418 nm is higher that the one at 552 nm, 
meaning that the signal  at this wavelength is more sensible than  at 552, therefore 
giving a better signal to noise ratio.  
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The  stopped  flow  measurements  were  performed  with  the  three  complexes 
analysed  until  now  (wild  type,  wild  type  His  tagged  and  acidic  domain  deletion 
mutant) at 418 nm, with syringes kept at 10 ° C by the use of a water bath. For each 
complex the effects of Pf inhibitors (such as stigmatellin) and Pm ones (such as 
MOA-stilbene and myxothiazol) were tested, after overnight incubation with a 10-fold 
excess of inhibitor. 
3.5.2  Kinetics observed mixing against ascorbate, with and  
without inhibitors 
Each of the three complexes studied showed a biphasic reduction in the stopped 
flow  experiments:  as  seen  in  Fig.  48, the  signal  obtained  can  not  be fitted  to  a 
monoexponential equation, since the residual plot shows a deviation of the model 
from  the  data.  Fitting  to  a  biexponential  equation  gives  a  much  better  result, 
indicating that the trace is composed of two phases, a fast and a slow one, whose 
constants are indicated in Table 13. 
 
 
Fig. 48: Mono- and bi-exponential fit of one of the traces (black line) obtained with the 
wild type cytochrome bc1 complex mixed with ascorbate. Left plot: the fit to a single 
exponential (red line) does not fit properly, since the residual plot (green line) is not 
flat  indicating  the  model  deviates  from  the  experimental  data.  Right  plot:  fit  to  a 
double  exponential  equation,  showing  a  much  better  correspondence  between  the 
model and the data. 
 
The rate constants show different behaviours: the PFO constant for the fast phase 
increases linearly with the concentration of ascorbate, whereas for the slow phase 
shows a hyperbolic dependency (Fig. 49). The the slow phase tends to saturation, i. 
e. increasing the ascorbate concentration does not change the PFO rate constant 
anymore.  Results 
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  Wild type  
[M
-1s
-1] 
WT His tagged 
[M
-1s
-1] 
His tagged deletion 
mutant 
[M
-1s
-1] 
kFAST  54.4  59.9  66.1 
Table 13: Second order rate constant for the reduction of the cytochrome bc1 complex 
in presence of ascorbate. The slow phase is hyperbolically dependent on ascorbate 
concentration, so no linear fitting can be done. Errors are within 10 % of the measured 
values. 
 
 
Fig. 49: Dependency of the PFO rate constants on the ascorbate concentration. Left 
column: kFAST. The constant increases linearly with the ascorbate concentration. The 
slope from the plots is the second order kinetic constant (M
-1s
-1) of the fast phase. 
Right  column:  kSLOW.  The  constant  increases  with  the  ascorbate  concentration 
hyperbolically: at high ascorbate concentration, the process described by the slow 
constant tends to saturation, with no further increase of the kSLOW. Results 
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The amplitudes of the fast and the slow phase displaying that the first increases, 
whereas the second diminishes with increasing ascorbate concentrations, means 
that for low ascorbate concentrations the highest absorption change observed is due 
to  the  slow  phase  (about  70  %  of  the  total  amplitude).  While  increasing  the 
ascorbate  concentration,  the  curve  reaches  a  point  where  the  two  processes 
contribute each of them with 50 % to the total absorption change. Further increasing 
ascorbate, the contribution of the slow phase becomes significantly lower reaching 
about  30  %  of  the  total  amplitude.  This  demonstrates  that  the  kinetic  process 
represented by the fast phase is predominant.  
 
 
 
Fig.  50:  Amplitudes  (expressed  as  pergentage  of  the  total  amplitude)  of  the  two 
phases  for  the  cytochrome  bc1  complex  reduction  in  presence  of  ascorbate.  The 
amplitude of the fast phase increases with the ascorbate concentration (black line), 
whereas the one of the slow phase diminishes (red line).  
 
Incubating the protein solution overnight with a 10 fold excess of stigmatellin, the 
kinetics are much slower than in the uninhibited complex: this effect is clear in Fig. 
51, where a trace recorded with 4 mM ascorbate clearly shows the difference in the Results 
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presence of stigmatellin. Cytochrome c1 reduction is slower than in the absence of 
inhibitor. 
 
 
Fig.  51:  Comparison  between  one  of  the  traces  obtained  from  the  first  experiment 
(inhibitor  free,  black  line)  and  the  trace  in  the  same  condition  with  excess  of 
stigmatellin (red line).  
 
Upon binding of stigmatellin to the Qo site, the PFO constant for the fast  phase 
becomes hyperbolically dependent on ascorbate concentration. The kSLOW on the 
other hand is now showing a linear behaviour, with values indicated in Table 14. 
This indicates that the binding of stigmatellin, which docks the ISP head domain 
onto  cytochrome  b,  fixing  it,  acts  on  the  kinetics  clearly  reducing  the  rate  of 
cytochrome c1 reduction. It is interesting to note that the process is still biphasic. 
With the ISP fixed in the b position, ascorbate should transfer electrons directly to 
the cytochrome c1, resulting in monophasic signals. The biphasicity is, though, still 
observed (see 4.3). 
 
  Wild type 
[M
-1s
-1] 
His tagged wild 
type 
 [M
-1s
-1] 
His tagged deletion 
mutant 
[M
-1s
-1] 
kSLOW  0.2  0.1  0.2 
Table 14: Linear fit of the PFO kSLOW. Values of the second order rate constant for the 
reduction of the cytochrome bc1 complex in presence of stigmatellin. Errors are within 
10 % of the measured values. Results 
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Fig. 52: PFO constants in presence of 40 µM stigmatellin (in the left column, kFAST; 
right  column;  kSLOW).  The  kSLOW  shows  a  linear  behaviour  now,  and  the  kFAST  is 
hyperbolically dependent on the ascorbate concentration.  
 Results 
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Fig. 53: Amplitudes of the kinetic process in presence of 40 µM stigmatellin. Upon 
addition of stigmatellin, the amplitude of the slow phase is predominant over the one 
of the fast phase. The amplitudes tend to remain constant troughout the experiment. 
 
The  amplitudes  upon  binding  of  stigmatellin  are  independent  on  the  ascorbate 
concentration,  meaning  that  the  cytochrome  c1  amount  reduced  during  the  two 
phases is constant.  The amplitude of the slow phase is now predominant, being 
90 % of the total amplitude and stays constant during ascorbate titration. 
In presence of MOA-stilbene, also a Pm inhibitors, the overall situation is changed: 
kinetics are faster, with a kFAST increasing almost by a factor of two in comparison to 
the one uninhibited complex. Results are listed in Table 15, showing this remarkable 
effect. The dependence on ascorbate concentration is linear, exactly as observed 
for the uninhibited complex. The kSLOW, on the other side, shows in a more definite 
way its hyperbolic dependency on ascorbate concentration, reaching saturation at 
lower ascorbate concentrations than in the first case (Fig. 54).  
 
 Results 
126 
  Wild type 
[M
-1s
-1] 
His tagged wild 
type 
 [M
-1s
-1] 
His tagged deletion 
mutant 
[M
-1s
-1] 
kFAST  79.7  82.4  94.0 
Table  15:  Linear  fit  of  the  PFO  kFAST  results  in  values  for  the  second  order  rate 
constant for the reduction of the cytochrome bc1 complex in the presence of MOA-
stilbene. Errors are within 10 % of the measured values. 
 
 
Fig. 54: PFO constants of 40 µM MOA-stilbene inhibited complex. The kFAST increases 
linearly with ascorbate concentration, revealing a second order constant clearly faster 
than  in  the  case  depicted  in  Fig.  48  (uninhibited  complex);  kSLOW  shows  the  same 
hyperbolic dependence as observed before.  Results 
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The amplitudes for the MOA-stilbene inhibited complex are shown in Fig. 55. For the 
fast phase, the amplitude tends to diminish, whereas the one of the slow phase 
increases.  A  similar  situation  was  already  observed  in  the  experiments  without 
inhibitor,  but  the  amplitude  of  the  fast  phase  increases  much  faster  than  in  the 
previous case. Indeed, the intersection of the two phases is reached at  a lower 
ascorbate concentration than before (about 1 mM ascorbate after mixing).  
 
 
Fig. 55: Amplitudes of the fast and the slow phase in presence of 40 µM MOA-stilbene. 
Upper left: wild type complex; upper right: His tagged wild type complex, and, lower 
panel, deletion mutant complex. At 1 mM ascorbate, both phases contribute each for 
50 % of the total amplitude, opposite to what observed with the inhibitor free complex.  
 
Another Pm inhibitor has been also tested, mixothiazol. Its effect is less evident than 
the one of MOA-stilbene (Fig. 56). In Table 16, the bimolecular rate constants for the 
experiments with myxothiazol are indicated. A slight increase in the rates, but less 
evident  than  in  presence  of  MOA-stilbene,  is  observed.  The  amplitudes  have  a 
similar trend to the ones observed with the other Pm inhibitor and the wild type. 
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  Wild type 
[M
-1s
-1] 
His tagged wild 
type 
 [M
-1s
-1] 
His tagged deletion 
mutant 
[M
-1s
-1] 
kFAST  64  71  60 
Table 16: Second order rate constant for the fast phase describing the reduction of 
the  cytochrome  bc1  complex  after  overnight  incubation  with  excess  (40  µM)  of 
mixothiazol in presence of ascorbate. Errors are within 10 % of the measured values. 
 
 
Fig.  56:  Comparison  of  the  PFO  constants  for  the  three  complexes  achieved  by 
stopped flow experiments in presence of 40 µM myxothiazol. The kFAST (left) has a 
linear behaviour, and the slope gives a slightly faster second order constant than in 
absence  of  inhibitors.  The  kSLOW  shows,  even  more  clearly  than  in  previous 
experiments, its hyperbolical dependence on the ascorbate concentration.  
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Fig. 57: Amplitudes of the fast and the slow phase in presence of 40 mM mixothiazol 
during the assay. From the upper right plot, wild type complex, His tagged wild type 
and deletion mutant complex respectively. The amplitude of the fast phase increases 
and the one of the slow phase diminishes throughout the experiment: a clear trend for 
the intersection is not visible as for the other cases. 
 
3.5.3  Kinetic measurements using the fbcF gene with the 
 S157C mutation 
The contribution of the ISP cluster to the biphasic kinetic was studied more in detail 
with a mutant complex missing the Rieske cluster. The mutant was first described by 
Gutierrez-Cirlos et al. (86) where the mutation S183C (in the ISP gene from yeast) 
resulted in a complex where the apo-protein was still inserted but no signal for the 
Rieske cluster was detected in CD spectroscopy. The insertion of the Cys residue 
for the Ser leads, most likely, to the formation of an internal disulphide bridge with 
one  of  the  Cys  residues  involved  in  the  binding  of  the  iron  atom  of  the  cluster, 
leading to loss of the cofactor (Fig. 58).  Results 
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Fig.  58:  Stick-representation  of  the  Rieske  cluster  coordinating  side  chains  in  the 
yeast cytochrome bc1 complex (PDB 1KYO). The protein backbone is shown in the 
ribbon representation in green. The Rieske cluster is in the middle, with the sulphur 
atoms in yellow and the iron ones in green. The residues Cys
159 and Cys
178 may be 
involved  in  the  disulphide  bridge  with  the  thiol  group  of  the  Cys
183  in  the  mutant 
S183C (P. denitrificans numbering S157C). 
 
 
Fig.  59:  redox  spectra  of  the  S157C  mutants,  demonstrating  the  presence  of 
cytochrome  c1  and  cytochrome  b  in  the  purified  protein.  The  peaks  observed 
correspond to the ones expected for a wild type protein (see Fig. 9, panel A). Results 
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The mutation was inserted by inverse PCR into a cloning vector containg the acidic 
domain  deletion  mutant  fbc  operon  (pMC14)  and  checked  via  sequencing.  The 
operon was subcloned into the pRI2 expression vector to obtain the plasmid pMC16 
and mated in P. denitrificans for expression. From pMC14, the fragment containing 
the mutation has been subcloned via Pfl23II/SacI directed cloning into pTK33 and 
pRI2(436) to obtain pMC17 and pMC18, respectively.  
The membranes obtained from these strains were solubilised following the same 
protocol  used  for  the  corresponding  wild  type  complex,  and  purified  by  ionic 
exchange or affinity chromatography. The redox spectra in Fig. 60 display the peaks 
for  cytochrome  b  (560  nm)  and  cytochrome  c1  (553  nm)  present  in  the  purified 
complex. The presence of the iron sulphur apoprotein confirmed by a Western blot 
using an antibody against the ISP. 
 
 
Fig. 60: Left panel: Western blot to reveal the ISP subunit of the strains MC16, MC17 
and MC18. PC: positive control, TK56 P. denitrificans membranes with a Strep tagged 
version of the cytochrome bc1 complex. NC: negative control, T. thermophilus wild 
type  membranes,  showing  no  cross  reactivity  with  the  used  antibody.  A  signal  is 
visible in the lanes MC16, MC17 and MC18. As expected the negative control does not 
show  any  band,  and  in  the  positive  control  the  two  typical  bands  for  the  ISP  are 
visible. The presence of the 18 kDa molecular band could be the consequence of an 
incomplete denaturation of the sulphide bridges coordinating the cluster. Right panel: 
Western blot to follow the purification of MC16 as an example of the three strains on 
different fractions. Lane 1: solubilised membranes, lane 2: column flow through; lane 
3:  washing  step;  lane  4:  eluted,  and  concentrated  protein.  Negative  and  positive 
control as described above. This Western blot shows that the iron sulphur apo-protein 
is present not only in the membrane but also in the purified protein, meaning that the 
absence of the cluster is not affecting the assembly and the stability of the complexes.  
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The mutant complexes were also tested for turnover under steady-state conditions 
to  check  the  functionality  of  the  so  obtained  cytochrome  bc1  complex.  With  the 
cluster not present, as expected, no electron bifurcation can take place at the Qo site 
and, therefore, no significant absorbance changes could be measured. Even if the 
kinetic  tests  indicated  the  mutants  were  inactive,  the  complexes  were  further 
analysed by CD spectroscopy to verify the presence of the characteristic signal the 
Rieske cluster shows in response to polarized light. The results are depicted in Fig. 
61. From these, it becomes clear that there is no ellipticity change in the region 
where  for  the  wild  type  the  signal  of  the  Rieske  cluster  is  expected.  All  those 
evidence taken together confirm that the mutation caused the loss of the FeS cluster, 
but  still  allows  expression  and  correct  insertion  of  the  Rieske  apoprotein  in  the 
complex assembled in membranes. 
 
 
Fig. 61: CD spectra. Wild type: spectra obtained from the wild type cytochrome bc1 
complex. The complex has been measured in the oxidized state, ascorbate reduced 
and dithionite reduced. At wavelength 500 nm the signal for the ISP is visible. The 
complexes MC18, M17 and MC16 were also analysed by CD spectroscopy, and only 
the signals for the hemes are observed. This directly demonstrates that the cluster is 
not present as a consequence of the mutation S157C.  Results 
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The  measurements  were  repeated  with  the  complexes  lacking  the  ISP,  in  the 
presence  and  absence  of  the  inhibitors.  The  signals  obtained  from  those 
measurements  were  monophasic,  and  the  amplitude  was  independent  of  the 
ascorbate  concentration.  In  Fig.  62  a  typical  signal  obtained  from  the  three 
complexes and the residual plot from the fitting to a single exponential is shown, 
clearly indicating that the previously observed biphasicity comes from the presence 
of the Rieske cluster. The presence of inhibitors did not show any effect on the 
kinetics anymore. This strikingly demonstrates that the biphasicity is beyond any 
doubt due to the Rieske cluster (Fig. 63, 64 and 65). 
 
 
Fig. 62: Fitting of a trace obtained by the S157C mutated complexes (MC17) to a single 
exponential. The residual plot (green line) indicates a good correspondence  of the 
data to the mathematical model used.  
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Fig.  63:  PFO  plots  for  the  kOBS  obtained  from  the  experiments  with  the  complexes 
MC17 and MC18 (upper panels) and relative amplitudes (lower panels). The constants 
are  linearly  dependent  on  the  ascorbate  concentration.  The  amplitudes  remain 
constant  throughout  the  experiments,  meaning  a  complete  reduction  of  the 
cytochrome c1 already at the lower ascorbate concentration (0.5 mM after mixing). 
 Results 
135 
 
Fig.  64:  PFO  plots  and  amplitudes  fort  he  reduction  of  MC18  with  ascorbate  and 
inhibitors.  Addition of inhibitors did not produce any change compared to the plot 
indicated in Fig. 62. 
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Fig.  65:  PFO  plots  and  amplitudes  for  the  reduction  of  MC17  by  ascorbate.  As 
previously observed (Fig. 64), no change occurs upon binding of inhibitors. 
 
In the case of MC16 (deletion mutant complex with the S157C mutation in the fcbF 
gene), a small biphasicity is still observed. The traces can still be fitted to a single 
exponential model for with low ascorbate, but the fitting tends to show deviation from 
the experimental data at higher concentrations (Fig. 66). In Fig. 67 is shown the 
PFO plot for the kFAST and kSLOW for the stopped flow experiment with MC16. The 
fast phase has very small amplitude (only 10 % of the total absorption change) and Results 
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the constant is hyperbolically dependent on the ascorbate concentration, only in the 
case of MC16, and this could be due to the atypical behaviour already shown by the 
deletion mutant complex in the experiments of section 3.4.2, where the presence of 
ascorbate  lead  to  reduction  of  both  cytochrome  c1  and  the  cytochrome  b. 
Nevertheless, the slow phase in Fig. 67 has a much bigger amplitude than the fast 
phase  and  the  kinetic  constant  is  in  the  range  with  the  other  two  complexes, 
meaning that the fast phase observed is most likely to assign to the reduction of 
cytochrome c1 in presence of ascorbate previously observed.  
 
 
Fig.  66:  Residual  plot  of  the  monoexponential  and  biexponential  fit  of  one  of  the 
traces  obtained  from  the  SF  experiments  with  MC16  (7  mM  ascorbate).  The 
biexponential fit indicates a very good correspondence with the experimental data, 
whereas the monoexponential fit leads to significant deviations. Therefore, the traces 
have been fitted to a biexponential equation and only the slow phase considered for 
the analysis.  
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Fig. 67: PFO constants and amplitudes from the MC16 SF experiments with data fitted 
to a biexponential equation. Upper panel left: kFAST, upper panel right: kSLOW; lower 
panel: amplitudes. 
 
The assays in presence of inhibitors show no differences to the ones where the Qo 
site is unoccupied, meaning that the biphasic kinetics observed in section 3.5.2 are 
due to the presence of the FeS cluster (Fig. 68). In table 17 all the kinetic constants 
are  reported  for  the  experiments  with  the  complexes  MC16,  MC17  and  MC18, 
showing  no  effect  of the  inhibitors  on the reduction  of  cytochrome  c1. This  is  in 
contrast to the observation of the complexes with the Rieske cluster. 
 Results 
139 
 
 
Fig. 68: PFO plots for the MC16 reduction kinetics in presence of different Qo site 
inhibitors. Left column, the kSLOW for MC16 in presence of stigmatellin (upper right), 
myxothiazol (middle right) and MOA-stilbene (lower right). Left column, the respective 
amplitudes. Only the kSLOW and the amplitude of the slow phase are shown, since the 
fast phase is most likely due to an artifact seen only with the deletion mutant complex, 
as explained in the text. 
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MC16  No inhibitor 
[M
-1s
-1] 
+ stigmatellin 
[M
-1s
-1] 
+ myxothiazol 
[M
-1s
-1] 
+MOA-stilbene 
[M
-1s
-1] 
  1.1  1.3  1.3  1.1 
MC17  No inhibitor 
 [M
-1s
-1] 
+ stigmatellin 
[M
-1s
-1] 
+ myxothiazol 
[M
-1s
-1] 
+MOA-stilbene 
[M
-1s
-1] 
  1.6  0.9  0.8  0.9 
MC18  No inhibitor 
 [M
-1s
-1] 
+ stigmatellin 
[M
-1s
-1] 
+ myxothiazol 
[M
-1s
-1] 
+MOA-stilbene 
[M
-1s
-1] 
  0.6  0.7  0.6  0.7 
Table  17:  Summary  for  the  stopped  flow  experiments  with  the  S157C  mutants.  No 
difference  is  present  in  the  measurements  in  absence  and  presence  of  inhibitors, 
meaning that the Rieskecluster is effectively responsible for the biphasicity observed 
with the wild type complexes. Errors are within 10 % of the measured values. 
 
The experiments presented here show that the cytochrome  c1  is reduced in two 
phases  by  ascorbate:  a  fast  phase,  with  increasing  amplitude  at  increasing 
ascorbate concentrations, and a slow phase, with diminishing amplitude. The PFO 
rate constant of the fast phase is linearly dependent on the ascorbate concentration, 
whereas the one of the slow phase shows a tendency to a hyperbolic dependency. 
This indicates that, at high ascorbate concentrations, the process defined by the rate 
constant is ascorbate independent. The presence of Pf inhibitors makes the kFAST 
hyperbolically dependent on ascorbate concentration, while Pm inhibitors make the 
hyperbolic dependenc of kSLOW from the substrate much more evident. The mutation 
S157C  causes  the  lack  of  the  Rieske  cluster,  abolishing  the  biphasicity  and 
indicates no more effects of inhibitors on the cytochrome c1 reduction.  
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4  Discussion 
The  aim  of  this  work  is  the  functional  analysis  of  the  cytochrome  bc1  complex, 
obtained  by  studying  the  dimeric  nature  of  the  complex,  the  interaction  with  its 
substrate and the inter-dimer electron transfer. For this stud, the cytochrome bc1 
complex from  Paracoccus  denitrificans  has  been  chosen  as  a model  for  several 
reasons: first of all, according to the endosymbiotic theory describing the origin of 
mitochondria (1), P. denitrificans shows a high degree of similarity with the ancestral 
ʱ-proteobacterium which started the symbiosis at the origin of the eukaryotic cell. 
The  respiratory  chain  of  mitochondria  corresponds  to  the  one  of  
P. denitrificans, composed of a complex I, II, a ubiquinone utilizing complex III, and 
an aa3 cytochrome oxidase reducing O2 to H2O. Beside those, alternative oxidases 
are  also  present  to  allow  fast  adaptation  to  environmental  changes  (ba3  quinol 
oxidase, cbb3 oxidase, mostly expressed in conditions of low oxygen concentration). 
Moreover, the protein complexes of the aerobic respiratory chain in P. denitrificans 
are more basic versions of the mitochondrial ones, since no accessory subunit are 
present,  allowing  to  work  with  smaller  complexes  still  possessing  the  same 
properties  as  the  eukaryotic  counterparts.  Bacteria  offer  the  possibility  of  more 
convenient handling: as cultivation is less cumbersome and the genetic material is 
easily accessible for manipulation and modifications. 
This work addresses open questions concerning the mechanism of the cytochrome 
bc1 complex, such as the relationship between the putative dimeric nature of the 
complex and the catalytic cycle. Furthermore intermonomeric electron transfer, an 
internal  regulation  mechanism  and  how  the  two  monomers  communicate,  were 
intensively discussed in the last ten years (108, 142, 143, 148, 183-185). 
Additionally,  the  rotation  of the ISP  head  domain  has  been  investigated,  by fast 
kinetic measurements, in order to gain insights on the mechanism which regulates 
the switching between cytochrome b and cytochrome c1 and the electron bifurcation 
at the Qo site. Several mechanisms have been proposed to explain how the ISP is 
kept in a specific position, and the regulation of its release from the Qo site to reach 
cytochrome c1 (67, 74, 127, 128, 130). The rotation of the ISP is a key step in the 
enzymatic turnover, since inhibitors binding at the Qo site impair the electron transfer 
by  blocking  or  displacing  the  ISP  head  domain  (65).  Several  cytochrome  bc1 
complex inhibitors are today used as herbicides (186), antimalaria agents (187-189) Discussion 
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and  fungicides  (186,  190),  so  that  the  ISP  movements  and  the  interaction  with 
inhibitors (from several crystal structures, (48, 65)) assume quite a big relevance.  
P. denitrificans cytochrome bc1 comples has a unique feature on the cytochrome c1 
gene, a 150 amino acid acidic domain (102, 104), which shows similarity to a small 
acidic subunit present in the eukaryotic complex involved in the interaction with the 
substrate (94, 111, 114). Since the domain is not present in any other organism, 
therefore representing a specific characteristic of P. denitrificans bc1 complex, it has 
been deleted and the resulting complex tested with different kinetic approaches, in 
order to define the eventual role in regulating the interaction with cytochrome c552, 
the physiological electron acceptor. 
Finally, the internal electron transfer pathway has been analysed by stopped-flow 
kinetics. The complex has been reduced with increasing amounts of ascorbate and 
the bimolecular rate constants calculated for the reduction of the c1 heme. Studies 
with mutants depleted of the Rieske cluster and inhibitor titrations (143) suggested 
that the Rieske cluster could affect the reduction of cytochrome c1, by acting as an 
intermediateaffecting the rate of electron transfer to the c1 heme. 
 
4.1  Half-of-the-sites mechanism and dimeric nature  
of the cytochrome bc1 complex 
In all the crystal structures available at the moment, the cytochrome bc1 complex is 
a  homodimer  (49,  52,  55,  65,  191).  Each  monomer  contains  cytochrome  b, 
cytochrome  c1  and the Rieske ISP as catalytic subunits, plus up to 8  organism-
specific additional subunits, according to the organism. Taking a closer look at the 
crystal structures and the position of the cofactors in the dimer, it is evident that the 
bL hemes in the two cytochromes b in the dimer are in electron transfer distance 
(about 12 Å, edge to edge, Fig. 69 (65)), possibly allowing intermonomeric electron 
transfer.  Discussion 
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Fig. 69: Cytochrome bc1 complex from S. cerevisiae (PDB: 1KYO). In red, cytochrome 
b, in green the ISP and in light blue the cytochrome c1. In blue, the bL hemes in the 
cytochrome b and in violet the bH hemes. The bL hemes are 12 Å apart, a distance 
allowing fast electron transfer across the dimer. 
 
Electron transfer across the dimer has the aim to avoid the formation of detrimental 
ROS (192), which leads to cellular aging (193). In normal turnover conditions, quinol 
oxidation is so fast that both electrons are transferred almost simultaneously to the 
Rieske cluster and cytochrome bL (194, 195). While an inhibitor is bound to the Qi 
site, after the first electron reaches the Rieske cluster, the second electron coming 
from  quinol  cannot  be  transferred  to  a  quinone/semiquinone  molecule.  A  similar 
situation  is  obtained  in  presence  of  ischemia  in  tissues,  where  the  low  oxygen 
concentration impaires the electron flow in the respiratory chain and allowing them 
to  react  with  molecular  oxygen,  producing  superoxide  (60).  The  protective 
distribution of electrons to the other monomer at the level of the bL hemes allows 
electrons to find a quinone/semiquinone at the second Qi site. The mechanism is 
effective only if the two monomers are not oxidizing quinol at the same time, so that 
for one electron entering the low potential chain there are two Qi site theoretically 
available to accept it. Covian et al. (61) proposed a mechanism according to which Discussion 
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only one Qo site in the dimer is able to oxidize quinol at a given time, and electrons 
can  equilibrate  across  the  dimer.  The  occupancy  of  the  Qi  site  defines  which 
monomer oxidizes quinol. The Qi site can react with the Q-pool accomodating quinol 
and  oxidizing  it  to  a  semiquinone  or  quinone,  hereby  reducing  one  (or  two)  bH 
heme(s) in the process (141). This process stabilizes the species bound at the Qi 
site, able to accept electrons coming from quinol oxidation, and at the same time 
impeding  them  to  react  with  oxygen.  The  presence  of  a  ligand  at  the  Qi  site 
stimulates the other monomer to oxidize quinol at the Qo site, communicating the 
presence of an available electron acceptor. The mechanism, called half-of-the-sites, 
is depicted in Fig. 7 (see Introduction 1.2.4.3). The way chosen here to verify the 
presence  of  such  a  regulation  mechanism  was  the  creation  of  a  heterodimeric 
cytochrome  bc1  complex,  where  one  Qo  site  is  inactivated  by  a  mutation  which 
impairs  quinol  oxidation  but  does  not  modify  the  affinity  of  the  enzyme  for  the 
substrate. If the mechanism is valid, and only one monomer accounts for the activity 
of  the  complex  at  a  given  time,  the  introduced  mutation  would  not  diminish  the 
turnover number in steady state conditions. Moreover, the stimulation of the second 
quinol oxidation site in the dimer should not occur in the heterodimeric complex, 
being the second Qo site unable to oxidize the substrate. In the absence of any 
regulation mechanism, with each monomer responsible for 50% of the total activity, 
the mutation should allow only 50% of activity to be recorded. 
The heterodimeric complex has been obtained by cloning the two different copies of 
the  fbc  operon  in  two  separate  expression  vectors,  with  different  origins  of 
replication.  As  discussed  more  in  detail  in  paragraph  4.4,  the  deletion  mutant 
complex has been chosen for these experiments since LILBID analysis indicated 
that it has a dimeric structure (Kleinschroth et al., manuscript submitted). The wild 
type  complex  is  purified  as  a  “dimer  of  dimers”(177):  in  this  case,  several 
combinations of affinity tags can be obtained, which do not allow purific ation of the 
heterodimer. 
The  two  different  expression  vectors  have  been  transferred  by  conjugation  into  
P. denitrificans cells to allow homologous expression. The clones were screened by 
plasmidic DNA preparation and Western blotting to identify the presence of the two 
affinity  tags.  The  separation  of  the  heterodimer  was  achieved  by  a  sequential 
purification, first on a Ni
2+-NTA column, followed by a Streptactin column. Once the 
cells  are  able  to  express  the  two  versions  of  the  Δfbc  operon,  three  different Discussion 
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combinations can be achieved: a dimer with only mutated, inactive monomers, one 
with  fully  active  monomers  and  the  desired  heterodimer.  On  the  first  column  is 
achieved the separation of just Strep tagged monomers from the ones containing 
two His tags and the heterodimer. With the second column, only heterodimers are 
eluted in a single step, using desthiobiotin. By Western blot, the presence of the two 
tags  has  been  proven  on  the  purified  complex  and  redox  spectra  showed  the 
expected peaks for the cytochrome bc1 complex. Reduction of cytochrome c from 
horse heart in pre steady-state conditions confirmed that the complex measured is 
really a heterodimer: the kinetics of both monomers composing the heterodimer can 
be seen and identified (63). 
To  validate  the  half-of-the-sites  mechanism,  three  experiments  have  been 
performed.  In  steady-state  kinetics,  it  has  been  shown  that  the  heterodimeric 
complex has a vMAX comparable to the fully wild type dimer, meaning that only one 
monomer  accounts  for  the  activity  measured.  In  the  pre  steady  state  kinetics  in 
presence  of  antimycin  was  shown  that  when  electrons  can  enter  the  complex 
through  the  only  active  Qo  site,  the  reduction  of  one  cytochrome  c1  and  two 
cytochrome bH is obtained, due to intermonomer electron transfer.Finally, by titrating 
the  complex  with  antimycin,  a  stimulation  of  the  complex  was  demonstrated  by 
activating the second monomer in the complex. The effects observed following the 
introduction of the mutation in one monomer are not due to changes in the affinity of 
the complex for the substrate, since steady state activity measurements showed that 
the  KM  for  quinol  is  not  changed.  Residue  Tyr147  is  thought  to  be  involved  in 
transferring the electron coming from quinol oxidation to the bH heme, being halfway 
between the two. The substitution to Ser eliminates the aromatic ring blocking so the 
electron transfer.  
A  consequence  of  the  half-of-the-sites  mechanism  is  also  the  inhibition  of  the 
complex with one stigmatellin molecule per dimer: binding of stigmatellin at only one 
Qo site blocks the ISP in the b position, kind of simulating the binding of substrate. 
As a consequence, quinol oxidation in the second monomer is blocked. Discussion 
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Fig. 70: electron density round the Qo site from the deletion mutant cytochrome bc1 
complex from P. denitrificans. In yellow, the iron sulphur cluster. In red, stigmatellin. 
In  light  blue,  the  E
272of  the  PEWY  sequence,  hydrogen  bonding  stigmatellin  (and 
quinol) and involved in substrate oxidation. In green, the Y
147, most likely being an 
electron bridge between the E
272 and the bL heme (side view, orange). Picture from 
Kleinschroth et al., manuscript submitted) 
 
The  results  show  clearly  that  the  half-of-the-sites  mechanism  is  regulating  the 
activity  of  the  two  monomers  in  the  cytochrome  bc1  complex,  and  that  the 
oligomerization state has not just a structural meaning (since the ISP structurally 
belonging  to  one  monomer  is  catalytically  active  in  the  second  one)  but  also  a 
functional one. 
It still is unclear how the activation of the second monomer takes place, even though 
hints come from the crystal structures available. Cytochrome b has both N- and C-
termini facing the negative side of the membrane, the matrix in mitochondria and the 
cytoplasma in bacteria. The N-termini of the two cytochrome b are very close in the 
dimeric structure (Fig 43), and this could be the junction transferring the signal that 
the  binding  of  antimycin/semiquinone  at  one Qi  site generates  in  one monomer. 
Conformational changes after the occupation of the Qi site can be transferred by 
highly conserved residues in close contact with the His
202 (yeast numbering), a key 
residue for catalysis at the Qi site, and the N-terminus of the second cytochrome b 
(62).  Discussion 
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Fig. 43: Enlargement of the N-termini in the cytochrome b (PDN: 1zrt). In red, the bH 
hemes and in green the bL hemes. In the circle, the close contacts that the N-terminal 
sequence of the cytochrome b (blue monomer) makes with the helices surrounding 
the bH heme in the cytochrome b (orange monomer). 
 
A recent publication (196) discussed the presence of a regulation mechanism in the 
cytochrome  bc1  complex of  Rhodobacter capsulatus. The approach used  was to 
fuse together the genes for two cytochromes b in order to create a forced dimer, and 
have the possibility to introduce selectively in one or the other monomer inactivating 
mutations at the Qo and Qi site, to check not only the intermonomer electron transfer 
but  also  the  regulation  mechanism.  The  authors  could  not  identify  any  kind  of 
regulation in the activity of the cytochrome bc1 complex, and affirmed that the two 
monomers are working in an independent manner. The weak point in this study is 
that by fusing together the C-terminus of a cytochrome b with the N-terminus of the 
cytochrome  b  in  the  second  monomer,  the  proposed  communication  pathway  is 
broken  by  fixating  the  termini.  Therefore,  it  is  to  expect  the  absence  of  any 
regulation. Several groups now address this topic topic at the moment, all of them 
agreeing  on  the  intermonomer  electron  transfer.  The  communication  between Discussion 
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monomers and the controlled activation of the second quinol oxidation site is more 
highly debated. 
4.2  Internal electron transfer and ISP movements 
A central step in the Q cycle is the bifurcation of electrons at the Qo site. From the 
oxidation of quinol, two electrons are released and split between the high and the 
low potential chain. The electron accepted from the Rieske cluster is transferred to 
cytochrome c1, after the ISP head domain moves towards the c1 heme. To oxidize 
quinol, the ISP is fixed in the b position since a part of it is required to complete the 
Qo site: one of the His coordinating the Rieske cluster has a hydrogen bond with 
quinol, forming a quinol-imidazolate complex (56, 68, 82, 85, 122, 125, 197-200). 
The same His is involved in coordination of stigmatellin via a hydrogen bond (71), 
blocking  the  movements  of  the  head  domain  towards  the  cytochrome  c1.  Two 
different binding pockets have been identified in the Qo site (73): a proximal and a 
distal  part,  where  inhibitors  like  MOA-stilbene  and  stigmatellin,  respectively,  bind 
(48). This lead to the idea that possibly two quinol molecules are accommodated at 
the Qo site, one of them being completely oxidized and the second one working as a 
“cofactor”. This hypothesis is known as “double occupancy model” (83, 124, 201) 
and  is  just  one  of  the  many  suggestions  concerning  the  mechanism  of  quinol 
oxidation. 
From  crystal  structures  it  was  clear  that  whenever  the  ISP  was  not  blocked  in 
proximity of cytochrome b it was difficult to assign electron density to it, and only a 
part of the transmembrane helix was visible (52). This was the first hint towards the 
idea that movements were implicated in the catalytic cycle of the cytochrome bc1 
complex. On the other hand, it was difficult to state what the position of the head 
domain  was  in  absence  of  inhibitors  or  in  the  case  of  no  substrate  bound  and 
therefore no electron transfer takin place. Moreover, it is still unclear which signal 
allows the release of the head domain from cytochrome b after quinol oxidation. Di 
Xia  et  al.  (127)  proposed  a  mechanism  based  on  observations made  on  crystal 
structures of inhibitor complexed bc1 complexes, according to which the ISP head 
domain has, prior to substrate binding at the Qo site, no fixed conformation. When 
quinol  enters  the  Qo  site  binds  first  in  the  distal  pocket,  and  the  cd1  helix  of 
cytochrome  b  opens  up  allowing  the  ISP  to  fit  perfectly  onto  cytochrome  b  and 
forming the complete Qo site. Quinol now forms two hydrogen bonds, one with the Discussion 
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His
161 coordinating the Rieske cluster and one with the Glu
272 (bovine numbering) of 
the conserved PEWY sequence of the ef helix in cytochrome b (Fig. 71). Quinol is 
then oxidized and electrons are split between the ISP and the bL heme. With the 
movement of the substrate to the proximal pocket, and/or with the electron transfer 
from bL to bH, the cd1 helix goes back to the initial position and the ISP is released 
from  cytochrome  b,  free  to  move  in  direction  of  cytochrome  c1  and  transfer  its 
electron.  
 
 
Fig. 71: Mechanism of electron bifurcation at the Qo site. The mobile ISP head domain, 
normally oxidized (yellow) has no fixed position in the complex. As quinol enters the 
Qo site distal part, the cd1 helix moves (pink) and gives space so that the substrate is 
accommodated  between  the  PEWY  sequence  (ef  helix)  and  the  cd1  helix  itself  in 
cytochrome b. Now the ISP head domain can interact with the bound quinol and is 
blocked in the b position. The reduced ISP (violet) gets reduced but stays in the b 
position as long as semiquinone moves to the proximal part of the Qo site or as soon 
as the electron from the bL heme is transferred to the bH heme. After one of the two 
events, the ISP is released and free to move towards cytochrome c1, which is then 
reduced (graphic from (127)). Discussion 
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In this work, flash photolysis experiments were used to investigate the movements 
of the ISP were studied, in presence and absence of ligands at the Qo site. If the 
complex was reduced only with ascorbate and TMPD, meaning only endogenous 
quinone  available  in  the  dimer,  two  phases  could  be  identified  in  reduction  of 
cytochrome  c1:  a  fast  and  a  slow  phase,  with  rates  of  9,000  s
-1  and  1,000  s
-1, 
respectively. The amplitude of the two phases is relatively small: the fast phase is 
only 9 % of the total photooxidized cytochrome c1, and the fast phase only 17 %. 
The results until now indicate that a small fraction (9 %) of the reduced ISP without 
added  Qo  site  ligands  is  in  proximity  of the  cytochrome  c1,  able  of fast  electron 
transfer, and another fraction (17 %) is in a position closer to cytochrome b, so that 
the electron transfer rate is lower. Another significant fraction of the ISP is not at all 
able to react and transfer electrons, since the amount of cytochrome c1 reduced 
after flash is relatively small. In these experiments the Qo site has no added ligands, 
and  only  endogenous  quinol/quinone  is  present.  The  amount  of  endogenous 
quinone  present  in  the  preparations  has  been  measured  at  the  University  of 
Strassbourg in the group of Prof. Petra Hellwig, and all three preparations used 
have two quinol/quinone molecules bound per complex monomer, most likely one at 
the Qo and one at the Qi site (data not shown). 
Adding Pm inhibitors, such as MOA-stilbene or myxothiazol, significantly increases 
the amplitudes of the two phases. Hereby the total amount of reduced FeS cluster is 
able to transfer electrons to the cytochrome c1 is now higher as a result of ligand 
added at the Qo site. The rate of the fast phase  remains changed, but the slow 
phase is two times faster than what previously measured. This clearly indicates that 
only  one  of  the  two  conformations  of  the  ISP  is  affected  by  the  binding  of  Pm 
inhibitors at the Qo site. This suggest that the slow phase represents the ISP close 
to the cytochrome b: binding of Pm inhibitors at the Qo site causes a displacement of 
the ISP head domain from cytochrome b and allows faster electron transfer. The 
rate of the fast phase is not changed, since the amount of ISP closer to cytochrome 
c1 is unaffected by the inhibitor binding. 
Pf inhibitors (stigmatellin, JG-144) change the picture again: stigmatellin is the only 
inhibitor  able  to  coordinate  the  His
161  (bovine  numbering)  with  a  hydrogen  bond 
which keeps the ISP head domain fixed in the b position. Hereby it does not allow 
any  movement  towards  cytchrome  c1,  as  shown  by  the  results  in  section  3.4.2, 
where the signal is totally quenched in presence of stigmatellin. In presence of JG-Discussion 
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144, the rate of both phases is drastically diminished, meaning that the inhibitor 
lowers  the  rate  at  which  the  ISP  head  domain  can  transfer  electrons  to  the 
cytochrome  c1.  This  is  consistent  with  the  information  obtained  from  crystal 
structures (70) where JG-144 makes no hydrogen bonds with the ISP head domain, 
so that its movement is not blocked but significantly slower. This indicates as well 
that the hydrogen bond between stigmatellin and the His161 coordinating the cluster 
is  necessary  to  keep  the  ISP  head  domain  fixed  in  the  b  conformation.  JG-144 
cannot fix the ISP close to cytochrome b but affects the release of the ISP head 
domain from the b position, indicating that an intrinsic regulation mechanism has to 
be present.  
Binding of quinol at the Qo site does not change the electron transfer rates of the 
two phases but increases the amplitudes, meaning that its presence allows a larger 
ISP fraction to move towards the cytochrome c1. The fast phase is almost 20 % of 
the  total  flash-oxidized  cytochrome  c1,  and  the  slow  phase  is  about  45  %.  The 
analysis of the data taken together confirm the mechanism proposed by Di Xia et al 
(70, 127), where the cd1 and the ef helices sens the binding of quinol at the Qo site, 
and open up allowing the binding of the ISP onto cytochrome b. Binding of quinol at 
the Qo site would allow the formation of a hydrogen bond with the His
161 of the ISP 
and  a  proton  coupled  electron  transfer  would  reduce  the  Rieske  cluster.  The 
subsequent electron transfer of the second electron to the  heme bL and then bH 
causes quinol to leave the distal pocket and the sensory helices cd1 and ef to close. 
This releases the ISP head domain and after movement to the c position allows 
electron transfer to cytochrome c1. The effects of the two inhibitor classes (Pf and 
Pm)  and  the  effects  upon  quinol  binding  are  consistent  with  the  proposed 
mechanism and could be verified by fast kinetics in this study. The results discussed 
here indicate that the binding of ligands at the Qo site and the ISP head domain 
motions are tightly linked and most likely playing a role also in ensuring the electron 
bifurcation avoiding short circuits which lead to the generation of ROS with serious 
consequences  for the  organism.  Some  authors  (128)  proposed that the  electron 
transfer from the bL to the bH represents the key factor in the electron bifurcation at 
the Qo site, and the experiments presented in this work cannot exclude the presence 
of other factors (such as coulombic gating of the motion of the semiquinone (202, 
203), the conformations of water or amino acid side chains in the Qo pocket (66, 136, Discussion 
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137, 198, 202) or the redox state of cytochrome b (61-63, 86, 129, 130, 133, 138, 
141, 142, 145, 204-207) being also involved in the regulation of this mechanism.  
4.3  Kinetics of reduction with ascorbate and interaction  
between the ISP and the cytochrome c1 
The ISP to cytochrome c1 interaction was analysed also on a different time scale 
than with the flash photolysis approach described before using stopped flow kinetics. 
The  oxidized  cytochrome  bc1  complex  was  mixed  against  increasing  ascorbate 
concentrations used in high excess compared to the protein amount, in order to 
achieve pseudo-first-order conditions (PFO). In this way, a second order reaction 
can be studied as if it was of first order. By plotting the kOBS against the substrate 
concentration  the  second  order  rate  constant  is  obtained.  The  results  from  this 
analysis revealed the presence of two phases for the reduction of cytochrome c1 by 
ascorbate: a fast phase, which is linearly dependent on the ascorbate concentration, 
with a second order rate constant of about 55 M
-1s
-1, and a slow phase. The slow 
phase is hyperbolically dependent on ascorbate concentration. This suggests that 
the slow phase defines a kinetic process, assuming a zero order trend by increasing 
ascorbate concentration. The presence of the two phases was suprising, since the 
expected result was a monoexponential kinetic, defined by only one kinetic constant 
and related to the direct electron transfer from ascorbate to the cytochrome c1. The 
latter has a redox potential close to the one of the Rieske cluster (85), so ascorbate 
can actually not only reduce both redox centers. This suggests that the presence of 
the  two  phases  is  due  to  the  combination  of  several  processes,  such  as  direct 
electron transfer to the cytochrome c1 from ascorbate and from the reduced ISP to 
the  c1  heme.  Therefore,  also  the  movement  of  the  ISP  head  domain  towards 
cytochrome c1 (see 3.4.2) plays an important role in the electron transfer kinetics 
with  ascorbate.  To  test  this  hypothesis,  the  same  experiment  was  performed  in 
presence of stigmatellin. The oxidized protein was incubated with a 10 fold excess 
of stigmatellin over night and the following day kinetics with increasing amounts of 
ascorbate recorded at the stopped flow. The traces were still biphasic, and the rate 
constants were determined with a different dependence on ascorbate concentration: 
The second kFAST was now hyperbolically dependent on ascorbate concentration, 
with values of 0.1 M
-1s
-1. The kSLOW is now linear. Also the effects of other inhibitors, 
such as MOA-stilbene and myxothiazol were tested: both molecules indicate that the Discussion 
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kFAST  is  faster  than  without  inhibitors  and  linearly  dependent  on  substrate 
concentration, and the kSLOW show in a more definite manner the hyperbolic trend. 
The  slow  phase  is  in the  beginning  predominant,  with  the fast  phase increasing 
throughout the experiment to reach about 80 % of the observed kinetic. In presence 
of stigmatellin, though, the amplitudes remain constant. 
This result was somehow surprising, since binding of stigmatellin at the Qo site fixes 
the ISP in the b position. Preventing the cluster to take part in electron transfer to 
the cytochrome c1 heme was expected to modify the behaviour of the kinetics, in 
particular a shift from a biphasic to a monophasic mechanism. In order to analyse 
the role of the ISP in the electron pathway in detail, a mutant has been cloned and 
expressed, where the Ser
157 (P. denitrificans numbering) was mutated to a Cys. The 
Ser
157 is close to the two Cys residues coordinating the cluster, and it has already 
been shown in the yeast complex (86) that the mutation leads to the expression of 
the ISP protein without the cluster. The reason for the loss of the Rieske cluste is 
probably the formation of an internal disulphide bridge with one of the Cys involved 
in cluster coordination. Using the purified mutant, with only the apoprotein present in 
the  complex  for  the  experiments,  monophasic  kinetics  were  observed.  The 
bimolecular rate constant was calculated to be about 2 M
-1s
-1, in line with the results 
of Julia Janzon (116). This represents the rate for the electron transfer between the 
cytochrome c1 and ascorbate and indicates also that the slow phase observed with 
the wild type complex is, most likely, a process influenced by more factors than first 
thought.  
To  analyze  the  aforementioned  electron  transfer  processes,  a  model  has  been 
developed at the university of Rome “La Sapienza” with Prof. Francesco Malatesta, 
which takes into account also the relative position of the ISP to cytochrome c1. The 
model is called “cube model” and is shown in Fig. 72.  Discussion 
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Fig. 72: Cube model for the reduction of cytochrome bc1 by ascorbate under pseudo-
first order conditions. Each species is labeled as follows: b00 and c00 = fully oxidized 
protein with the FeS protein in the “b” or “c1” position, respectively; b11 and c11 = 
corresponding to 2-electron reduced species (the electron being represented by a dot 
•); b10 and c10 are a 1-electron reduced species with the electron on the FeS protein; 
b01 and c01 are 1-electron reduced species with the electron on cytochrome  c1. The 
species are connected by second-order processes (single headed arrows) with rate 
constants  kf„s  and  kc„s  multiplied  by  the  ascorbate  concentration  (A).  Horizontal 
double arrows represent the conformational transitions of the Rieske protein between 
“b” or “c1” states (light and dark gray ovals), and the diagonal double arrow direct ET 
bewteen FeS and c1. Cytochrome b is colored in light blue, cytochrome c1 in red and 
the Rieske protein in yellow with the 2 iron atoms of the FeS cluster shown as hard 
spheres  in  cyan.  The  structures  were  fitted  by  using  the  program  Chimera  of  the 
USCF (208) 
 
According to this model, ascorbate can reduce both cytochrome c1 and the Rieske 
cluster.  The  latter  can  assume  two  different  positions,  the  b  position  (light  grey 
ovals) and the c1 position (grey ovals). For simplicity, any intermediate configuration 
of the ISP head domain is not considered, and it is assumed that the reduction of 
the ISP and cytochrome c1 does not change dependending on the conformation of 
the first or the redox state  of the redox cofactors. The fast phase is most likely 
described by the reduction of the FeS by ascorbate, the movement into direction of 
cytochrome c1 and the reduction of it. The slow phase, on the other side, can be 
described  as  a  complex function  of the  rate  constants  in the  mechanism  and  is 
approximated by the pseudo-first order rate constant for reduction of cytochrome c1 Discussion 
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by ascorbate. It is important to point out that the experiments are performed without 
addition of external substrate, and therefore the kinetic here described is only an 
approximation of the cytochrome c1 reduction kinetics, which would resemble more 
the native situation in presence of substrate bound at the Qo site. The saturation 
observed for the slow phase is probably due to competition between the reduction of 
cytochrome  c1  by  ascorbate  or  the  ISP.In  the  presence  of  stigmatellin,  the  fast 
phase  becomes  hyperbolically  dependent  on  the  ascorbate  concentration,  which 
could be explained by assuming that the inhibitor dissociates from the Qo binding 
site and allows a portion of the ISP which is otherwise fixed in the b state to reach 
cytochrome c1 and reduce it. In presence of the two Pm inhibitors, MOA-stilbene 
and myxothiazol, the kFAST increases as a consequence of the displacement of the 
Rieske protein from the fixed position. 
The analysis of the cube model has been performed by Prof. Francesco Malatesta. 
All  the  reactions  involved  in  the  mechanism  are  first  order  or  pseudofirstoder 
reactions, which are dependent on the rate constant and the initial conditions of the 
reaction. The differential equations describing the time dependence of each species 
can be written as follows:  
     
              Equation 9 
 
K  represents  a  matrix  describing  the  kinetic  constants  for  each  reaction  in  the 
mechanism.  From  an  Eigenvalues-Eigenvectors  analysis  of  the  matrix  K,  the 
following equation can be obtained: 
 
                Equation 10 
 
In this equation, ci represents a vector related to intial conditions, bi are column 
vectors of the eigenvector matrix and, i are the Eigenvalues of K, i.e. the observed 
rate  constants, which are determined experimentally and estimated by fitting the 
data to mono-  or bi-exponential equations. The  i  = ci  bi  products represent the 
observed amplitudes, also determined experimentally.  
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The mechanism has been simulated using the program MatLab and in Fig. 73 the 
time courses obtained from this simulation are shown. 
 
 
 
 
Fig. 73: Kinetic simulation of the amplitudes (upper panel) and for the rate constants 
(lower panel) for the fast and the slow phase obtained by using the cube model. In 
both cases a good simulation can be obtained for the experiments where no inhibitor 
have been added. Futher simulations are currently going on. 
 Discussion 
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As visible form the Fig. 73, the cube model simulates quite well the experimental 
data  obtained  with  the  stopped-flow  experiments  for  both  amplitudes  and  rate 
constants.  At  the  moment,  further  analysis  is  in  progress  for  a  more  complete 
description of the model, in order to obtain a mathematical expression which can be 
used to completely fit the data and verify the simulations.  
4.4  Deletion mutant of the cytochrome bc1 complex from  
P. denitrificans and interaction with the substrate 
The cytochrome bc1 complex from P. denitrificans is unique, since its cytochrome c1 
protein has a 150 aminoacid long domain, which is rich in acidic residues (mostly 
Glu) and Pro, suggesting that the domain is not completely folded in a secondary 
structure, and, most likely, flexible. As already discussed in 1.2.3, in the eukaryotic 
complex a subunit is present, which is very rich in negatively charged residues as 
well. It is involved in long range interactions with the substrate. In P. denitrificans, 
without additional subunit is present, the acidic domain of the cytochrome c1 leads to 
the question whether it may have a similar function.  
In  this  work  experiments  have  been  performed  with  the  deletion  mutant  of  the 
complex,  lacking  the  acidic  domain.  The  complex  has  been  purified  by  affinity 
chromatography,  since  the  acidic  domain  was  the  feature  which  allowed  the 
purification of the wild type complex on an ion exchange chromatography (DEAE). 
The tag of choice was a 10x  His tag,  introduced by SOEing PCR. Activity tests 
indicated that the affinity tag at the C-terminus of cytochrome b was not significantly 
affecting the turnover number of the complex or showing changes in redox spectra. 
The  purification  protocol  using  imidazole  to  elute  the  complex  has  been  first 
established by Thomas Kleinschroth, who worked with the His tagged version of the 
wild type complex. The deletion mutant can only be purified efficiently by using an 
affinity chromatography. The first elution trial with the complex was performed with 
imidazole.  The  complex  appeared  fully  normal  in  SDS  PAGE,  but  the  turnover 
number was very low (only 20 % residual activity) and the reducibility of the protein 
by  ascorbate  was  strongly  impaired.  Dithionite  fully  reduced  the  complex,  but 
ascorbate could only reduce a small amount of cytochrome b and only when present 
in  strong  excess.  This  is  an  unexpected  result,  since  ascorbate  can  selectively 
reduce cytochrome c1 and the Rieske cluster, because of its redox potential. In the 
literature, the same effect is described for the Rhodobacter sphaeroides cytochrome Discussion 
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bc1  complex  (209),  but the  problem  was  solved  by  using  histidine  in  the  elution 
buffer  instead  of  imidazole.  The  same  strategy  has  been  applied  to  the  P. 
denitrificans complex, restoring the turnover number to values comparable to the 
wild type complex and the reducibility of cytochrome c1 in presence of ascorbate. 
Imidazole is thought to change the network of hydrogen bonds in the heme cleft and 
therefore displacing the Met liganding the c1 heme. This effect was observed only in 
the  oxidized  complex  in  Rhodobacter  sphaeroides,  since  the  reduced  complex 
incubated with imidazole does not show any change in comparison with the wild 
type (178, 179).  
The deletion mutant complex has been analyzed by LILBID (152, 177), revealing a 
dimeric structure. Even if the dimeric structure is expected for the cytochrome bc1 
complex, the wild type complex, analyzed with the same technique, appeared as a 
dimer of dimers (152). The deletion of the acidic domain seems to cause a change 
in the oligomerization state of the complex, determining the separation of the two 
dimers, otherwise purified together. How the acidic domain in the cytochrome  c1 
affects the formation of dimers of dimers is not clear: one speculation is that the 
domain, probably not having a defined secondary structure, causes the aggregation 
of two dimers. If this is the case, this must happen on a site far away enough from 
the heme cleft so that the activity is not affected by the association of the two dimers. 
Interestingly, two dimers are present in the supercomplex purified from the digitonin 
solubilised  membraned  of  P.  denitrificans  (151),  so  this  unusual  “tetrameric 
structure” could also be the natural association of two dimers in the supercomplex 
arrangement.  Neither  the  wild  type  complex,  nor  the  supercomplex  have  been 
crystallized so far, so no structural data are vailable. On the other hand, the crystal 
structure of the deletion mutant was obtained from it in collaboration with the group 
of Prof. Carola Hunte at the University of Freiburg (Kleinschroth et al. manuscript 
submitted)  shows  that  the  deletion  has  no  effects  on  cytochrome  c1  folding.  In 
section 3.4.2 it was shown that in the mutant complex cytochrome b can be reduced 
in presence of ascorbate, which was unexpected. The redox potentials have been 
checked to exclude any change which could justify the reduction of the low potential 
chain in presence of ascorbate, but no difference has been observed with the wild 
type. Probably, the dimer of dimers is not just the aggregation of two dimers in an 
unorganized  manner,  but  a  defined  process  which  stabilizes  the  protein.  The Discussion 
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globular domain of the cytochrome c1 seems to be more open and more accessible 
to small molecules (such as ascorbate). 
 
Fig. 74: Superimposition of the cytochrome c1 structure of the acidic domain deletion 
complex and the yeast structure (pdb:1kyo). Red: cytochrome c from yeast. Yellow: 
Qcr6p. Blue: QcrC. Green: cytochrome c1
Δac. The structure of the deletion varian of the 
cytochrome c1 from P. denitrificans clearly shows that the deletion does not cause 
any change in protein folding. 
 
To test wheter the acidic domain is involved in any interaction with the substrate, 
similar to the role played by the small acidic subunit in the eukaryotic complex (96-
98,  102,  104,  106-108,  112,  210,  211),  flash  photolysis  experiments  have  been 
performed using two different cytochromes c coupled to Ru as electron acceptors 
(119, 181). The protein of choice are the isoform 1 of the yeast cytochrome c, known 
to have a strong association with the yeast cytochrome bc1 complex (93, 113, 114, 
119), and the correspondent cytochrome  c in the aerobic respiratory chain of  P. Discussion 
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denitrificans, the cytochrome c552. The latter being a membrane bound protein (149), 
a soluble fragment of it has been used and coupled to Ru, in order to avoid the 
additional purification of a membrane protein. A new crystal structure obtained from 
a different soluble fragment of cytochrome c552 (150) confirmed the previous, know 
structure of the heme binding domain, therefore indicating that the production of a 
soluble fragment does not change the heme binding or positioning and that soluble 
fragments represent a feasible to work with. The measurements presented in this 
workhave  already  been  performed  previously  using  soluble  fragments  of  the 
cytochrome c1 and the same electron acceptors (116, 118), but studying the whole 
complex allows brings the situation closer to the scenario in membranes. Soluble 
fragments  are  free  to  diffuse  in  the  buffer  but  whole  membrane  complex  are 
embedded in a detergent micelles and much bigger than the soluble counterparts. 
This limits to free diffusion, and allows also the observation of eventual effects that 
the  other  redox  cofactor  in  the  protein  have  on  the  analyzed  electron  transfer. 
Moreover, the experiments discussed in this section represent a possibility to verify 
the results previously obtained with the soluble fragments.  
From the results presented in section 3.3.5, it can be concluded that the deletion of 
the  acidic  domain  does  not  affect  the  interaction  with  the  substrate:  The  acidic 
domain  interacts  neither  directly  with  the  substrate,  nor  steers  long  range 
interactions  with  it  (as  observed  for  the  small  acidic  subunit  in  the  eukaryotic 
complex), otherwise altered ionic strength dependence should be observed in the 
Brønsted plot in the case of the deletion mutant. This is not the case, even if the 
electron  acceptor  is  the  yeast  isoform  1  cytochrome  c,  meaning  that  the  acidic 
domain on the cytochrome c1 plays no role at all in the interaction with cytochrome c. 
Kinetic  observation  with  the  complexes  from  other  organisms  indicate  that  the 
interaction between the cytochrome bc1 complex and the cytochrome c appears to 
share similar properties, where ionic long range interaction orientate the reaction 
partners and hydrophobic interactions define the binding of them (111, 114). Most 
likely, the acidic domain is involved in the interaction with one of the other c-type 
cytochromes taking part in the other metabolic pathways of P. denitrificans; as this 
bacterium possesses a quite versatile and flexible metabolism, allowing growth on 
different  substrates  and  a  fast  adaptation  to  variations  in  the  environment.  The 
acidic  domain  could  also  define  the  interaction  with  other  respiratory  complexes Discussion 
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under  specific  conditions,  representing  the  possibility  to  connect  otherwise 
separated metabolic pathways. 
 Summary 
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5  Summary 
The ubiquinol:cytochrome c oxidoreductase is a key component of several aerobic 
respiratory chains in different organisms. It is an integral membrane protein complex, 
made up of three catalytic subunits (cytochrome b, cytochrome c1 and Rieske iron 
sulphur protein) and up to eight additional subunits in mitochondria. The complex 
oxidizes one quinol molecules and reduces two cytochrome c during the Q cycle, 
originally described by Peter Mitchell. Electrons are split between the low and the 
high potential chain and protons are released on the positive side of the membrane, 
increasing  the  protonmotive  force  needed  by  the  ATP-synthase  for  energy 
transduction. The cytochrome bc1 complex from P. denitrificans is a perfect model 
for  structural  and  functional  studies.  Bacteria  are  easy  to  grow  and  the  genetic 
material is readily accessible for genetic manipulation. Moreover, the P. denitrificans 
aerobic  respiratory  chain  is  very  close  to  the  mitochondrial  one:  the  complexes 
involved in electron transfer resemble the ones found in mitochondria, but lack most 
of the additional subunits. As a unique feature, P. denitrificans has a strongly acidic 
domain  at  the  N-terminal  region  of  the  cytochrome  c1,  a  sequence  of  150 
aminoacids  which  does  not  correlate  with  any  known  protein.  An  analogous 
composition can be found in the eukaryotic cytochrome bc1 complex as a part of an 
accessory subunit, proposed to be involved in facilitating electron transfer between 
the complex and the electron acceptor cytochrome c. In order to study the function 
of this domain in the P. denitrificans cytochrome bc1 complex, a deletion mutant has 
been previously cloned and modified with an affinity tag as a C-terminal extension of 
cytochrome b.  
The complex  is  purified  by affinity chromatography  and characterized by steady-
state kinetics  using not only horse heart cytochrome  c  but also the  endogenous 
electron  acceptor,  the  membrane  bound  cytochrome  c552,  employed  here  as  a 
soluble fragment. Steady–state kinetics indicate that the deletion of the long acidic 
domain had effects neither on the turnover rate nor on the apparent affinity for the 
substrate.  To  understand  wether  the  deletion  affects  the  reaction  between  the 
cytochrome bc1 complex and the substrate, laser flash photolysis experiments are 
performed, showing that the interaction observed was not changed in the complex 
missing  the  acidic  domain.  The  results  presented  in  this  work  confirm  the  ones Summary 
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previously obtained by Julia Janzon using soluble fragments of the same interaction 
partners. 
The deletion, however, affected the oligomerization state of the complex, as shown 
by  LILBID  (Laser  Induced  Liquid  Bead  Ion  Desorption)  analysis.  The  wild  type 
complex has a tetrameric structure, better described as a “dimer of dimers”. The 
deletion of the acidic domain on the cytochrome c1 results in the separation of the 
two  dimers,  yielding  the  canonical  dimer.  Therefore,  the  complex  deleted  in  the 
acidic  domain  is  used  for  cloning  and  expression  of  a  heterodimeric  complex, 
containing an inactivating mutation in the quinol oxidation site in only one monomer, 
thus allowing a selective switch-off for half the complex. Such a complex is needed 
for the verification of an internal regulation mechanism, the half-of-the-sites reactivity. 
According to it, the dimeric structure of the cytochrome bc1 complex has functional 
implications, since the two monomers can communicate and work in a coordinated 
manner. This approach confirms that substrate oxidation does effectively take place 
only in one of the two monomers constituting the dimer, and that the binding of 
substrate at the Qo and Qi site regulates the switch between active and inactive 
monomer. Moreover, this mechanism works also as an effective protection against 
the  reaction  of  quinone  intermediates  with  oxygen  and  the  formation  of  reactive 
oxygen species (ROS), responsable for cellular aging.  
The motion of the ISP head domain is also addressed in this work; in particular the 
mechanism  which  regulates  the  movements  towards  the  cytochrome  c1  and  the 
electron bifurcation at the quinol oxidation site. Laser flash kinetics in presence of 
several inhibitors and the substrate allow studying the response of the ISP to the 
binding of different species at the quinol oxidation site. The binding of ligand at the 
Qo site in the complex triggers the conformational switch in the ISP head domain, 
supporting the mechanism proposed in the literature according to which the Qo site 
is able to “sense” the presence of substrate and transfer the information to the ISP, 
regulating its mobility. 
The internal electron pathway between the ISP and the cytochrome c1 has been 
analyzed also by stopped-flow kinetics, in presence and absence of inhibitors. The 
results indicate that two kinetic phases describe the reduction of cytochrome c1 by 
the ISP, and a model for the simulation of the data is proposed. 
 Summary 
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6  Zusammenfassung 
Der Cytochrom bc1 Komplex ist der zentrale Membranproteinkomplex der aeroben 
Atmungsketten  vieler  Organismen.  Er  besteht  aus  den  drei  redox-aktiven 
Untereinheiten Cytochrom b, Cytochrom c1 und dem Rieske Eisen-Schwefel-Protein 
(ISP),  sowie  speziesabhängig  aus  bis  zu  acht  weiteren  akzessorischen 
Untereinheiten. Der Komplex oxidiert in einem kompletten katalytischen Zyklus zwei 
Chinol-Moleküle und reduziert hierbei zwei Cytochrom c und ein Chinon zu Chinol. 
Dieser als Q-Zyklus bekannte Mechanismus wurde ursprünglich von Peter Mitchell 
bereits in den 1960er Jahren vorgeschlagen. Dabei werden die Elektronen zwischen 
der  high  potential  und  der  low  potential  Kette  von  Redoxkofaktoren  aufgeteilt. 
Während dieses Prozesses werden Protonen auf der positiven Seite der Membran 
abgegeben, die zum Aufbau des chemiosmotischen Gradienten beitragen, der von 
der  ATP-Synthase  in  zellulär  verfügbare,  chemisch  gebundene  Energie 
umgewandelt wird.  
Der  in  dieser  Arbeit  untersuchte  Cytochrom  bc1  Komplex  des  Bodenbakteriums 
Paracoccus denitrificans stellt aus mehreren Gründen ein geeignetes Studienobjekt 
dar:  einerseits  ist  die  aerobe  Atmungskette  dieses  Bakteriums  der  der 
eukaryontischen Mitochondrien sehr ähnlich, jedoch vielfach als Minimal-Komplex 
aufgebaut  aus  den  essentiellen  Untereinheiten.  In  der  Literatur  wird  davon 
ausgegangen,  dass  die  heutigen  Mitochondrien  und  P.  denitrificans  einen 
gemeinsamen Vorfahren hatten, der gemäß der Endosymbionten-Theorie von einer 
phagozytotisch lebenden Zelle aufgenommen und sich im Laufe der Evolution in die 
Organelle umgewandelt hat. Das Bakterium ist überdies im Labor gut zu kultivieren, 
die  genetische  Information  durch  etablierte  Verfahren  zugänglich,  und 
gentechnische Veränderungen lassen sich im Vergleich zu Eukaryonten einfacher 
einfügen.  
Der  Cytochrom  bc1  Komplex von  P. denitrificans  weist im Cytochrome  c1 jedoch 
einen  einzigartigen  Unterschied  zu  anderen  Komplexen  auf.  Er  enthält  am  N-
Terminus einen Einschub von 150 Aminosäuren, die zu 40 % saure Seitengruppen 
tragen.  Für  diese  Domäne  können  aufgrund  ihres  ungewöhnlichen  Aminosäure-
Gehalts  keine  Sekundärstrukturen  vorhergesagt  werden.  Eine  ähnliche 
Zusammensetzung,  mit  hohem  Anteil  an  sauren  resten,  findet  sich  in  einer  der 
akzessorischen  Untereinheiten  der  eukaryontischen  Komplexe,  für  die 
vorgeschlagen wurde, dass sie im Elektronentransfer die wichtige Ausrichtung des Summary 
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Cytochroms c fördert. In dieser Arbeit wird deshalb eine Variante des P. denitrificans 
Komplexes ohne die saure Domäne (“ac“), jedoch mit einem C-terminalen His-tag 
am Cytochrom b, untersucht. 
Die  ac  Variante  des  Komplexes  wurde  aufgereinigt  und  die  Enzymaktivität  mit 
ihren Michaelis-Menten-Parametern bestimmt. Die Deletion dieser großen Domäne 
hat keinen Einfluss auf die Enzymaktivität, unabhangig davon, ob mit dem nativen 
oder  dem  in  den  Standardäktivitätstest  häufig  verwendeten  Cytochrom  c  aus 
Pferdeherz  gemessen  wurde.  Zur  Untersuchung  der  Elektronentransferprozesse 
und der für die Substratbindung beteiligten Ladungen wurden schnelle Kinetiken mit 
Hilfe  der  Methode  der  Laserblitz-Photolyse  aufgenommen.  In  diesen 
Untersuchungen  wurden  vergleichbare  Ergebnisse  erzielt,  so  konnte  zwischen 
Wildtyp  und  Variante  kein  Unterschied  in  den  Brønstedt-Graphiken  festgestellt 
werden,  die  die  Zahl  der  an  Interaktion  beteiligten  Ladungen  definieren.  Ein 
ähnlicher Trend wurde vorher bereits von Julia Janzon in einer vorangegangenen 
Arbeit  mit  löslichen  Fragmenten  des  Cytochrom  c1  und  Cytochrom  c  gezeigt.  In 
einer  weiteren  Studie  mit  Hilfe  der  LILBID  (Laser  Induced  Liquid  Bead  Ion 
Desorption)-Massenspektroskopie  stellte  sich  heraus,  dass  der  Unterschied 
zwischen  Wildtyp  und  Variante  in  einem  unterschiedlichen 
Oligomerisierungszustand  liegt.  Der  Wildtyp  liegt  als  Tetramer  (Dimer  aus  zwei 
funktionellen Dimeren) vor, die ac Varianten als funktionelles, für Cytochrome bc1 
Komplexe typischerweise beschriebenes Dimer.  
Dieser Befund machte es möglich, in einem weiteren Projekt einen heterodimeren 
Komplex  zu  konstruieren,  der  durch  eine  Tandemaufreingung  mittels  zweier 
verschiedener Affinitäts-tags isoliert werden konnte. Dies war vorher aufgrund des 
tetrameren  Assoziationszustandes  nicht  gelungen.  Für  dieses  Projekt  wurde  ein 
heterodimerer Komplex benötigt, der in einem Monomer dem Wildtyp entspricht und 
mit  dem  Strep-tag  versehen  ist  und  im  anderen  Monomer  eine  inaktivierende 
Mutation  im  Cytochrom  b  einführt  und  diese  mit  dem  His-tag  markiert.  Die  zur 
Kennzeichnung eingefügten tags wurden C-terminal am Cytochrom b angebracht. 
Hierfür wurden zwei entsprechende fbc-Operons konstruiert und in einen Cytochrom 
bc1 Komplex Deletionsstamm eingebracht. Dies geschah mit Hilfe zweier Vektoren, 
die  sich  sowohl  im  oriV  als  auch  in  den  vermittelten  Antibiotikaresistenzen 
unterschieden. So konnte ein Stamm erzeugt werden, in dem beide Plasmide stabil 
replizieren  und  exprimieren.  Der  aus  diesem  Stamm  nach  Solubilisierung  und Summary 
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Tandemaufreinigung  erhaltene  Komplex  wurde  mittels  Redox-Vis-Spektren 
untersucht  und  zeigte  alle  typischen  Signale  der  Redoxkofaktoren.  In  der  SDS-
Elektrophorese  konnten  die  drei  Untereinheiten  des  Komplexes  nachgewiesen 
werden.  Dieser  heterodimere  Komplex  wurde  für  pre-steady-state  Kinetiken  und 
Aktivitätsuntersuchungen herangezogen und lieferte eindeutige Ergebnisse, welche 
die  seit  langem  kontrovers  diskutierte  half-of-the-sites-Hypothese  bestätigten;  sie 
schlägt eine interne Kommunikation und damit Regulation des Komplexes vor, in 
dem  ein  Monomer  das  andere  Monomer  abschalten  kann.  Sie  beschreibt,  dass 
unter normalen Umständen nur ein Monomer im Komplex aktiv ist und damit für die 
gesamte Aktivität verantwortlich ist, was für den hier vorgestellten heterodimeren 
Komplex klar bewiesen wird. Die Michaelis-Menten-Parameter für diese Reaktion 
zeigen, dass der heterodimere Komplex und der Wildtyp sich in der Substratbindung 
nicht unterscheiden. Für die pre-steady-state Kinetiken ergibt sich im Vergleich mit 
der ac Variante und einer Mutante, welche die Mutation in beiden Monomeren trägt, 
dass  der  heterodimere  Komplex  eine  biphasische  Kinetik  beschreibt  aus  den 
Phasen  der  jeweiligen  homodimeren  Komponenten.  Eine  vergleichende 
Inhibitortitration  mit  der  ac  Variante  und  dem  beschriebenen  heterodimeren 
Komplex zeigt ebenfalls, dass die für den Wildtyp charakteristische Aktivierung des 
zweiten Monomers im Falle des heterodimeren Komplexes nicht mehr möglich ist. 
Zusammen  mit  der  Möglichkeit,  Elektronen  zwischen  den  Monomeren  auf  der 
Ebene  der  bL-Häme  auszutauschen,  dient  dies  dazu,  möglichst  viele 
Elektronenakzeptoren  in  der  Niedrigpotentialkette  zur  Verfügung  zu  stellen,  um 
damit  die  Bildung  von  Sauerstoff-Radikalen (ROS)  zu  vermindern.  Diese  spielen 
gerade  im  Hinblick  auf  Alterung  und  Zellschäden,  zum  Beispiel  in 
Hochenergiedurchsatz Geweben wie Nervenzellen, eine entscheidende Rolle.  
Die Elektronenübertragung zwischen dem Rieske-Protein und dem Cytochrom c1 ist 
an eine vorherige Bewegung des Rieske-Proteins gekoppelt; von seiner Position am 
Cytochrom b, wo es zunächst an der Oxidation des Chinols beteiligt ist und reduziert 
wird, bewegt es sich zum Cytochrom c1, und reduziert es. Die Elektronenbifurkation, 
der  Auslöser  für  die  Ablösung  vom  Cytochrom  b  und  für  die  Bewegung  mit 
nachfolgender  Reduktion  des  Cytochrom  c1  ist  in  dieser  Arbeit  mit  Laserblitz-
Photolyse und Stopped Flow-Experimenten untersucht, um ein breites Zeitfenster 
abzudecken.  Die  intrinsische  Regulation  der  Elektronenbifurkation  zwischen  der 
Hoch-  und  Niedrigpotentialkette  und  deren  Mechanismus  und  zeitlicher  Ablauf Summary 
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werden ebenfalls seit geraumer Zeit in der Literatur diskutiert. In den Stopped Flow-
Experimenten wurde der mit Substrat oder verschiedenen Inhibitoren vorinkubierte 
Komplex  mit  Ascorbatlösung  verschiedener  Konzentrationen  gemischt.  Ascorbat 
reduziert spezifisch nur die c-Häme und das Rieske-Protein. Erstaunlicherweise ist 
eine  biphasische  Kinetik  zu  beobachten,  die  eine  schnelle  und  eine  langsame 
Phase enthält. Aus den Experimenten lässt sich schließen, dass die schnelle Phase 
die Übertragung von Elektronen vom zuvor reduzierten Rieske-Protein beschreibt 
mit anschließender Reduktion des Cytochrome c1. Die langsame, direkt Ascorbat-
abhängige hyperbolische Phase ist die unmittelbare Reduktion des Cytochrome c1 
durch Ascorbat. Zur Klärung, welche der beiden Phasen die direkte Reduktion des 
Cytochrome c1 durch Ascorbat ist, wurde eine Mutante des Rieske-Proteins ohne 
Eisen-Schwefelcluster verwendet (S157C
ISP), die eine monophasisch Kinetik ergibt. 
Durch den Einsatz von Inhibitoren können die Anteile der schnellen und lagsameren 
Phase verschoben werden, so dass durch den Einsatz von Stigmatellin (Pf Inhibitor), 
welches  die  bewegliche  Domäne  des  Rieske-Proteins  am  Cytochrom  b  fixieren 
sollte,  die  schnelle  Phase  einen  geringeren  Anteil  hat  und  die  Abhängigkeit 
hyperbolisch wird. Die Pm Inhibitoren MOA-Stilben oder Myxothiazol erhöhen die 
Geschwindigkeit  und führen  zu  einem  höheren  Anteil  der  schnellen  Phase.  Dies 
bedeutet, dass das Stigmatellin zwar das Rieske-Protein am Cytochrom b stabilisiert, 
jedoch eine Bewegung über längeren Zeiten nicht verhindern kann, möglicherweise 
durch  die  Entlassung  des  inhibitors  aus  der  Bindungsstelle.  Die  proximalen 
Inhibitoren führen  zur  Freisetzung  der  beweglichen  Domäne  und  damit  liegt  das 
Rieske-Protein bereits vor der Reduktion durch Ascorbat näher am Cytochrom c1 
vor. Somit kann die schnelle Phase des Prozesses der Reduktion durch das Rieske-
Protein zugeordnet werden. Zur weitergehenden mathematischen Analyse wurde in 
Zusammenarbeit  mit  Prof.  F.  Malatesta  das  „cube“-Modell  entwickelt,  welches 
sowohl die Bewegung des Rieske-Proteins, als auch die Elektronentransferprozesse 
berücksichtigt.  
In  den  Laserblitz-Photolyse-Experimenten  wurde  der  Elektronenübertrag  vom 
Rieske-Protein auf das Ascorbat-vorreduzierte Cytochrom c1 auf einer schnelleren 
Zeitskala untersucht. Hier zeigte sich, dass bei vermutlich nicht voll besetzter Qo 
Bindungstasche ebenfalls zwei Phasen auftreten, die zu 9 und 17 % zur Reduktion 
des  Cytochroms  c1  beitragen.  Die  schnelle  Phase  entspricht  hierbei  dem 
Elektronentransfer zwischen der bereits näher am Cytochrom c1 liegende Rieske-Summary 
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Domäne, und die langsamere Phase der noch in der b-Position vorliegenden Rieske 
Kopfdomäne. Durch Zugabe von Pm Inhibitoren ist mehr reduziertes Rieske-Protein 
an  der  Reaktion  beteiligt,  die  schnelle  Phase  bleibt  unverändert,  die  langsame 
Phase  wird  jedoch  beschleunigt.  Auch  hier  führen  die  Pm  Inhibitoren  zu  einer 
höheren Aufenthaltwahrscheinlichkeit des löslichen Teils des Rieske-Proteins in der 
c1  Position.  Auf  der  kurzen  Zeitskala  dieser  Experimente  verhindert  Stigmatellin 
durch  Fixierung  die  Reduktion  des  Cytochrome  c1  vollständig.  Ein  weiterer  Pf 
Inhibitor,  JG-144,  der  keine  Wasserstoffbrücke  zum  Rieske-Protein  ausbildet, 
verlangsamt beide Phasen jedoch extrem. JG-144 ist demnach nicht in der Lage, 
das  Rieske-Protein  zu  fixieren,  jedoch  wird  seine  Entlassung  stark  verlangsamt. 
Hieraus kann wiederum auf eine Beeinflussung des intrinsischen, regulatorischen 
Mechanismus durch die Bindung eines Moleküls an das Qo-Zentrum geschlossen 
werden. Diese Daten untermauern den von Di Xia vorgeschlagenen Mechanismus 
der  Regulation  durch  Verschiebung  der  ef-Schleife  und  bilden  diesen  Prozess 
erstmals auf kinetischer Ebene ab. 
In  dieser  Arbeit  wurde  die  Rolle  untersucht,  welche  die  saure  Domäne  im 
Cytochrom bc1 Komplex von P. denitrificans spielt. Es konnte gezeigt werden, dass 
die Sequenz nicht am Elektronentransfer zwischen dem Cytochrom bc1 Komplex 
und  dem  Cytochrom  c  beteiligt  ist,  möglicherweise  aber  für  die  Interaktion  in 
anderen Stoffwechselwegen in P. denitrificans wichtig ist. Die Deletion führt zu einer 
Veränderung  des  Oligomerisierungzustandes  des  Komplexes  und  erlaubt  die 
Verwendung der ac Variante für die Validierung des half-of-the-sites Mechanismus. 
Durch  die  Bindung  von  Chinol  am  Qi  Zentrum  wird  die  Aktivierung  der  Chinol-
Oxidation auf einem oder auf beiden Monomeren des Cytochrom bc1 Komplexes 
ausgeübt.  Die  kinetische  Untersuchungen  zeigen  auch,  dass  die  Bindung  von 
Substrat  im  Qo  Zentrum  nicht  nur  die  Voraussetzung  für  die  Katalyse  ist;  sie 
kontrolliert  auch  einen  Mechanismus,  der  die  Bewegligkeit  des  Rieske  Proteins 
reguliert. 
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abs.        Absorbance 
Amp        Ampicillin 
APS        Ammoniumpersulfate 
ATP        Adenosine triphosphate 
Heme bH      high potential heme b 
Heme bL      low potential heme b 
bp        Base pairs 
BSA          Bovine serum albumine 
BCIP         5-Bromo-4-chloro-3-indolylphosphate  
CD        Circular dicroism sopectroscopy 
CIAP        Calf Intestinal Alkaline Phosphatase  
Cyt b        Cytochrome b 
Cyt c        Cytochrome c 
Cyt c1        Cytochrome c1 
CV        Column volume 
ac        Acidic domain deletion mutant complex 
dNTP        Desoxy-NTP 
DDM        -D-Dodecylmaltoside  
DMSO       Dimethylsulfoxide 
DNA        Desoxyribonucleic acid 
DSC        Double sector cuvette 
EDTA        Ethylen diamine tetra-acetic acid 
EPR         Electron paramangnetic resonance 
FAD        Flavin adenine dinucleotide 
Gm        Gentamycin 
His        Histidine 
[I]        Ionic strength 
ISC        Iron sulphur cluster 
ISP        Iron sulphur protein 
kbp, kb      Kilo base pairs 
kD        Kilodalton 
Km        Kanamycin 
KPi        Potassium phosphate Abbreviations 
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kCAT        Catalytic constant, turnover number 
KM        Michaelis constant 
kOBS        Observed rate constant 
kFAST        Fast phase rate constant  
kSLOW        Slow phase rate constant 
LB        Luria-Bertani 
LILBID       Laser-induced liquid bead ion desorption 
µs        Microseconds 
mA        Milliampere 
MES        2-(N-morpholino)-ethansulfonsäure 
MMP        Mtochondrial matrix processing peptidase 
MOAS       Methoxyacrylate-stilbene  
MOPS       3-(N-morpholino)propanesulfonic acid  
MS        Mass spektrometry 
mV        Millivolt 
NADH       Nicotin adenine dinucleotide  
NaPi        Sodium phosphate 
NBT        Nitro blue tetrazolium  
NCS        New Born Calf Serum 
NQNO       2-n-nonyl-4-hydroxyquinoline N oxide 
NMR        Nuclear magnetic resonance 
OD        Optical density 
p.a        Pro analysi 
PAGE       Polyacrylamide gel electrophoresis 
PCR        Polymerase chain reaction 
PDB        Protein Data Base 
PFO        Pseudo first order  
PNK        Polynucleotide kinase 
Qo        Quinol oxidation site 
Qi        Quinone reduction site 
Q- pool      Quinone pool 
Rif        Rifampicin 
Ruz    (2,2´bipirazine)2(bromomethyl-4´-methyl-2,2´- 
            bipyridine) 
Ru2D    [Ru(bpy)2]2(qpy)(PF6)4;  qpy,  2,2′:4′,4′′:2′′,2′′′- 
           quaterpyridine Abbreviations 
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UV        Ultra violet light 
rpm         Rounds per minute 
ROS        Reactive oxygen species 
SDS        Sodium dodecylsulfate 
Sm        Streptomycin sulfate 
SOEing PCR      Splicing by overlap extension PCR 
SQR        Succinate dehydrogenase, complex II 
TBE        Trisboric acid EDTA 
TBS        Tris buffered saline 
TBS-TT      TBS Triton Tweem   
TEMED      N, N, N`, N`-Tetramethylethylendiamin 
TMBZ        3,3`5,5`-Tetramethylbenzidin  
TNM        Tris-sodium chloride magnesium chloride 
Tris        Tris-(hydroxymethyl)-aminomethane 
UHDBT      5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole 
UQ6        Ubiquinone 6  
V        Volt 
w/w        Weight/weight 
w/v        Weight/volume 
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